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ABSTRACT 
 
 
Most drugs have a considerably low solubility in the environmentally friendly 
hydrofluoroalkane propellants (HFAs) currently used in pressurized metered 
dose inhalers (pMDIs). As a consequence, instability can occur from crystal 
growth and Ostwald ripening of the system altering the therapeutic performance 
of the pMDI. Understanding and being able to predict the behaviour of such 
drugs in the propellant will help in selecting the correct co-solvents and/or 
surfactants to increase the stability of such formulations. When anhydrous 
beclomethasone dipropionate (BDP) is suspended in 
tricholoromonofluoromethane (CFC-11) rapid crystal growth occurs, leading to 
the formation of a clathrate. Since chlorofluorocarbon (CFCs) propellants have 
been replaced by HFAs, many questions arose concerning the ability of BDP to 
form clathrates in the HFA and any stability issues that arise from such 
reformulation. Clathrates are crystalline compounds consisting of a lattice of one 
typH RI PROHFXOH WKDW KRVWV D VHFRQG W\SH RI ³JXHVW´ PROHFXOH ZLWKLQ LWV
structure. Since the solid state chemistry can significantly alter the physical 
interactions within a suspension formulation, it is crucial to determine the most 
stable crystalline form in the presence of the propellant. 
 
Successful formation of BDP CFC-11 clathrates were observed in this work as 
well as positive outcomes in terms of reduction in the surface energy and the 
force of adhesion within a model pMDI formulation (even after processing i.e. 
size reduction). Following this, HFA-134a and 227-ae were selected to 
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determine any potential clathrate formation and to monitor their stability within a 
pMDI formulation. The focus of this project was to determine the stability of 
BDP and budesonide in HFA propellants, as well as the appropriateness of each 
formulation for pMDI use. This project considered the potential use of 
complementary surface and solid-state analytical tools to provide fundamental 
understanding of clathrate formation and their physicochemical characteristics. A 
special interest in understanding the fundamentals behind the process of Ostwald 
ripening, a process that affects drug particle size and their related stability and 
hence ultimately dose consistency was also considered. Atomic force 
microscopy (AFM) was used in order to determine its applicability in studying 
Ostwald ripening and surface activity of the different APIs in model propellant. 
Furthermore, the effects of a range of parameters that included storage time, co-
solvents and surfactants on Ostwald ripening were taken into account. 
 
The work presented in this thesis has demonstrated that the formation of a 
propellant clathrate is favourable for APIs that to improve formulation stability 
through a reduction in particle surface energy. However, isolation and full 
characterisation of such HFA clathrates remains challenging due to their 
decreased stability when removed from the high pressure media of the pMDI 
device. This thesis shows that a combination of co-solvent and surfactant 
provides an effective reduction in instabilities due to Ostwald ripening of the 
pMDI formulation and a better control of particle size of the APIs within the 
formulation. This work provides a platform for future formulation development 
for pMDIs..  
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1 Chapter 1 Introduction 
 
 
1.1 General Introduction 
 
Inhaled medications have been in clinical use since earliest days of medical 
history. Their origin can be traced back 4000 years ago to India, where the leave 
of the Atropa Belladonna plant were smoked to suppress cough. In the 19th and 
early 20th centuries, cigarettes that contained stramonium powder mixed with 
tobacco were used to treat the symptoms experienced by asthmatic patients 
(Labiris and Dolovich, 2003b) and medication was added to boiling water for 
patients to breathe which showed to be quite effective. However, since this time, 
formulations and delivery devices of medications for inhalations have 
continually evolved (Anderson, 2001). Currently, the pulmonary route is widely 
accepted as being the optimal route for the first line the management of 
respiratory tract diseases such as asthma and chronic obstructive pulmonary 
disease (COPD) (Labiris and Dolovich, 2003a). Different devices have been 
developed in order to achieve effective delivery of active pharmaceutical 
ingredient (API) which are nebulizers, dry powder inhalers (DPIs) and 
pressurized metered dose inhalers (pMDIs) (Labiris and Dolovich, 2003b). 
Pressurized metered dose inhalers (pMDIs) are the most common devices used 
around the world for therapeutic aerosol delivery. pMDIs are believed to have an 
80% market share of all inhaled therapeutic devices (Brindley, 1999). These 
devices operate by the emission a drug aerosol, driven by propellant in the case 
of pMDI that the patient is able to inhale and will be deposited into the lung 
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(Labiris and Dolovich, 2003b). The advantage of pulmonary delivery of drugs is 
that it provides higher drug concentrations delivered to the desired site of action 
which provides rapid clinical response. Furthermore, it minimizes the risk of 
systemic side effects that are usually associated with oral delivery which results 
in a decrease in patient morbidity and mortality along side with an increase in the 
patient quality of life (Labiris and Dolovich, 2003b). Due to all these advantages, 
a growing attention has been given to pulmonary drug delivery as a non-invasive 
administration for systemic delivery of therapeutic agents such as peptides and 
proteins for the treatment of for example, diabetes (Frijlink and DeBoer, 1994, 
Anderson, 2001).  As a result of this, many efforts have focused towards the 
development of new inhaler devices that will make it possible to deliver larger 
drug doses to the airways to achieve greater deposition efficiency (Labiris and 
Dolovich, 2003a). 
 
Compared to other routes of delivery, pulmonary delivery of drugs has certain 
advantages. One of the major advantages is that it is very convenient to patients 
as most of the devices available are portable hand-held systems that are relatively 
easy to use (Fink, 2000). Furthermore, it is a non-invasive method for drug 
delivery and provides a needle-free delivery system for the treatment of systemic 
diseases (Labiris and Dolovich, 2003a).  The lung offers a large absorptive 
surface area (up to 100 m2) with an  extremely thin (0.1 µm ± 0.2 µm) absorptive 
mucosal membrane and good blood supply (Patton, 1996). Thus an API can be 
delivered directly to the lungs for the treatment of respiratory disorders such as 
asthma, COPD and cystic fibrosis (Anderson, 2001). The thin layer of epithelial 
cells present in the lungs can allow for drug absorption from the lungs into 
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systemic circulation. The advantages of this include rapid onset of action and 
avoidance of first-pass metabolism by the liver and poor gastrointestinal 
absorption (Byron and Patton, 1994). Furthermore, the lung provides a low 
enzymatic environment and high solute permeability. Moreover, delivering of 
smaller doses to provide good therapeutic effect decreases the likelihood of 
unwanted side effects induced by using larger doses for systemic drug exposure.  
Also, the pulmonary route can be considered a potential delivery method of large 
molecules with very low absorption rates as these can be absorbed in significant 
quantities due to lung periphery providing prolonged residency (Dolovich, 
1997). Furthermore, it will provide better drug delivery since oral administration 
of these macromolecules is difficult due to their poor intestinal membrane 
permeability and susceptibility to enzymatic degradation (Shoyele and 
Cawthorne, 2006). Also, inhaler therapy can be used for the specific targeting of 
specific lung cells in order to treat more localized diseases such as in the 
treatment of tuberculosis (Chellat et al., 2005). 
 
1.1.1 Chapter Aims and Objectives 
 
This chapter aims to give the reader an understanding of the issues surrounding 
pulmonary disorders and the general requirement for an effective drug delivery 
to the lung alongside the requirements of an inhaled delivery system as an 
effective and efficient therapeutic vehicle. In order to understand the importance 
of these devices in achieving a therapeutic effect, it is crucial to give a reader an 
appropriate background on the physiology and function of the lung. A short 
overview about the disorders affecting the lung as well as the treatments 
Chapter 1 ± Introduction 
 
 4 
available including the different inhaled delivery systems used nowadays will be 
covered. Particular attention will be given to pMDI devices, as these will be the 
focus of this project. Subsequently, the propellants commonly used in pMDI 
systems will be discussed. A particular focus will be made on the shift from 
ozone depleting propellant to the more environmentally friendly ones as this has 
raised stability issues with different APIs. Studies examining clathrate formation 
and assessing Ostwald ripening within a pMDI system will be reviewed. The use 
of atomic force microscopy (AFM) in determining the physico-mechanical 
properties of the APIs and surface-surface interactions within a pMDI 
formulation will be the main focus in studying pMDI formulation stability. 
Finally a general outline of the project will be given in terms of each chapter.  
 
1.2 Physiology and Function of the Respiratory Tract 
 
The lungs constitute an attractive route for drug delivery due to its advantages 
for both systemic and local applications as well as its non-invasive nature (Sung 
et al., 2007). The respiratory system works with the circulatory system to deliver 
oxygen from the lungs to the cells and remove carbon dioxide that is produced 
from cellular function and is returned to the lungs to be exhaled as a waste 
product (Smola et al., 2008).  
 
The respiratory system consists of all the organs involved in breathing. It 
includes the respiratory airways leading into the lungs, the lungs and the 
structures of the thorax involved in producing movements of the air through the 
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airways into and out of the lungs (Sherwood, 2008). It can be divided into 3 main 
parts (Fig. 1-1): 
 
 The upper respiratory tract, consisting of the nose, nasal cavity and the 
pharynx (Sherwood, 2008, Smola et al., 2008). 
 The lower respiratory tract consisting of the larynx, trachea and bronchi. 
 The lungs, which contain the respiratory bronchioles, alveolar ducts, 
alveolar sacs and alveoli. 
 
When breathing, air enters through the nose and mouth and travels down the 
pharynx through the larynx and into the trachea before entering the lungs 
(Marieb and Hoehn, 2007, Sherwood, 2008). Therefore, the upper respiratory 
system is very important in providing air conditioning and air conduction as well 
contributing to the olfactory and speech function (Marieb and Hoehn, 2007). The 
lower respiratory system gives structural support and protection against inhaled 
particles as well as playing the major role in gas conduction and exchange at the 
alveolar region. The trachea, which begins at the edge of the larynx, divides into 
two bronchi and continues into the lungs. The bronchi themselves divide into 
smaller bronchioles which branch in the lungs forming passageways for the air 
that end with the alveolar sac where gases are exchanged between the air and 
blood (Bailey and Berkland, 2009). The alveoli are the functional units of the 
lungs and they form the site of gaseous exchanges (Marieb, 2005). The 
conducting airways are lined with ciliated columnar epithelium, which transition 
to a cuboidal shape approaching the distal airways.  The bronchial airways lumen  
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Figure 1-1: Diagram of the respiratory tract (Virtualmedicalcentre.com, 2010). 
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is covered with a thin layer of lumen (0.1 µm) that helps entrapment of inhaled 
particles.  
 
At this area, the rhythmic beating of the celia cells helps moving the mucus up to the 
throat where it is swallowed. This process is known as the mucuscilary clearance 
and is a crucial method in the removal of inhaled particles from the respiratory 
system (Bailey and Berkland, 2009). 
 
The combination of the large surface of the lungs that is greater than 100 m2 
which contains a high number of alveoli (approximately 300 million) with the 
very thin alveolar epithelium that have an extremely thin barrier of 0.1 µm 
between the pulmonary lumen and the capillaries, creates an excellent condition 
for efficient exchange between the external environment and the systemic 
circulation (Smola et al., 2008, Bailey and Berkland, 2009). The alveolar surface 
is composed of several types of pulmonary cells: Type I pneumocytes (small 
type A) are non-phagocytic and share a basement membrane with the pulmonary 
capillaries. Attached to the basement membrane are the larger alveolar cells (type 
II) that are responsible for producing the pulmonary surfactant fluid that lines the 
lung that is essential in alveolar repair and prevents alveolar collapse (Smola et 
al., 2008, Bailey and Berkland, 2009). The alveoli also contain macrophages 
which are phagocytic cells that are responsible for cleaning larger bodies and the 
removal of inhaled foreign particles (Bailey and Berkland, 2009). 
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1.3 Pharmacological Basis of Management of respiratory Tract 
Disorders 
 
Pulmonary respiratory disorders include asthma, COPD and cystic fibrosis. The 
goals of treatment of these diseases are to improve the respiratory function and 
prevent any complications such as viral or bacterial infections. In the case of 
asthma, the treatment is divided into relief of symptoms which is achieved by 
bronchodilators which may reverse the early phase of asthma and prevention by 
using an-inflammatory agents (Randall and Neil, 2003). Bronchodilators include 
ȕ2-adrenoceptor agonists, muscarinic M-receptor antagonists and xanthines. 
Anti-inflammatory agents include corticosteroids. The focus on this project will 
be on corticosteroids. However, a brief description about the other APIs used in 
the treatment of asthma will be given. 
 
 ȕ2-adrenoceptor agonists 
7KHVHDUHWKHDJHQWVRIILUVWFKRLFHDQGDFWRQȕ2-adrenoceptor on the bronchial 
smooth muscle to increase cyclic adenosine monophosphate (cAMP), leading to 
rapid bronchodilations and reversal of the bronchospasms associated with the 
HDUO\SKDVH7KHUHDUHWZRW\SHVRIȕ2-adrenoceptor agonists. Short acting agents 
such as salbutamol and terbutaline which are used to relief the symptoms in the 
HDUO\ SKDVH DQG ORQJ DFWLQJ ȕ2-adrenoceptor agonists such as formoterol and 
salmeterol which cause a prolonged and persistent bronchodilation and are used 
for prevention (Asthma, 2009). 
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 Muscarinic M-receptor antagonists 
These agents such as ipratropium act by blocking the parasympathetic mediated 
bronchoconstriction with only limited side effects (Randall and Neil, 2003, 
Asthma, 2009). 
 
 Anti-inflammatory agents -  Glucocorticosteroids 
Glucocorticoids have an anti-inflammatory action via activation of intracellular 
receptors, leading to altered gene transcription. This results in decreased cytokine 
production and the synthesis of lipocortin, which inhibits phospholipase A2, and 
the production of the prostaglandins and leukotrienes (Asthma, 2009). 
Furthermore, they inhibit the influx of eosinophils into the lungs induced by 
allergen contact. Two glucocorticoids were used in this project and are detailed 
below: 
 
¾ Beclomethasone Dipropionate 
Beclomethasone dipropionate is a potent glucocortecoid used for the control of 
bronchial asthma in persons requiring continuous treatment. It is usually 
SUHVFULEHG ZLWK D VKRUW DFWLQJ ȕ2 agonist. It is used in a number of inhalation 
devices either as a suspension or a dry powder e.g. Beclozane® and Pulvinal® 
(BNF, 2009). Beclomethasone dipropionate is also used in oral therapies for the 
treatment of ulcerative colitis and as nasal sprays for the treatment of allergic and 
vasomotor rhinitis (BNF, 2009). Beclomethasone dipropionate undergoes 87% 
protein binding following conversion from a dipropionate to a monopropionate; 
it is metabolised via the hepatic route by esterase enzymes. It has a half life of 
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2.8 hours. However, the excretory route has not been characterised (British 
Pharmacopoeia, 2010). 
 
 
 
Figure 1-2: Chemical structure of beclomethasone dipropionate. 
 
¾ Budesonide 
Budesonide is prescribed for the prophylaxis treatment of asthma and the 
management of chronic asthma. It is formulated as an aerosol inhalation such as 
Pulmicort® or as a dry powder inhaler such as in Novolizer® (BNF, 2009). It is 
also used in oral therapy for the treatment of inflammatory bowel disease.  
Budesonide undergoes 85-90 % protein binding. It is metabolised by the hepatic 
route and is excreted in the urine and the faeces (British Pharmacopoeia, 2010). 
 
 
 
Figure 1-3: Chemical structure of budesonide. 
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1.4 Methods of Drug Delivery to the Lungs 
 
The development of an efficacious inhalation thereby not only depends on the 
active pharmaceutical ingredient, but also on its formulation and a well designed 
delivery systems. At present, there are three different types of inhaler devices 
that are used for drug delivery to the lung: dry powder inhalers (DPIs), 
nebulisers and pressurised metered dose inhalers (pMDIs). A particular focus 
will be given to pMDI as this is the device that is dealt with in this project. 
 
1.4.1 Dry Powder Inhalers (DPIs) 
 
DPIs have seen an increased interest in the recent past due to their propellant free 
nature, high patient compliance, high dose capacity and drug stability (Chougule 
et al., 2007). DPIs (Fig. 4-1A) are devices that are used to deliver a dry powder 
formulation of an active drug for local or systemic effect via the pulmonary 
route. DPIs are formulated either as loose agglomerates of micronized drug 
particles or as carrier-based interactive mixtures where drug particles are adhered 
to the larger surface of carrier particles (Islam and Gladki, 2008). The medication 
is commonly held either in a capsule for manual loading or a proprietary form 
from inside the inhaler. DPIs were designed to eliminate the co-ordination 
difficulties experienced by the patients when using other devices such as pMDIs. 
However, DPIs are designed to maximise drug delivery at a relatively high 
inspiration rate which make them difficult to use for young children or patients 
with severely compromised airways. Therefore, their efficiency may vary 
between patients (Virchow et al., 2008). DPIs lung deposition varies among the 
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Figure 1-4: Schematic diagram of A- Dry powder inhaler (DPI) B- Nebulizer and C- pressurized metered dose inhaler (pMDI) 
 
A B C 
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different DPI devices and is estimated to approximately 12-40% of the emitted 
dose delivered to the lungs with 20-25% of the dose still retained within the 
device (Labiris and Dolovich, 2003b). 
 
1.4.2 Nebulisers 
 
Nebulisers (Fig. 1-4B) have been used for many years to treat cystic fibrosis, 
asthma and other respiratory diseases. There are two basic types of nebulisers, jet 
and ultrasonic nebulisers which are non propellant alternatives for the delivery of 
inhaled therapeutics (Geller, 2005). They operate by pumping air or oxygen 
through a liquid formulation, which creates a vapour ready for inhalation by the 
patient. Nebulisers do not require a coordinated breathing manoeuvre or a strong 
respiratory effort; therefore, they can be used at any age, and for any disease 
severity or acuity (Anderson, 2001). Moreover, it is possible to mix more than 
one medication in a nebuliser and deliver them simultaneously as well as with 
very high drug doses. However, nebulisers are more time consuming than a DPI 
or an MDI with a large amounts of drug wastage of around 50% loss with 
continuously operated nebulisers (Labiris and Dolovich, 2003b). The physical 
properties of drug formulations such as viscosity, ionic strength, pH may prevent 
the nebulisation of some formulation and have an effect on the nebulisation rate 
and particle size (Labiris and Dolovich, 2003b). The nebulisers available in the 
market are quite expensive and larger in size than the portable DPI and MDI 
devices, however they are starting to become cheaper and more portable (Geller, 
2005). 
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1.4.3 Pressurised Metered Dose Inhalers (pMDIs) 
 
pMDIs are the most widely used device for drug delivery to the lungs. Over 70 
million patients in the world use them (Terzano, 2001). The popularity of pMDIs 
with patients is due to their small size, portability, ease of use and low cost 
(Geller, 2005). However, the technique and coordination required for efficient 
MDI use can make it the most difficult of all the aerosol devices (Fink, 2000). 
 
Little development has occurred on pMDIs since they were first discovered in 
1950s (Terzano, 2001). The first pMDI was developed by Riker Laboratories 
(now owned by 3M Healthcare Ltd) after a suggestion from the 13-year-old 
daughter of Riker to change her leaky hand bulb nebuliser into a spray-can like 
the ones used for perfumes and hair sprays. The first pMDI prototype was made 
using empty soda bottle as a pressure container and a bottle capper containing a 
propellant and alcohol to dissolve the drug (Fink, 2000, Terzano, 2001). 
Nowadays, a pMDI is typically a pressurised canister containing a mixture of 
propellants, surfactants and co-solvents with approximately 1% of the total 
contents being active drug (Fink, 2000). The mixture is released from the 
canister through a metering valve and stem that fits into an actuator boot (Fig. 1-
4C) (Clark, 1996). There are two types of pMDI, relating to their formulation 
characteristics ± solution pMDIs where the API is dissolved in the propellant and 
suspension pMDIs where an API-propellant suspension exists (Terzano, 2001). 
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1.5 Propellants, Co-solvents and Surfactants Used in pMDI 
Formulation 
 
Historically, pMDIs have used chlorofluorocarbons (CFCs) propellants as the 
energy source needed to disperse the formulation into respirable drug particles 
(Stein and Stefely, 2003). CFCs were used  due to their chemical inertness, high 
vapour pressures and low toxicity (Smyth, 2003). CFC-containing formulations 
in general had the characteristics to produce effective aerosols for lung delivery. 
However, because of their potential zone deleting effect, CFCs have been banned 
as per the Montreal Protocol (Labiris and Dolovich, 2003b). The Montreal 
protocol was implemented in 1996 after evidence that CFCs were contributing to 
the ozone depletion which led to a ban of all common aerosols products using 
CFCs (Molina and Rowland, 1974). However, the Montreal Protocol still permits 
the use of CFCs under special circumstances where there are no alternative 
substitutes, if it crucial and necessary for the health and safety and if it is crucial 
for the normal functioning of the society (McDonald and Martin, 2000). The 
search for possible replacements for CFCs for pMDI was defined in terms of 
toxicity, flammability, chemical stability and physical properties as well as 
environmental compatibility. CFC-11, 12 and 114 (Fig. 1-5), the propellants that 
were already in use were taken as a template in order to synthesise newly 
emerging hydrofluoroalkane propellants (HFAs). 
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Figure 1-5: The chemical structures of common CFC and HFA propellants 
 (Vervaet and Byron, 1999). 
 
1.5.1 Hydrofluoroalkanes (HFAs) 
 
Two propellants found to be effective substitutes for CFCs are 
hydrofluoroalkanes in nature (HFAs): tetrafluoroethane (HFA-134a) and 
heptafluoroethane (HFA-227) (Fig. 1-5) (Anderson, 2001). HFAs do not contain 
chlorine and thus have no ozone-depleting potential (Labiris and Dolovich, 
2003b). Furthermore, HFAs are non-flammable and chemically stable propellant 
with suitable vapour pressures for pMDI use. HFA and CFC propellants possess 
different physical and chemical properties and are generally poor solvents for 
many anti-asthma drugs and excipients currently used in pMDIs (McDonald and 
Martin, 2000),  thus the substitution to HFAs propellant changed the properties 
of some of the drugs delivered by CFC propellant systems and required 
reformulation of the drugs (Terzano, 2001).  
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The physical properties of the propellant (Table 1-1) can be related to details of 
the chemical structure and experimental investigations of propellant 
physicochemical behaviour. HFA 134a and 227 both have high vapour pressures 
and low boiling points (Vervaet and Byron, 1999).  These properties are caused 
due to the enhanced electronegativity of the HFA molecules which created a 
distinct dipole on the hydrogen-carbon bonds in both propellants. These 
characteristics not only affect the physicochemical properties of the HFA 
propellants but also their water solubility as shown in Table 1-1 (Vervaet and 
Byron, 1999). The water solubility data indicates a very significant difference 
between CFC and HFA propellants which is due to the hydrofluoroalkane 
SURSHOODQWV¶ HOHFWURSRVLWLYH SURWRQV. These proton(s) act as sites for solute-
solvent dipole-dipole attractive interactions which is carried through into HFA-
ethanol blend. This implies that the dipolar interactions between HFAs and 
ethanol were not capable of completely displacing the HFA-water interactions in 
the liquid formulation (Vervaet and Byron, 1999). Therefore, this results in 
higher ingress rates of water into HFA formulation which may decrease in the 
IRUPXODWLRQ¶V VKHOI-lives and decrease product stability due to physical and 
chemical degradation (Williams, 1998). Thus the solvent properties of these 
propellants must be taken into account when moving from a CFC formulation to 
a HFA one especially when these are used with other co-solvent and other 
surfactants. 
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Table 1-1: Physicochemical properties and water solubility of the different pMDI propellants (adapted from (McDonald and Martin, 2000, Smyth, 2003)). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
N/A: Not Applicable 
 
Property CFC-11 CFC-12 CFC-114 HFA-134a HFA-227ae 
Boiling point (°C) 24 -30 4 -26 -16 
Vapour pressure (kPa) 89 566 182 572 390 
Density (g/cm3) 1.49 1.33 1.47 1.23 1.42 
Viscosity (mPa.s) 0.43 1.33 1.47 1.23 1.42 
Water solubility (pure propellant) (ppm) 100 N/A 91 610 2220 
Water solubility (propellant containing 
10% (v/v) Ethanol) (ppm) 
N/A 9900 N/A 11000 13500 
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1.5.2 Surfactants and Co-solvents 
 
Surfactants were traditionally used in CFC-based pMDIs for several reasons 
such as to stabilize the formulation and also to help solubilise drug and prevent 
crystal growth during the storage period in solution formulations (Smyth, 2003). 
Furthermore, surfactants were incorporated in CFC pMDIs in order to improve 
valve lubrication during the depression and release cycle associated with 
container emptying (Vervaet and Byron, 1999). Several surfactants are currently 
approved for use in pMDIs including oleic acid, sorbitan trioleate, and soya 
derived lecithin (McDonald and Martin, 2000). These surfactants are highly 
soluble in CFC but are not soluble in HFAs, hence, the requirement of a co-
solvent to dissolve the surfactants in the HFA propellants (Vervaet and Byron, 
1999). However, other approaches where adopted in which suspension 
formulations were developed where no other excipients were used other than the 
propellant (Cripps et al., 2000). 
 
Ethanol is one of the most commonly used co-solvents in pMDI formulation. It 
is used in order to help lower the vapour pressure of HFA propellants which is 
required to produce smaller, more respirable drug fractions (Leach, 2005). 
However, ethanol can decrease the volatility and stability of the formulation 
which will have an effect of the efficiency of drug delivery (Stein and Stefely, 
2003). Furthermore, ethanol can enhance the solubility of certain APIs which can 
lead to an increased crystal growth in some HFA systems (William III et al., 
1999). Crystal growth in propellants may become a problem as it may involve a 
change of the physical form of the drug, modify the drug surface characteristics 
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which tend to retard the rate of dissolution (Vervaet and Byron, 1999). 
Moreover, the use of ethanol can increase the rate of Ostwald ripening, which is 
a phenomenon that arises due to surface area favouring dissolution of smaller 
micronized particles and drug recrystallization on larger particle (Vervaet and 
Byron, 1999, Smyth, 2003). This phenomenon will be discussed further in the 
next sections. A consequence of particle size changes is a general reduction in 
the stability and shelf life of the formulation as well as irregularities in the 
emitted doses due to the entrapment of the API in the pMDI device and hence 
affecting the amount of drug reaching the patient (Smyth, 2003). Ethanol also 
increases the chances of water ingress into the formulation. Water shows a high 
affinity to HFA propellants due to the presence of electropositive proton(s) as 
site for solute-solvent dipole-dipole attractive interactions which will result in a 
decreased solubilisation of the surfactant leading to a phase separation and 
precipitation of the drug (Vervaet and Byron, 1999, Smyth, 2003). 
 
1.6 pMDI Formulation and Stability Issues 
 
The use of co-solvents in HFA formulations is not always possible as these may 
trigger adverse effects in the formulation, such as a decrease in chemical and 
physical stability. Co-solvents may also lead to an increased tendency to crystal 
growth via Ostwald ripening. Changes in particle size distribution of aerosolized 
particles have an effect on the deposition profile in the lung following inhalation. 
Large particles of 5-ȝPZLOOWHQGWREHGHSRVLWHGLQWKHPRXWKDQGWKHXSSHU
airway, while intermediate particle of 3- ȝP travel further down the airways 
and reach the bronchi and bronchioles. However, smaller particles of less than 
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 ȝP PLJKW IDLO WR EH GHSRVLWHG LQ WKH GHHS Oung due to being exhaled. 
Therefore, determining pMDI formulation stability is crucial as this will have an 
impact on dose uniformity and hence influence the dosage received by the 
patients.  
 
1.6.1 Clathrates 
 
Clathrates are a class of inclusion compound that generally consist of two 
molecular species that arrange themselves in space so that one molecule (host) 
entraps another molecule (guest) (Englezos, 1993). The host molecules are 
usually linked through hydrogen bonding to form a regular 3D structure from 
connected network (Plumridge and Waigh, 2002) and create cavities (host 
lattice) that can enclose a large variety of particles (guests) (Englezos, 1993).  
 
1.6.1.1 Structural and Physicochemical properties of Clathrates 
 
Clathrates are inclusion compounds of a guest molecule in a host lattice. The 
hypothetical lattice formed by the host molecules is known as the empty lattice. 
The formation of the lattice is due to the hydrogen bonding of the host molecules 
forming a network of polyhedral cavities (Englezos, 1993, Koh, 2002). The 
unfilled structure is thermodynamically unstable and is rendered stable when 
entrapping a molecular species under suitable pressure and temperature 
conditions (Englezos, 1993). Guest molecules occupy fully (hydrogen bonded to 
the host lattice) or partially the cages in the host framework made up of the host 
molecules (Patchkovskii and Tse, 2003). The thermodynamic stability of a 
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clathrate depends strongly on the size and shape of the guest molecules (Buffett, 
2000). The guest molecules must be small enough to fit into the empty lattice but 
need to be large enough to provide stability to the structure (pseudo-close 
packing) (Buffett, 2000). The polyhedral cavities enclathrate small molecules, 
usually non-polar in nature (Plumridge and Waigh, 2002). 
 
1.6.1.2 Kinetics of Clathrate Formation 
 
The most challenging questions regarding clathrates concern the kinetic of their 
formation. Two fundamental questions have to be answered in the process of 
clathrate formation concerning the formation and the dissociation of these latter 
as well as the time it takes to start their formation at a certain temperature and 
pressure (Englezos, 1993, Dendy Sloan, 1998). The process of clathrate 
formation involves nucleation and growth. Nucleation has a key role in the 
crystallization and the stabilisation of clathrate (Rodriguez-Spong et al., 2004). 
Following this, a growth period might be associated with the formation of the 
first crystals (Englezos, 1993).  
 
1.6.1.2.1 Clathrate Nucleation 
 
In the first stage of clathrate formation, small clathrate crystals (i.e. nuclei) grow 
and disperse to achieve critical size for continued growth (Dendy Sloan, 1998). 
This stage is known as the nucleation process.  Nucleation mechanisms can be 
divided into two main categories: homogeneous and heterogeneous nucleation 
(Rodriguez-Spong et al., 2004).  
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Homogeneous nucleation 
Homogeneous nucleation involves the collision of many molecules 
simultaneously that will lead to a solidification in the absence of impurities 
(Dendy Sloan, 1998). During nucleation, a particle may either grow or dissolve 
depending on its radius until a critical size is reached (Fig. 1-6). When a particle 
attains a critical size, growth occurs.   
 
 ¨G
¨G*
Surface Energy 
Free Energy 
Change 
Work of Nucleation
Radius (r) 
r *
 
Figure 1-6:  Homogenous nucleation: Any nuclei with a radius  r>r* will grow while any nuclei 
with a r<r* will dissolve. 
 
The thermodynamics of nucleation can be described by Gibbs free energy 
analysis in the following equation 1-1: 
 
¨* ¨H - 7¨6
   
    Equation 1-1 
 
:KHUH¨G LVWKHIUHHHQHUJ\FKDQJHDVVRFLDWHGZLWKWKHSKDVHWUDQVLWLRQDQG¨S 
is the entropy and ¨H is the enthalpy and T is the temperature (Rodriguez-Spong 
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et al., 2004). The rate of nucleation can be controlled by, molecular or ionic 
transport, viscosity, supersaturation, solubility, solid-liquid interfacial tension, 
and temperature (Rodriguez-Spong et al., 2004). Any increase in solubility will 
lead to an increase in the nucleation rate. This is due to a decrease in the 
interfacial energy and an increase the potential molecular collisions (Rodriguez-
Spong et al., 2004). 
 
Heterogeneous nucleation 
Heterogeneous nucleation occurs due to the presence of a foreign particle or a 
surface that will promote nucleation(Dendy Sloan, 1998). The reactivity of solid 
surfaces as heterogeneous nucleants has significant consequences on the 
isolation of the desired solid-state (Rodriguez-Spong et al., 2004), since the 
foreign surface effectively lowers the free energy required for suitable growth 
(Dendy Sloan, 1998).  
 
Nucleation times are stochastic and cannot theoretically be determined 
(Englezos, 1993). Formation of  a clathrate typically occurs as heterogeneous 
nucleation at the vapour-liquid-interface, not only because the interface lowers 
the Gibbs free energy of nucleation, but also because the interface is the location 
of the required very high concentrations of host and guest molecules (Dendy 
Sloan, 1998). 
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1.6.1.2.2 Clathrate Growth 
 
For the formation of a clathrate crystal, first the host matrix needs expansion and 
secondly the guest molecule must be incorporated into the cavities (Logvinenko 
et al., 2007). The first stage is an exothermic process, where there is a decrease 
in the entropy system, while the second stage is endothermic and leads to an 
increase in the entropy of the system (Logvinenko et al., 2007).  
 
Barrer and Ruzicka suggested that growth rates were controlled by transport of 
the guest molecules to the surface of the clathrate (Barrer and Ruzicka, 1962a, 
Barrer and Ruzicka, 1962b, Dendy Sloan, 1998). Also, Graauw and Rutter 
determined that interfacial mass transfer was a rate limiting for step for clathrate 
formation and growth (Graauw and Rutten, 1970, Dendy Sloan, 1998).  Englezos 
et al. based their clathrate model on homogeneous crystallisation that described 
growth throughout the bulk and not only restricted to the vapour-liquid interface 
as in heterogeneous nucleation. This model describes the initial growth period 
typically to be less than two hours (Englezos, 1993, Dendy Sloan, 1998). On a 
molecular level, clathrate growth can be considered to be a combination of two 
factors: 1) the kinetics of crystal growth at the clathrate surface and 2) mass 
transfer of components to the growing crystal surface (Dendy Sloan, 1998). 
Clathrate crystal growth occurring in the liquid phase is a first order irreversible 
homogeneous reaction (Koh, 2002). Rate of clathrate crystal nucleation and 
growth as well as their structural morphology is affected by supercooling, 
pressure and temperature, composition, and state of the clathrate-forming system 
(Englezos, 1993).  
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No models exist of the kinetic rate for clathrate growth, independent of mass 
transfer effects. All models of clathrate growth data have ignored heat transfer 
and assumed constant temperature systems (Dendy Sloan, 1998). 
 
1.6.1.2.3 Clathrate Inhibition and Decomposition 
 
Clathrate dissociation has only been determined and measured using thermal 
simulation (Englezos, 1993, Dendy Sloan, 1998). However, quantification 
studies using depressurisation as a mean of decomposing the clathrate is under 
investigation. In the thermal simulation studies of clathrate decomposition, 
pressure was kept constant and heat was applied in order to dissociate the 
clathrate structure (Dendy Sloan, 1998). The dissociation process of clathrates 
can divided into two different stages: 1) the removal of the guest molecule and 2) 
the collapse of the empty matrix (Logvinenko et al., 2007). Thermodynamically, 
the first stage is endothermic where entropy of the increases, while the second 
stage is an exothermic process, and the system entropy decreases (Logvinenko et 
al., 2007). The model for thermal simulation of clathrate dissociation assumes an 
instantaneous decomposition limited only the rate of heat transfer (Logvinenko 
et al., 2007). 
 
1.6.1.2.4 Clathrate Stability 
 
It is useful to know to what extent the guest-host molecule interaction 
contributes to the stability of clathrates (Schober et al., 2003). Clathrate are 
unstable and tend to dissociate rapidly from the cage like structure (Beauchamp, 
2004). The addition of one or more guest molecules within the cavity can 
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stabilize the structure (Beauchamp, 2004). The guest molecules prevent the 
collapse of the open framework structure at higher temperatures due to their 
excluded-volume effect (Schober et al., 2003), and any removal needs structural 
reorganisation (Logvinenko et al., 2007). In fact, the interactions lower the free 
energy of the host molecules, making the clathrate structure stable when a 
sufficient number of cavities are filled (Buffett, 2000).  The reduction in free 
energy of the host molecules depends only on the occupancy of the small and 
large cavities (Buffett, 2000). Ab initio geometry optimisation has been used to 
determine the effect of guest molecules on the stability of the clathrates and has 
shown that  the guest atoms act as spacers preserving initial cage structure and 
that the specific configuration of a given cluster influences its stability (Schober 
et al., 2003).  
 
1.6.2 Ostwald Ripening 
 
The delivered dose and aerodynamic size distribution from a pMDI may change 
as a function of the number of doses used by the patient and storage time.  Over 
longer storage times, changes in temperature and humidity may cause an increase 
in water content inside the containers. Such water ingress may cause aggregation 
of the suspension as well as crystal growth inside the pMDI due to the increased 
solubility of the APIs. This effect leads to changes in dose uniformity (Vervaet 
and Byron, 1999).  
 
Crystal growth in the suspension is thermodynamically inevitable and, if 
uncontrolled, it may affect the emitted aerodynamic size distribution. This 
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phenomenon is of  Ostwald ripening is due to entropy favouring the dissolution 
of micronized particles to contribute to the growth of a small number of larger 
more-ordered clusters. To avoid this, ideally, pMDI suspension should be 
formulated with drug substances which are insoluble in the continuous phase. 
However, if partially soluble micronized drugs are utilised, the addition of 
surfactants and co-solvents should be considered in order to reduce dissolution 
and drug solubility (Vervaet and Byron, 1999).  
 
Ripening means that one single particle is growing at the expense of dissolving 
smaller particles. Therefore, clusters are either growing or dissolving at rates 
depending on their size as determined by the Kelvin equation (Equation 1-2) 
(Madras and McCoy, 2001). The competing growth and dissolution processes for 
a large and small clusters will lead to an increase in the size of large particles  
while smaller particles dissolve, and dissolution that decreases the number of 
clusters (Madras and McCoy, 2002b). The growth rate of a precipitate particle 
may be separated into two processes: First the transportation of molecules to the 
interface, which is controlled by diffusion of molecules through the solution to 
react at the cluster surface or rate of any stirring (Marqusee, 1983). The second 
stage is the incorporation of monomers into the precipitate particle that is driven 
by the surface free energy of the colloidal particle (Marqusee, 1983).  
 
    
Equation 1-2 
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Where p is the actual vapour pressure, p0 LVWKHVDWXUDWHGYDSRXUSUHVVXUHȖLVWKH
surface tension, Vm is the molar volume, R is the universal gas constant, r is the 
radius of the droplet, and T is temperature. 
 
The three basic processes in condensation (e.g.: vapour to liquid, liquid to solid) 
phase transition are nucleation, growth and ripening (Madras and McCoy, 
2002c). These three processes are not really distinguishable, as they overlap 
during the evolution from a supersaturated phase to a single condensed ripened 
particle in equilibrium with a non-condensed phase. During nucleation, a new 
phase is formed out of a metastable phase, generating a large number of particles 
with a narrow distribution of sizes (Marqusee, 1983). The second stage consists 
of nuclei growing rapidly at the expense of the initial phase. Small particles 
generated in the nucleation phase may cause deposition on the nuclei and cause 
growth of clusters (Madras and McCoy, 2002c). Therefore, nucleation without 
accompanying growth is impossible (Madras and McCoy, 2002c). The 
nucleation phase is close but not equal to an equilibrium value. Ostwald ripening 
is the third and final stage of condensation (Madras and McCoy, 2003) where the 
phase evolves to minimise its surface free energy and it ends where there is 
complete phase separation (Marqusee, 1983). As growth and nucleation rates 
decline, the Gibbs-Thomson effect becomes significant, as large clusters grow 
due to their surface curvature at the expense of the smaller particles which will 
dissolve due to their thermodynamic instability on reaching their critical nucleus 
size leading to growth particle growth in the bulk (Madras and McCoy, 2002c, 
Madras and McCoy, 2003). 
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1.6.2.1 Theory of Ostwald Ripening 
 
Ostwald ripening is the final stage of a first order transition for condensation of a 
metastable phase (Madras and McCoy, 2002b, Schober et al., 2003). It is 
generally thought to be a slow, diffusion-controlled process which occurs 
subsequent to phase separation under just under-saturation levels (Baldan, 2002). 
The driving force for this process is a decrease in the total surface free energy 
(Baldan, 2002, Madras and McCoy, 2003). Unlike simple crystal growth driven 
by supersaturation, this process occurs by dissolution of small clusters that give 
up their monomers to the growth of large particles (Baldan, 2002). An example 
of Ostwald ripening for a model bubble system is illustrated in Figure 1-7 
(Mezzenga et al., 2005). Larger clusters accordingly will grow as supersaturation 
decreases during ripening. The explanation for such ripening is based on the 
Gibbs-Thomson relationship for interfacial and thermal energy that suggests that 
smaller clusters are more soluble than larger ones (Madras and McCoy, 2002b). 
The Gibbs-Thomson equation for a given supersaturation gives an expression for 
the critical nucleus size, where a cluster larger than the critical nucleus grows 
and those below will dissolve leading to a transfer of mass to the solution which 
is incorporated in to the larger cluster (Madras and McCoy, 2001, Madras and 
McCoy, 2002b). The growth of clusters might be influenced by different factors 
such as diffusion (Madras and McCoy, 2002b).  
 
Different models have been proposed in order to explain this phenomenon. Some 
researchers included dissolution in their model (Madras and McCoy, 2002a), as 
dissolution can occur during growth and ripening when supersaturation 
decreases, causing an increase in the critical nucleus size. Therefore, any 
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particles smaller than critical nucleus size are unstable and instantly dissolve 
(Madras and McCoy, 2002a). Ultimately, Ostwald ripening should lead to the 
formation of one single condensed cluster containing all the available material; 
however, this does not occur due to the decrease in the growth rate as the size of 
the particle increases (Tadros et al., 2004). 
 
 
 
Figure 1-7: Bubble circumferences are drawn in red a, at the beginning of the experiment, and 
b±d, after 25, 50 and 75 minutes, respectively, showing the progressive loss of small bubbles due 
to gas diffusion towards big bubbles which progressively enlarge (Mezzenga et al., 2005). 
 
1.6.2.2 Distribution Kinetics 
 
Cluster size distribution (CSD) can be determined and expressed using the 
distribution kinetics approach that is generally applicable to growth, dissolution, 
or ripening. The CSDs can be influenced by the size-dependent rates for cluster 
growth and dissolution or the creation of new particles (Marqusee, 1983, Madras 
and McCoy, 2002b). Madras and McCoy defined CSD by c(x, t)dx, which 
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expresses the concentration of clusters at time t in the mass range (x,x+dx). The 
concentrations of the clusters are defined as integrals over the mass, 
 
       (Madras and McCoy, 2001)  Equation 1-3 
 
The deposition process where monomers are reversibly added to or dissociated 
from a cluster can be writer following this reaction, 
 
   Kg(x) 
C(x) + M ([¶)   C([[¶) (Madras and McCoy, 2001)  
    Kd(x) 
 
where C(x) represents the cluster of mass x and M([¶) is the monomer. This 
process conserves mass. According to the molecularity equation 1-3, addition 
reactions are second order whereas dissociation reactions are first order (Madras 
and McCoy, 2002b). The growth rate kg may be specific for a stirred system or 
may be related to the monomer diffusion coefficient in an unstirred system, and 
therefore, depends upon cluster mass and local thermodynamic conditions 
(Madras and McCoy, 2001). 
 
1.6.2.3 Lifshitz-Slyosov-Wagner (LSW) Theory 
 
In order to express the nucleation and growth with subsequent ripening a 
numerical solution is needed (Madras and McCoy, 2002c). In the early phase of 
the numerical model, the CSD is zero and nuclei are formed at their critical size. 
       dxxtxctc nn ,
0
³f 
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At the second stage, the critical nucleus size grows leading to a reduced degree 
of metastabiltity, however the deposition of the monomer generated from the 
dissolving cluster have lead to the growth of larger clusters (Madras and McCoy, 
2002c). The LSW theory is often used to describe and quantitatively assess the 
coarsening due to Ostwald ripening (Meinders and van Vliet, 2004). LSW theory 
allows an estimation of the rate of Ostwald ripening (Welin-Berger and 
Bergenstahl, 2000). The theory uses the following assumptions so that the rate of 
Ostwald ripening can be estimated (Madras and McCoy, 2003): a) the disperse 
phase particles are spherical and are fixed in space, b) the monomer atoms 
diffuse to the spherical particle in a continuous phase, c) there is no interaction 
between neighbouring particles d) the volume fraction of the dispersed phase in 
the continuous phase is infinitely dilute system and is constant except near the 
particle boundaries (Lifshitz and Slyozov, 1959, Welin-Berger and Bergenstahl, 
2000, Baldan, 2002). However, by using all these assumptions quantitative 
conclusions are unaffected (Lifshitz and Slyozov, 1959).  The LSW assumption 
is that growth of the cluster radius depends on a driving force related to the 
difference of the inverse radii of cluster and critical nucleus equation 1-5 
(Berger, 2004), 
 
                                   Equation 1-4 
 
where R is the cluster radius, R* is the radius of the critical nucleus and K(LSW) is 
an empirical constant (Berger, 2004). dR/dt can be determined by the 
examination of the growth or dissolution of an isolated spherical particle in 
supersaturated media (Baldan, 2002). Therefore, the rate of Ostwald ripening is 
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directly proportional to the solubility of the disperse phase in the dispersion 
medium (Welin-Berger and Bergenstahl, 2000). Droplets with R>R* will grow 
while droplets with R<R* will dissolve (Fig. 1-8) (Lifshitz and Slyozov, 1959, 
Meinders and van Vliet, 2004). The critical size is governed not only by the 
initial supersaturation, but also by the number of clusters (where this can be 
considered a fixed quantity) (Lifshitz and Slyozov, 1959). 
 
Critical nucleus size ( R*)
R < R*
Particles 
dissolve
R > R*
Particles 
grow
 
Figure 1-8: Schematic of the LSW theory. 
 
The change in the particle radius following the LSW theory is time dependent 
and the average particle radius R(t) was found to increase with time as shown in 
equation 1-5: 
 
R3(t) = KLSW . t + R3(0)  (Snyder, 2001)  Equation 1-5 
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where R is the radius of the particles, KLSW is the rate of Ostwald ripening and t 
is time. 
 
$V VWDWHG E\ 0DGUDV DQG 0F&R\ ³WKH LSW theory yields only an asymptotic 
solution, valid in the limit of a zero volume fraction of a quasi-steady state after 
a long, unspecified period of time´ (Madras and McCoy, 2003). Nevertheless, 
LSW theory has been widely adapted to determine the values of interfacial 
energy between the matrix and the dispersed phase (Baldan, 2002). 
 
1.6.3 Material Properties Influencing Particle Interactions 
 
There are several factors that influence particle interactions either with different 
materials or the particles with themselves. These factors are described below. 
 
1.6.3.1 Surface Roughness 
 
The principal interactions determining the adhesion between particles and 
surfaces are attractive van der Waal forces and electrostatic in case of charged 
particles (Eve et al., 2002). Elastic properties of the surface, surface morphology, 
particle shape and particle surface roughness is a main factor to consider in terms 
of adhesion and friction (Staniforth, 1995, Podczeck, 1998a). This is due to the 
degree of surface irregularities in the particle shape. Surface interactions will be 
diminished for spherical particles. Hence, any increase in irregularities in the 
particle shape will result in an increased interparticulate forces (Podczeck, 
1998a). However, it has been shown that increasing surface roughness can be 
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used as a mean of significantly improving the adhesion properties between two 
surfaces at the nanoscale (Podczeck, 1998a, Rabinovich et al., 2000). This is due 
to decreasing contact area between the two surfaces with increasing roughness 
and hence less interaction between the two bulks and also to an increase in the 
distance between the bulk surfaces (Rabinovich et al., 2000). However, increased 
surface roughness can increase the adhesion between particles and surfaces if the 
particles are very small and thus can slip into the valleys between the asperities 
and have more contact with the surface (Fig. 1-9) (Podczeck, 1998b). 
 
Smooth Surface
 No asperities, with
maximum contact region
Rough Surface (1)
 Asperities smaller than
particle diameter with
minimised contact region
Rough Surface (2)
 Asperities larger than
particle diameter with larger
contact region
Particle
Contact 
region
 
Figure 1-9: The relative effect of surface roughness on surface interactions. 
 
1.6.3.2 Surface Energy 
 
6XUIDFHIUHHHQHUJ\ȖFDQEHYHU\FORVHO\UHODWHGWRWKHDGKHVLRQEHWZHHQWZR
surfaces brought into contact. Therefore, a knowledge of surface energy is very 
useful in predicting and modelling the interactive behaviour between two 
different components of a pMDI formulation (Zhang et al., 2006). Surface 
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energy is defined as the free energy change during an increase in surface area by 
one unit in vacuum (Podczeck, 1998c). Surface energy can also be defined as the 
excess energy at the surface of the material compared to the bulk and it is 
derived from an unsatisfactory bonding potential at the surface of a material, 
resulting in free energy at the surface. Surfaces must be intrinsically less 
energetically favourable than the bulk of a material. However, this does not 
occur at a surface due to the exposure to different molecules. Therefore, the 
molecules will rearrange and react with the adjacent molecules to reduce their 
free energy. However, due to the lower strength of this interaction compared to 
the interaction with the surrounding molecules, there is an increased attraction of 
that molecule that will contract the material at the surface. Hence, the presence 
of surface tension at the surface of materials (Buckton, 1995). 
 
The determination of surface energy of a pharmaceutical formulation is a 
recognized step in predicting a range of properties that may be displayed by a 
powder that include adhesion and its result on performance. For example, in a 
pMDI formulation, the surface energies of drug particles, excipients and the 
packaging materials can be used to predict the strength of interaction between 
each of these ingredients and hence help determine the suitability of the 
formulation and its stability (Davies et al., 2005, Zhang et al., 2006). 
 
1.6.3.3 Adhesion Model 
 
Different adhesion models theories are used in the literature to analyze pull-off 
force (Fig. 1-10). However, most models used to characterise particle 
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inteUDFWLRQV XVH WKH ³+HUW] PRGHO RI DGKHVLRQ EHWZHHQ FRQWDFWLQJ VSKHUHV´ DV
their basis (Davies et al., 2005). Based upon the Hertz theory, two contact 
mechanics models were developed: Johnson-Kendall-Roberts (JKR) (Johnson et 
al., 1971) and Derjaguin-Muller-Toporov (DMT) (Derjaguin et al., 1975) and are 
frequently employed. The difference between these models is that the DMT 
theory calculates the force with the assumption that surface forces act outside the 
contact region (Johnson et al., 1971, Hooton et al., 2004). During this project, the 
JKR model has been followed and is described below. 
 
 Pull off force
 
Figure 1-10: Schematic showing the pull off force 
 
 
- The Johnson-Kendall-Roberts (JKR) Theory 
 
The JKR model was developed by Johnson-Kendall-Roberts in 1971 and is the 
most used model for the determination of the adhesion between two materials 
(Johnson et al., 1971). The JKR theory calculates adhesion force (Fadh) by 
assuming that surface forces act only inside the contact region (Figure 1-11). 
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Figure 1-11: Applicability of the JKR model. 
 
This model is based on the Hertz model and is described by the general Hertz 
Equation: 
 
*
on3
0 E4
FR3
a  
       Equation 1-6 
 
Where a0 is the contact radius, Fon is the loading force, R is the radius of the 
sphere and E* is the reduced <RXQJ¶V PRGXOXV RI WKH V\VWHP ZKLFK LV
calculated using the following equation: 
 
2
2
2
1
2
1
*
111
E
v
E
v
E
 
      Equation 1-7 
 
where E1 and E2 are the Young¶s modulus of the sphere and surface respectively, 
while Ȟ1 and Ȟ2 DUHWKH3RLVVRQ¶s ratios of the sphere and surface.  
 
Tension Point Tension Point 
Contact Region 
Surface forces act only 
within the contact area 
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The fundamental principle on which the JKR model is based is a case where a 
smooth sphere, with elastic properties, contacts a flat substrate (Davies et al., 
2005). The systems used throughout the project do not reflect this situation 
perfectly due to the use of different substrates with different surface 
characteristics. The JKR model is based upon the consideration that surface forces 
DFW LQVLGH WKH ³neck´ of the contact region and neglects any long-range force that 
might exist outside the contact region. Hence, it accounts for an infinite stress at 
the boundary of the contact zone as the load is reduced and the particle removed 
from contact (Hooton et al., 2003, Davies et al., 2005). The JKR model 
correlates the adhesion force (Fadh) with work of adhesion (Wa) through the 
following equation. 
 
Fadh  ʌ5:a          Equation 1-8 
 
Where R is the radius of the sphere, Fadh is the force of adhesion and Wa is the 
work of adhesion. The work of adhesion can be calculated using the following 
equation; 
 
Wa = 2¥Ȗ1Ȗ2         Equation 1-9 
 
:KHUHȖ1 DQGȖ2 are the dispersive components of the surface energy of particle 
and surface respectively. For work of adhesion between identical materials, the 
work of cohesion (Wc) is calculated following this equation; 
 
WC  Ȗ        Equation 1-10 
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1.7 Methods of Determining Particle-Surface Interactions 
 
Different techniques can be used in order to study the interactions between 
particles and different surfaces. These techniques are vibration techniques, 
centrifugal techniques and scanning probe techniques (SPM). Atomic force 
microscopy (AFM) is a scanning probe technique that is now widely used for 
studying particle surface interactions. AFM is used during this project since it is 
the main technique used for studying particle surface interactions in different 
environment throughout the project. 
 
1.7.1 Atomic Force Microscopy (AFM) 
 
Atomic force microscopy (AFM) (Fig. 1-12) is a very high-resolution type of 
scanning probe microscopy (SPM). It was invented by Binnig, Quate, and 
Gerber in 1985. AFM imaging can be used to quantitatively determine surface 
topography and measure surface roughness with a nominal 5nm lateral and 
0.01nm vertical resolution on all types of samples (Morris et al, 1999). The AFM 
works by scanning a probe over the sample surface, building up a map of the 
height and topography (Giessibl, 2003). A very sharp nanoscale tip, usually 
made from silicon or a nitrous silica compound, is used at the end of a flexible  
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Figure 1-12: A Schematic diagram of an AFM (wikipedia.org, 2010). 
 
cantilever and is scanned over a surface. The AFM utilizes an optical lever to 
monitor the motion of the tip mounted at the end of a reflective cantilever using a 
laser that is focused on the back of the cantilever (Morris et al., 1996). When 
scanning the surface sample, the tip undergoes upward and downward 
movements with the changes in the surface topography leading to the deflection 
of the laser into a segmented photodiode that traces the laser movement. The 
difference in light intensities between the upper and lower photo-detectors are 
monitored and converted into a voltage by the photo-detector (Morris et al., 
1996). This latter generates a feedback mechanism that enables the piezo-
ceramic transducers to maintain the tip at a constant force that allows real time 
determination of height information, or constant height to determine the 
deflection force above the sample (Giessibl, 2003). The images generated from 
the detector are three-dimensional topographical maps of the surface which are 
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constructed by plotting the local sample height versus horizontal probe tip 
position (Morris et al., 1996). 
 
1.7.1.1 AFM Imaging Modes 
 
The primary modes of operation are contact mode and tapping mode. In contact 
mode, the AFM tip is scanned across the sample whilst in constant contact with 
the sample surface (Morris et al., 1996). The tip deflection is monitored via a 
laser optical lever and used to generate a feedback signal. Because the 
measurement of a static signal is prone to noise and drift, low stiffness 
cantilevers are used to boost the deflection signal. However, close to the surface 
of the sample, attractive forces can be quite strong, causing the tip to 'snap-in' to 
the surface on approach. In contact mode, the force between the tip and the 
surface is kept constant during scanning by maintaining a constant deflection by 
the use of the feedback signal to control the piezo positioning. One of the main 
disadvantages of contact mode AFM is the unsuitability for soft or loose surfaces 
due to the deformations occurring to the surface due to the cantilever being 
dragged across the surface at constant and often relatively large force (especially 
lateral forces) (Morris et al., 1999).  In addition to that, loose particles on the 
sample could be moved by the tip during imaging and thus giving a false surface 
topography imaging (Hooton et al., 2003). 
 
In tapping mode, the cantilever is oscillated up and down at near its resonance 
frequency by a small piezoelectric element mounted in the AFM tip holder while 
being scanned across the sample surface. Upon contact with the sample surface, 
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changes in oscillation amplitude are detected and converted into a topographical 
image (Morris et al., 1996). A tapping AFM image is therefore produced by 
displaying an image of the feedback signal required to maintain constant 
amplitude of oscillation. This overcomes the problem of contact AFM related to 
sample damage due to lateral forces (Butt et al., 2005). 
 
1.7.1.2 AFM Force Measurements Mode 
 
In addition to these topographic measurements, the AFM can also provide much 
more information. As the AFM relies on the forces between the tip and the 
sample, it can be used to measure the long range attractive or repulsive forces 
between the probe tip and the sample surface at a single point or across a surface, 
elucidating local chemical and mechanical properties like adhesion and elasticity, 
and even molecular bond rupture strength (Butt et al., 2005a). The force is not 
measured directly, but calculated by measuring the deflection of the lever, and 
knowing the stiffness (spring-constant) of the cantilever following +RRN¶V ODZ
(Equation 1-11) 
 
 F = -kz            Equation 1-11 
 
where F is the force, k is the spring constant (the stiffness of the lever), and z is 
the deflection distance of the cantilever.  
 
Force curves (force-versus-distance curve) (Fig. 1-13) typically show the 
deflection of the free end of the AFM cantilever as the fixed end of the cantilever 
is brought vertically towards and then away from the sample surface. 
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Experimentally, this is done by applying a triangle-wave voltage pattern to the 
electrodes for the z-axis scanner. This causes the scanner to expand and then 
contract in the vertical direction, generating relative motion between the 
cantilever and sample. The deflection of the free end of the cantilever is 
measured and plotted at many points as the z-axis scanner extends the cantilever 
towards the surface and then retracts it again.  
 
Similarly to the imaging mode, force measurements can be obtained for different 
surfaces under different conditions either in air or in liquid environment which is 
beneficial in terms of collecting data when particle-surface interactions are 
within a liquid environment such as in pMDI surface interactions where the APIs 
are suspended in the propellant. 
 
 
 
Figure 1-13: Typical AFM force curve cycle (adapted from (Allen et al., 1998)). 
 
 
A- No contact between tip and 
sample 
B- 7LS DQG VDPSOH ³MXPS LQWR
FRQWDFW´GXHWRDWWUDFWLYHIRUFHV 
C- Tip in contact with surface. 
Approach continues until the 
maximal nominal loading force is 
reached 
D- As the cantilever is withdrawn, 
adhesion or cohesion formed 
during contact with the surface 
may cause the cantilever to adhere 
to the sample. The force needed to 
separate the tip and sample is the 
maximum force of 
adhesion/cohesion  
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1.7.1.3 AFM Use in Inhaled Particle Interactions 
 
In recent years, many techniques have been developed in order to study and 
assess interparticulate interactions. AFM is one of the most utilized techniques in 
order to assess and quantify adhesion and cohesion between individual particles 
and sub-micron particle. Roberts highlighted how this technique could be used 
for the quantification of the adhesion forces and the significant potential of using 
AFM in formulation development (Roberts, 2005). 
 
Several research groups used the potential of AFM in the area of inhalation 
where the knowledge of particle interactions and the components of the delivery 
device such as pMDI or DPI as well as with excipients. In one of his papers 
Ashayer et al. studied the forces of interaction between inhalable formoterol 
fumarate dehydrate particles and various components of a pMDI in the presence 
of a model HFA propellant and different surfactant polymers (Ashayer et al., 
2004). Their studies were able to demonstrate a degree of instability of the 
formulation in a model HFA propellant in the presence and absence of polymers. 
Using AFM to determine the adhesion measurements, they also showed that the 
adhesion forces to the canister walls were diminished upon the addition of the 
surfactant polymers and that the use of block or comb copolymers may provide a 
better option in reducing the possibility of bringing interactions. 
 
The effect of humidity on inhaled formulations has been the subject of a number 
of studies. Young et al. have demonstrated that the effect of an increase in the 
relative humidity may lead to an increase in drug cohesion in some materials and 
a decrease in drug cohesion for others (Young et al., 2004). Hooton et al. have 
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also showed that variation in particle contact morphology for the same material 
cause similar behaviour in terms of increased drug adhesion with increasing 
humidity (Hooton et al., 2004). Furthermore, they used AFM in order to 
investigate the effect of contact area acquired adhesion force measurements in a 
model pMDI propellant system, then relating those measurements to contact area 
and work of adhesion. Also, it was shown that it was possible to acquire three-
dimensional representations of the area of contact of the particle and hence 
ability to compare different particles (Hooton et al., 2003). Moreover, Jones et al. 
demonstrated the ability of AFM in monitoring the recrystallization of 
amorphous regions in micronized particles in order to improve their 
processability and physico-chemical stability (Jones et al., 2008). 
 
Williams and co-workers were able to show the use of AFM to study the 
delivery performance and the stability of pMDI formulation containing 
beclomethasone dipropionate (BDP) and triamicinolone acetonide (TAA) in 
HFA propellant in terms of particle crystal growth and also that the differences 
in the surface roughness of a pMDI canister were a function of the type of the 
propellant, temperature and storage conditions (Williams III et al., 2000). 
Ostwald ripening has also been studied by Madras and co-workers (Madras and 
McCoy, 2002c, Madras and McCoy, 2003). Sedimentation and creaming where 
studies in order to provide a better understanding of these phenomena and how 
these can be prevented (Jeelani et al., 2005, Watson et al., 2005).  
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1.8 Thesis Aims and Objectives 
 
The work presented in this multi-disciplinary project aims to characterise and 
understand the physicochemical and solid state behaviour of drugs in HFA-134 
and 227 propellants employed in metered dose inhaler devices.  The project aims 
to investigate the long term stability of crystalline drugs in HFA-134 and 227 
and the requirements for the formation of HFA clathrates in drug compounds for 
inhalation. The project will investigate several aspects contributing to the 
efficiency of a pMDI formulation such as: 
 
x The physicochemical properties of a model CFC clathrate and HFA 
clathrates 
x The surface characteristics of the different APIs and pMDI components 
x The surface energy and forces of adhesion of the different APIs and their 
correspondent clathrates within a pMDI formulation 
x The effect of size reduction on the surface energy and the force of 
adhesion of the different drug in a pMDI formulation 
x Understand the process of Ostwald ripening and any effect of EtOH or 
surfactant on this phenomena in a pMDI formulation 
 
In order to investigate these aims, the work will be detailed in the following 
manner; 
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Chapter 2 will cover the main materials and methods used to investigate and 
characterize clathrate formation and API-pMDI interactions and the process of 
Ostwald ripening. 
 
Chapter 3 will investigate and characterise the physico-chemical properties of 
beclomethasone dipropionate (BDP) crystallized from 
trichloromonofluoromethane (CFC-11).  Following the surface characterisation 
of the BDP CFC-11 clathrate, the effect of different BDP, CFC-11 
concentrations will be used in order to determine their effect on the clathrate 
formation. 
 
Chapter 4 will characterise and compare two different clathrates of BDP 
crystallized from HFA-134a and 227 and determine the effect of EtOH on their 
formation within a pMDI formulation. Surface characterisation and any 
polymorphic changes following heating will be determined in order to study the 
stability of BDP HFA propellant entities formed within a pMDI formulation. 
 
Chapter 5 will capture the details of the study of the effect of size reduction on 
API interactions with different pMDI components. It will also determine the 
surface free energy (SE) and forces of adhesion (Fadh) of the different BDP 
entities used in this study with different pMDI components in a model propellant 
(decafluoropentane) and determine the effect of size reduction on the latter. 
 
Chapter 6 aims to investigate and try to understand the process of Ostwald 
ripening for different BDP entities used during the project as well as budesonide 
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and determine the effect of ethanol and surfactant (oleic acid) on it within a 
pMDI formulation. Furthermore, AFM will be used in order to see any surface 
changes occurring during the process of Ostwald ripening and determine the 
effect of formulation excipients on these latter. 
 
Chapter 7 will provide a brief summary of the findings of this project with an 
overview of the main conclusion obtained in each chapter and the general 
conclusion from the work. Furthermore, some suggested future work with 
respect to formulation-device interactions and other techniques that might be 
used to study Ostwald ripening process in a pMDI formulation. 
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2 Chapter 2  Materials and Methods 
 
 
 
2.1 Chapter Aims and Objectives 
 
This chapter will provide the reader with a full knowledge of both the materials 
and the experimental procedures employed to produce the results detailed in this 
thesis. The active pharmaceutical ingredients, excipients, co-solvents and the 
model propellant used in this project will be presented and discussed. 
Subsequently the experimental protocols used to generate the results will be 
detailed. These techniques include scanning electron microscopy, atomic force 
microscopy, X-ray photoelectric spectrometry, differential scanning calorimetry 
and Raman spectroscopy, amongst others. 
 
2.2 Materials 
 
2.2.1 Active Pharmaceutical Ingredients 
 
Two different pharmaceutical ingredients (APIs) were used throughout the 
course of this project. They are both widely used in pressurized metered dose 
inhalers and their formulation suffers some stability issues especially in the new 
hydrofluoroalkane propellants. These are as follow: 
 
Beclomethasone Dipropionate:  
Beclomethasone Dipropionate is a corticosteroid. It is a white/almost white 
crystalline powder, which is practically insoluble in water, soluble in acetone 
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while sparingly soluble in alcohol (96 per cent) (Figure 1-2, Chapter 1, Section 
1.3) (British Pharmacopoeia, 2010). 
 
Budesonide: 
Budesonide is a corticosteroid. It is a white/almost white crystalline powder, 
which is partially soluble in water, freely soluble in methylene chloride, 
sparingly soluble in ethanol (96 per cent) (Figure 1-3, Chapter 1, Section 1.3) 
(British Pharmacopoeia, 2010). 
 
2.2.2 Propellants 
 
Trichlorofluoromethane (CFC-11) was used as a model for the initial phase of 
the project for the characterization of the clathrate, as it stable at ambient 
temperature and has been used previously used in pressurized metered dose 
inhalers before being replaced with 1,1,1,2-tetrafluoroethane (HFA-134a) and 
1,1,1,2,3,3,3-heptafluoropropopane (HFA-227). HFA-134a and HFA-227ae were 
also used for the potential synthesis and characterisation of the API clathrate 
crystallized from the latter. 2H, 3H decafluoropentane was used as a model HFA 
propellant (referred to as mHFA therein after) as its properties are very similar to 
the more commonly used HFA-134a, HFA-227, but it is stable at ambient 
temperature and pressure and hence suitable for analysis where the pressure 
UHTXLUHGWRNHHS+)$¶VOLTXLGFDQQRWEHDSSOLHG. The chemical structures of the 
different propellants used in this study are shown in Figure 2-1. 
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Figure 2-1 Chemical structure of the different propellants used in this study. 
 
From Figure 2-1 we can observe that CFC-11 is completely halogenated and 
thus, the carbon backbone is shrouded entirely by large electronegative mantel 
atoms while the HFAs have one or two small, asymmetrically positioned, 
hydrogen atoms in their mantels (Vervaet and Byron, 1999). The enhanced 
electronegativity in the halogen mantel of the HFAs creates a distinct dipole on 
the hydrogen-carbon bonds in both propellants (Vervaet and Byron, 1999). 
mHFA is well characterised (Rogueda, 2003). The carbon backbone of mHFA is 
almost completely fluorinated, with the exception of two hydrogen atoms at 
positions 2 and 3 which make it structurally similar to the HFA 277 propellants. 
Therefore, it is believed to be a better model for the HFA 227 rather than HFA 
134a (Rogueda, 2003, Selvam et al., 2006). The chemical properties of each 
HFA propellant are summarised in Table 2-1. 
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Table 2-1: The comparative properties of mHFA, CFC-11, HFA134a and HFA 227  
(adapted from (Vervaet and Byron, 1999, Rogueda, 2003)). 
 
      *at 18.06 Hz 
 
2.2.3 Co-solvents 
 
Ethanol (EtOH) and isopropyl alcohol (IPA) are used as a co-solvent in many 
HFA-containing pMDI suspension formulations in order to increase the 
solubility of APIs and certain surfactants in the propellant. The chemical 
structure of both ethanol and IPA is shown in Figure 2-2. 
 
 
                                                 
 
               Ethanol                         Isopropyl Alcohol 
 
Figure 2-2: Chemical structure of ethanol and isopropyl alcohol. 
 
 
mHFA CFC-11 HFA-134a HFA-227 
Molecular weight (g/mol) 252.05 137.37 170.03 102.03 
Density (g/cm3) 1.58 1.494 1.388 1.208 
Boiling Point (°C) 53.6 23.77 -16.5 -26.3 
Melting Point (°C) -80 -110.48 -131 -101 
Water Solubility (ppm) 390 100 610 2200 
Surface Tension (mNm-1) 13.59 17.7 7.55 8.69 
Dynamic Viscosity (mPa) 0.537 0.74 0.266 0.211 
Dielectric Constant 15.05* 2.3 4.071 9.46 
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Ethanol is a short chain alcohol, which has considerable solvent attributes, and is 
also non-toxic to humans in small volumes (Stein and Stefely, 2003). In contrast, 
IPA  is used as co-solvent amongst other short alcohols with different APIs in 
pMDI formulation in order to form a crystalline solvate and thus lead to a more 
stable formulation (Jinks, 1989).  The solubility of a drug in a solvent is reliant 
on its ability to form dipole-dipole interactions with the solvent (Vervaet and 
Byron, 1999). When one considers the small molecular size of these two 
alcohols, along with their GLSROH H[LVWHQFH DW WKH µPHWK\O-K\GUR[\O MXQFWLRQ¶
their reason for use as a co-solvent in the new generation of HFA pMDI 
formulations is clear. 
 
2.2.4 pMDI Components 
 
Different pMDI components were utilized throughout this project, as a 
representation of the different components used in pMDI systems. These 
components were used for the assessment of the API-pMDI component 
adhesion. These are as follow: 
 
Aluminium Canisters (non-coated) and Fluorinated Ethylene Propylene (FEP) 
Aluminium Canisters: 
The pMDI canister is where the formulation resides. As a result, one would 
assume that most of the interactions between the API particles and the pMDI 
component will occur more frequently in this part of the pMDI. Stainless steel 
and aluminium canister have been developed due to the feature that they exhibit 
which are strengthened thicker walls and ellipsoidal base (Chan and Burt, 2009). 
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Aluminium canisters can be used as non-coated or FEP-coated with a submicron 
thick layer of a fluorinated polymer (Fig. 2-3) (Ashayer et al., 2004). This 
polymer is used reduce friction properties and improve non-reactivity (Ashayer 
et al., 2004). Throughout the different studies, both non-coated and FEP-coated 
aluminium canisters were used for direct assessment of API particle interactions. 
The non-coated aluminium canisters would assume a direct aluminium 
interaction with the API particles. However, fluorine, carbon and hydrogen will 
be predominantly interacting with the API particles in the case of the FEP-coated 
aluminium canister. 
 
 
Figure 2-3: Chemical structure of Fluorinated Ethylene Propylene (FEP) molecule. 
 
Ethylene-propylene-diene-monomer (EPDM) Valve Seal and Nitrile Valve Seal: 
The pMDI valve seals are responsible for helping careful control of delivery of 
the metered dose during actuation and to provide precise through-life dose 
uniformity. Two commercially available seals are ethylene-propylene-diene 
monomer (EPDM) valve seals and nitrile valve seals. In this project, the two 
types were used and compared, with respect to adhesion to selected APIs. While 
both valve types are polyvinyl in nature, they have very different surface 
chemistries.  
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Stainless Steel Metering Chamber: 
The metering chamber allows a metered quantity of the pMDI formulation to be 
dispensed or delivered with each actuation. The metering valve is required to 
retain and protect the contents of the canister while delivering a fixed volume 
(usually 25±100 ml) of the formulation accurately and reproducibly throughout 
use by the patient (McDonald and Martin, 2000). The metering chamber, along 
with other components including the valve seals make up most of the metering 
valve. At rest, the chamber is open to the bulk liquid. During actuation, the inner 
seal closes and outer opens so that only the contents of the chamber are 
discharged under the vapour pressure of the propellant. Therefore, there is the 
potential for significant API interactions with the metering chamber within the 
metering valve (McDonald and Martin, 2000). There are a number of 
commercially available metallic or polyvinyl valve components. For this study, 
metallic stainless steel valve components were used.  
 
2.3 Methods 
 
2.3.1 Scanning Electron Microscopy (SEM) 
 
Scanning electron microscopy is a very powerful technique in terms of yielding 
information about the surface topography, morphology, composition and 
crystallographic information (Butt et al., 2004). SEM employs a beam of highly 
energetic electrons to examine objects on a sub-micron scale. A stream of 
electrons is generated by an electron gun in high vacuum (Egerton, 2005). This 
stream is accelerated towards the specimen by a high voltage (between 1 keV and 
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400 keV depending on the system) towards the sample. The sample is then 
irradiated by the beam and interactions occur inside the irradiated sample. The 
interaction of primary electrons with the sample surface results in the generation of 
lower-energy secondary electrons from the surface. These secondary and 
backscattered electrons are collected by a detector and subsequently the signal 
resulting from their emission is amplified and optimised in order to allow 
visualisation on a monitor (Egerton, 2005). A schematic diagram outlining the key 
components of an SEM is shown in Figure 2-4 with an example of a resultant 
image with respects to micronized particles in Figure 2-5. 
 
 
Figure 2-4: Schematic diagram of an SEM (Encyclopaedia and Britannica, 2008). 
 
Due to the high vacuum and condition and the utilization of electrons to form an 
image, special preparations must be done to the sample. Non-conductive samples 
need to be made conductive by covering the sample with a thin layer of 
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conductive material (usually gold) so as to avoid charging the sample by the 
electron beam and subsequent distortion of the image. 
 
 
Figure 2-5: An example of an SEM image of micronized particles. 
 
2.3.2 X-Ray Powder Diffraction (X-RPD) 
 
X-ray powder diffraction (X-RPD) is a rapid analytical technique primarily used 
for phase identification of a crystalline material and can provide information 
about unit cell dimensions of a compound. X-ray diffraction is now a common 
technique for the study of crystal structures and atomic spacing. A schematic 
diagram of an X-Ray diffractometer is shown is Figure 2-6. 
 
Figure 2-6: Schematic of an X-ray powder diffractometer (Chalupa, 2009). 
Chapter 2 ± Materials and Methods 
 
 70 
X-ray diffraction is based on constructive interference of monochromatic X-rays 
and a crystalline sample. When a monochromatic X-ray is projected onto a 
crystalline material, diffraction occurs when the distance travelled by the rays 
reflected from successive planes differs by complete number n of wavelengths. 
%\ VFDQQLQJ WKH VDPSOH WKURXJK D UDQJH RI ș angles, all possible diffraction 
directions of the lattice should be attained due to the random orientation of the 
powdered material and the Bragg's Law conditions are satisfied QȜ G VLQ ș 
(Warren, 1990). This law relates the wavelength of electromagnetic radiation (Ȝ) 
to the diffraction angle ș and the lattice spacing (d) in a crystalline sample. 
Conversion of the diffraction peaks to d-spacing allows identification of the 
compound because each compound has a set of unique d-spacing. Typically, this 
is achieved by comparison of d-spacing with standard reference patterns 
(Warren, 1990). Where a mixture of different phases is present, the resultant 
diffractogram is formed by addition of the individual patterns. An example 
showing the X-RPD data for two polymorphs of paracetamol is shown in Figure 2-7. 
 
During the course of this work, X-RPD will be used to characterise the 
crystalline nature of powder samples intended for analysis as well as solving the 
crystal structure of some of them. 
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Figure 2-7: X-RPD pattern of paracetamol showing two different forms  
(Nichols and Frampton, 1998, Stone et al., 2009). 
 
2.3.3 X-Ray Photoelectron Spectroscopy (XPS) 
 
X-ray photoelectron spectroscopy (XPS) is a an extremely surface sensitive 
spectroscopic technique that provides quantitative information about the 
elemental composition (with exception of hydrogen and helium), empirical 
formula, chemical state and electronic state of the elements that exist on or near 
the surface of a material (Nefedov, 1988).  
 
XPS provides quantitative compositional information from the top 10 atomic 
layers of a sample surface for the elements. The samples are irradiated with a 
monochromatic X-ray beam. XPS is based upon the photoelectric effect. The 
energy of the X-ray photon excites the surface and induces the escape and 
emition of the core electron from the atoms at the surface of the sample 
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(O'connor et al., 1992). The emitted electron have a specific kinetic energy 
related to its origin and is referred to as a photoelectron. The distribution of 
kinetic energies of the photoelectrons can be used to identify and quantify the 
amounts of elements and bonding environments on a sample due to the slight 
difference in binding energies (O'connor et al., 1992). A schematic 
representation of an XPS instrument is represented in Figure 2-8. 
 
 
 
 
 
 
 
 
 
Figure 2-8: Schematic representation of an XPS instrument 6&.&(1. 
 
2.3.4 Differential Scanning Calorimetry (DSC) 
 
The main application of DSC is in studying phase transitions, such as melting, 
glass transitions, or crystallization. These transitions involve heat capacity 
changes that can be detected by DSC with great sensitivity (Menczel et al., 
2009). DSC is utilized to measure the temperature differences between the 
investigated sample and a reference samples as a function of temperature (Höhne 
et al., 2003). Both the sample and reference are maintained at nearly the same 
temperature throughout the experiment using constant heat flow rates. The 
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reference sample should have a well-defined heat capacity over the range of 
temperatures to be scanned.  
 
The basic principle underlying this technique is the detection of changes in heat 
flow between the sample and the reference as the sample undergoes a physical 
transformation showing as endothermic or exothermic peaks (Sepe, 1997). By 
observing the difference in heat flow between the sample and reference, 
differential scanning calorimeters are able to measure the amount of heat 
absorbed or released during such transitions (Menczel et al., 2009). Calibration 
may be carried out using standards of known melting points such as sapphire or 
indium that are available as heat capacity standard. DSC curves can be used to 
calculate enthalpies of transitions. This is done by integrating the area under the 
curve corresponding to a given transition. It can be shown that the enthalpy of 
transition can be expressed using the following equation 2-1: 
 
ǻ+ .$        Equation 2-1 
 
ZKHUHǻ+LV WKHHQWKDOS\RIWUDQVLWLRQ.LV WKHFDORULPHWULFFRQVWDQWDQG$LV
the area under the curve. The calometric constant will vary from instrument to 
instrument, and can be determined by analyzing a well-characterised sample with 
known enthalpies of transition (Menczel et al., 2009). 
 
During the course of this work heat-flux DSC was used, a schematic 
representation of the DSC instrument is shown in Figure 2-9.  
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Figure 2-9: A schematic representation of a DSC instrument (R is the reference and S is the 
sample). 
 
Temperature Modulate DSC (TMDSC) was also used during this work as 
complementary technique to conventional DSC. TMDSC is a modification of 
DSC which allows the differentiation of overlapping transitions. In TMDSC, a 
sinusoidal modulation is applied on top of the linear heating rate in order to 
measure the heat flow that responds to changing heating rates. This results in an 
improved resolution and sensitivity. Depending on the underlying heating rate, 
the period and amplitude of modulation, Fourier Transformation analysis is then 
used to separate the resulting raw experimental heat flow into the heat capacity 
related (reversible) and kinetic (non-reversible) heat flows.  
 
2.3.5 Thermogravimetric Analysis (TGA) 
 
Thermogravimetric analysis (TGA) is a thermal analysis techniques used to 
characterise a wide variety of materials. It provides complimentary 
characterisation information to the most commonly used thermal technique, 
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DSC. TGA measures the amount and rate of change in the mass of a sample as a 
function of temperature or time in a controlled atmosphere (Sepe, 1997).  
 
The basic principle underlying this technique involves a continuous monitoring 
of changes in weight as a constant heating rate is applied to the sample in a TGA 
pan following a tare procedure. Typical weight changes results are analyzed for 
the amount or percent of weight change whether weight gain or loss at any given 
temperature, the amount or percent of non-combusted residue at some final 
temperature, and the temperatures of various sample degradation processes 
(Bruce Prime et al., 2009). 
 
2.3.6 Raman Spectroscopy 
 
Raman spectroscopy has become an important analytical and research tool used 
for a wide range of applications. It is a spectroscopic technique that is used to 
provide useful information used for chemical identification, characterization of 
molecular structures, effects of bonding, environment and stress on a sample.  
 
Raman spectroscopy is based on inelastic scattering of a monochromatic light 
from a laser source. When light is scattered from a molecule most photons are 
elastically scattered due to the excited photons returning to the same vibrational 
state and thus, having the same energy and wavelength as the incident photons 
(Rayleigh effect). However, a small fraction of radiation is scattered inelastically 
at some different wavelengths (Stokes and Anti-Stokes Raman scattering) (Fig. 
2-10) (Schrader and Bougeard, 1995). 1 in 107 photons is scattered at optical 
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frequencies different from, and usually lower than, the frequency of the incident 
photons. If a molecule is promoted from a ground to a virtual vibrational state 
and then returns back to a higher energy vibrational state then the resulting 
frequency is reduce and therefore have a longer wavelength. This is referred to as 
Stokes scattering. However, if the molecule at the time of interaction is already 
in a vibrational state then the scattered releases more energy and hence has a 
shorter wavelength as returning to the ground vibrational state. This phenomenon 
is referred to as anti-Stokes scattering (Schrader and Bougeard, 1995).  
 
The Stokes and anti-Stokes scattered light will be shifted to an equal distance on 
opposite sides of the Rayleigh scattered light and is determined by the spacing 
between the vibrational states and the ground state. This shift provides 
information about vibrational, rotational and other low frequency transitions in 
molecules. 
 
 
Figure 2-10: Energy level diagram for Rayleigh scattering and Raman scattering: Stokes Raman 
scattering and anti-Stokes Raman scattering. 
Chapter 2 ± Materials and Methods 
 
 77 
Dispersive Raman has been used throughout this project. Dispersive Raman has 
become the largest and most widely used of the Raman systems, with an 
instrument typically consisting of a monochromator (spectrometer or 
spectrograph), a CCD detector, and various laser sources- ranging from UV to 
NIR. A microscope is often used to enable micron scale analysis (Fig. 2-11).  
 
 
 
 
 
 
 
 
 
 
Figure 2-11: A schematic representation of a simplified Raman spectrometer (Sayfa, 2008). 
 
Variable temperature Raman spectroscopy (VT-Raman spectroscopy) was also 
used during this work in order to study any potential polymorphic changes 
occurring to the different clathrates and APIs.  
 
2.3.7 Atomic Force Microscopy (AFM) 
 
2.3.7.1 Sample Preparation 
 
API samples were placed onto an AFM stub. The API chosen was sprinkled 
across the top adhesive layer of a silicon wafer that was covered with a thin 
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sheen of epoxy resin (Loctite, Henkel Ltd, Hatfield, UK). Any excess API was 
removed by exposing the sample to a gentle stream of nitrogen for 30 seconds. 
When preparing samples of pMDI components, each sample was adhered 
directly onto an AFM stub using epoxy resin, and being allowed to dry at least 
24 hours before use (Fig. 2-12). 
 
 
 
Figure 2-12: An example of an AFM stub sample preparation. 
 
2.3.7.2 Topographical Imaging 
 
Each of the pMDI components and the API samples were examined using AFM 
topographical imaging using an EnviroScope AFM (Veeco, Santa Barbara, CA, 
USA). Tapping mode was used for the acquisition of the images with NPS 
cantilevers (Veeco, Santa Barbara, CA, USA). A scan rate of 1.0 Hz was used 
RYHUDȝP[ȝPVFDQVL]H for the pMDI and the API samples. A slow scan 
rate was employed in order to reduce the chances of any lateral movement of the 
sample. Topographical imaging also allowed for the determination of roughness 
parameters (the root mean square (RMS) roughness) of each sample. RMS was 
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achieved using the topographical software incorporated within the AFM system 
following equation 2-2: 
 
Rrms= ¦
 
n
i
iy
n 1
21
       Equation 2-2 
 
where n is the number of points in the topography profile, i is the asperities and 
yi is the distance between the asperities. A typical 3D-processed AFM image is 
shown in Figure 2-13. 
 
 
 
 
 
 
 
 
 
Figure 2-13: An example of a 3D-processed AFM Image of a 5 x 5 micron surface 
 
2.3.7.3 Colloid Probe Preparation 
 
The force measuring principle of colloid probe AFM is identical to that of a 
standard AFM (Kappl and Butt, 2002) but particles of each API material were 
attached to AFM cantilevers and challenged against each pMDI component 
surface (Davies et al., 2005) (Figure 2-14). Sharpened Silicon Nitride Probe . 
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(a) AFM Cantilever
(b) Attached API particle
(c) Substrate, e.g. pMDI
component surface of
corresponding API
particles
Colloid probe brought into
contact with substrate
Colloid probe retracted from
contact with substrate but
adhesive force between tip and
substrate maintains their
contact
Colloid probe brought out of
contact with substrate at the
point where force of retraction
equals the maximum adhesion
force
(a)
(c)
(b)
 
Figure 2-14: The AFM colloid probe technique. 
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(DNP-S, V-shaped) cantilevers were used for this procedure. The spring constant 
of each lever, the resonant frequency (RF) and Q values of each tip were 
determined using the AFM before they were functionalized with an API particle 
and the spring constants calculated by Saders method (Sader et al., 1995). The 
spring constants for the V-shaped tips were between 0.3 and 0.5 Nm-1. Each of 
the API particles was mounted onto the AFM cantilevers using the EnviroScope 
AFM. A black card was attached to a metal stub using a carbon stub where a thin 
line of glue was spread in the middle of the black card surface. 
 
A sacrificial tip was used to draw thin perpendicular lines of the adhesive glue 
from bulk glue in order to enable the functionalization of the tip. This tip was 
then replaced with a silicon V-shaped cantilever of known spring constant for the 
functionalization, and the cantilever tip was then approached to the thinner line 
of the glue, to enable the coating of the tip with the glue. Immediately after 
coating the tip with the glue, the resin substrate was then removed and replaced 
with the appropriate powder sample. Using the optical view of the AFM system, 
small individual powder particles/crystals were identified and aligned with the 
position of the tip. The cantilever was then positioned over a single API particle 
and carefully lowered manually onto a single particle. Enough pressure was 
maintained to all the attachment of the API particle onto the tip. On retraction of 
WKH FDQWLOHYHU WKHSDUWLFOHZDV DGKHUHG WR WKH WLS DQG WKLV µFROORLGSUREH¶ZDV
left to dry for a minimum of 24 hours before further use. Each API probe was 
produced in triplicate. Correct positioning of the particle on the cantilever was 
verified using SEM before and after AFM analysis. Samples were not gold 
coated, as this will render the tips unsuitable for force determination. The colloid 
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probes were mounted to carbon disks attached to aluminium stubs suitable for 
SEM use, then imaged using an acceleration voltage of 2.5 kV and a spot size of 
45mm. Other parameters were adjusted in order to achieve better resolution 
images. An example of a SEM image of a colloid probe is shown in Figure 2-15. 
 
 
Figure 2-15: SEM image of a colloid probe (drug particle attached to an AFM cantilever) 
suitable for subsequent AFM analysis. 
 
2.3.7.4 AFM Tip Characterization 
 
Preceding any force measurement analysis, each of the colloid probes was 
imaged using an AFM tip-characterisation method. Tip characterisation was 
performed using an EnviroScope AFM (Veeco, Santa Barbara, CA, USA) and a 
tip characterization grid (TGT01; NT-MDT, Moscow, Russia), which is 
composed of a series of repeating sharp spikes, using a method detailed 
elsewhere (Hooton et al., 2004). To summarize the method for characterizing the 
tip, a topographical image of the particle surface is produced as the colloid probe 
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is scanned over the nanoscaled spike. The resulting topographical image is due to 
the spike being sharper than the asperities present on the surface and hence 
leading to an inverse imaging of the colloid particle rather than the surface of the 
grid (Williams et al., 1996). This approach allows the visualisation of any 
morphological changes occurring to the colloid probe particle following 
adhesion measurements. Furthermore, it allows the determination of the contact 
radius and contact area between the particle and a surface. 
 
2.3.7.5 AFM Force Measurements 
 
Each pMDI component stub or API stub was placed in a glass sample chamber 
to undertake AFM force measurements using an EnviroScope AFM (Veeco, 
Santa Barbara, CA, USA). Each colloid probe was inserted into a cantilever 
holder suitable for liquid AFM work. This latter was then placed onto the AFM 
and accurate laser alignment was established onto the tip of the colloid probe. 
The colloid probe was then lowered towards the surface until it was 
DSSUR[LPDWHO\ȝPDZD\IURPWKHVXUIDFHPORIPRGHOSURSHOODQW++
decafluoropentane (referred to mHFA hereafter) (Apollo Scientific, Stockport, 
UK) were then added to the sample chamber that allowed the sample and the 
probe to be completely submerged in the propellant. A Laser re-alignment was 
performed, before approaching the surface and undertaking force measurements 
once contact had been made. One hundred force measurements were taken over a 
 ȝP [  ȝP DUHD XVLQJ HDFK SUREH DJDLQVW HDFK VXUIDFH 7KH force 
measurements were conducted at 10°C and force data was calculated using 
custom software. 
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The force data is produced in the form of a force curve. If the cantilever and 
sample are kept in fixed lateral positions, the substrate (or cantilever) can be 
moved onto and off the cantilever (or substrate) by applying a voltage. When 
nearing contact the sample will very often attract the tip prior to a fixed level 
FRQWDFWFDXVLQJDµMXPSLQ¶GHIOHFWLRQLHWLSEHQGVLQWRFRQWDFWZLWKVXUIDFH
The piezo input then continues the sample/cantilever movement until a pre-set 
value for the stage height (z-coordinate) is reached. The stage then reverses, and 
the sample and tip will separate. However this separation will occur only when 
the restoring force of the cantilever (spring constant) surpasses the interaction 
force of the tip and sample, and as such the negative deflection of the cantilever 
below the non-contact output can be used to quantify the interaction force 
described (Sindel and Zimmermann, 2001)%\DSSO\LQJ+RRNH¶VODZ(TXDWLRQ
2-3): 
 
Fadh = -kz        Equation 2-3 
 
Where k is the spring constant of the cantilever and z is the cantilever deflection 
at the moment of separation, the interaction force Fadh can be calculated. This 
PHWKRG RI RSHUDWLRQ LV FDOOHG µIRUFH¶ PRGH DQG )LJXUH -16 shows a 
representation of the generation and interpretation of a single force curve and the 
relative deflection signals involved: 
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Figure 2-16: A typical AFM force curve cycle (Sindel and Zimmermann, 2001). 
 
If a particle of interest (i.e. drug particle) is attached to the cantilever tip prior to 
force measurement, the force of interaction between that particle and the 
substrate can be measured (Ducker et al., 1991). While other techniques 
(centrifugation, tensiometry etc) may offer control over selected variables and 
bulk adhesion assessment (Salazar-Banda et al., 2007, Lohrmann et al., 2007), 
AFM offers the chance to manipulate several variables (temperature, humidity, 
force of contact etc.) without compromising other elements of the technique. 
Significantly this technique affords a method of experimentally determining the 
Fadh on a single particle level, and therefore a mean to explore the interfacial 
forces involved (Butt et al., 2005).  
 
However, the use of real particles to probe surfaces has obvious problems 
DVVRFLDWHG ZLWK LW 0RVW FULWLFDOO\ E\ XVLQJ D µUHDO¶ SDUWLFOH WKHUH is an almost 
complete loss of control of the morphology of the tip and hence the contact 
region with a substrate. Considering the importance of contact geometry upon 
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such fine scale interaction, as described above, this has rendered adhesion 
measurements made by this technique specific on a probe by probe basis. Hence, 
even adhesion measurements on the same substrate made with two different tips 
of the same material, may often exhibit huge differences in the forces calculated, 
and therefore it is very difficult to compare experimental data (Farshchi-Tabrizi 
et al., 2006). To ease any relative conclusions to be drawn between two sample 
materials, the same tip therefore needs to be employed for force measurement. 
This can be problematic in itself, as continued tip use can lead to wear of a 
particle and hence change in the contact area and potentially the form (Butt et al., 
2005).  
 
The calculated adhesion forces can be presented as a frequency distribution in 
order to illustrate the distribution of force measurements recorded during an 
experiment. If each set of force curves are normalised for contact radius, and are 
normally distributed, it follows that the data from different probes may be 
grouped together, allowing for the mean and the standard deviation to be 
calculated. Normally distributed force data is illustrated in Figure 2-17. 
 
 
 
 
 
 
 
 
Figure 2-17: An example of a frequency distribution of normalised force of adhesion data. 
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2.3.8 Particle Size Determination 
 
Particle size in inhaler formulation is critical as the size of the particles is very 
important for efficient drug delivery and successful therapy. This is because 
particles larger than a certain size tend to simply land in the mouth and throat 
and mostly do not enter into the lung. A similar problem arises if the particles are 
too small, as these will be exhaled or swallowed by the patient. Thus, IPAs are 
usually designed to produce drug particles of the specific size range suitable for 
lung delivery (ca. 1-5µm). Particles within a pMDI formulation can be subject to 
many different factors that would lead to changes in particle size within the 
formulation.  
 
Light scattering (LS) is a phenomena that can be used to determine the size 
distribution profiles of particles in suspensions. It is one of the most popular 
methods used to determine the size of particles. In one approach, monochromatic 
light beam is scattered from ³spherical´ particles in Brownian motion causes a 
Doppler Shift and change in wavelength of the scattered light (Berne and Pecora, 
2000). This change is related to the size of the particle. It is possible to compute 
the sphere size distribution and give DGHVFULSWLRQRIWKHSDUWLFOH¶VPRWLRQLQWKH 
medium, measuring the diffusion coefficient of the particle and using the 
autocorrelation function. 
 
In another approach (and as used here) particles passing through a laser beam 
will scatter light at an angle that is directly related to their size (Aubin et al., 
2010). As particle size decreases, the observed scattering angle increases 
logarithmically. Scattering intensity is also dependent on particle size, 
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diminishing with particle volume. Large particles therefore scatter light at 
narrow angles with high intensity, whereas small particles scatter at wider angles 
but with low intensity (Berne and Pecora, 2000). It is this behaviour that 
instruments based on laser diffraction exploit in order to determine particle size. 
The dynamic range of the measurement is directly related to the angular range of 
the scattering measurement, with modern instruments making measurements 
from around 0.02 degrees through to beyond 140 degrees. The wavelength of 
light used for the measurements is also important, with smaller wavelengths (e.g. 
blue light sources) providing improved sensitivity to sub-micron particles 
(Agrawal et al., 1991). 
 
Particle size diVWULEXWLRQV DUH FDOFXODWHG E\ FRPSDULQJ D VDPSOH¶V VFDWWHULQJ
pattern with an appropriate optical model. Traditionally two different models are 
used: the Fraunhofer Approximation and the Mie Theory. The Fraunhofer 
approximation assumes that the particles being measured are opaque and scatter 
light at narrow angles. As a result, it is only applicable to large particles and will 
give an incorrect assessment of the fine particle fraction (Xu, 2000, Malvern, 
2010).  Mie Theory predicts scattering intensities for particles, and provides a 
more rigorous solution for the calculation of particle size distributions from light 
VFDWWHULQJ GDWD ,W LV EDVHG RQ 0D[ZHOO¶V HOHFWURPDJQHWLF ILHOG HTXDWLRQ 0LH
theories assumes that the particle are spherical and are present in a dilute 
suspension (Aubin et al., 2010). Mie Theory allows for primary scattering from 
the surface of the particle, with the intensity predicted by the refractive index 
difference between the particle and the dispersion medium (Malvern, 2010). The 
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Mie theory is more appropriate for analysis of the diffraction patter of particles 
that less than 10 µm. 
 
A Coulter LS 230 (Beckman, Coulter Corporation, USA) using Fraunhofer mode 
was used during this project. The Coulter LS 230 uses a laser of 750 nm and a 
double Fourier lens setup for focussing the scattered light on the ring-shaped 
detector setup (Fig. 2-18). The detection range (angles) for diffraction is 40 nm - 
2000 µm, thus theoretically covering the size range expected here. The LS uses 
reverse Fourier lens optics incorporated in a patented binocular lens system. This 
enables the LS to optimize light scattering across the widest dynamic range in a 
single scan (Coulter, 2010). The detector segments are arranged in three main 
areas: a low-angle detector (L) with 62 detector elements, mid- (M) and high-
angle (H) detector comprised of 32 elements each, allowing high-resolution of a 
wide particle size range (Pye and Blott, 2004). The amount of sample required is 
determined by the obstruction percentage of the laser beam through the sample  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2-18: Schematic diagram of the LS 230 Coulter (adapted from (Pye and Blott, 2004)). 
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cell, with the recommended range between 8 and 12 %, which equates 5mg of 
API suspended in 10ml of the propellant. The suspension was sonicated for 5 
minutes to allow disaggregation of the particles. 100 µl of the API suspension 
samples were diluted into 20 ml mHFA in the sample cell. Higher concentrations 
of API suspensions were used to achieve similar scattering intensities (about 
4 ml into 20 ml). 
 
2.3.9 Size Reduction 
 
Size reduction is used widely throughout the pharmaceutical industry for the 
reduction of API particle size and size range. Size reduction is used to increase 
surface area and improve formulation properties and is used in inhaler 
formulation for the production of a particle size that is suitable for inhalation It is 
also used to maintain a consistent particle size distribution (PSD) for a 
formulation, thus allowing for a better quality mixture especially for powder 
when used in tablets and capsules. The primary benefit of size reduction in 
inhaler formulation is the increase in solubility/bioavailability due to the increase 
in surface area. 
 
Size reduction on the different APIs used during this project was carried out by 
ball milling using a Restsch® MM 400 ball-miller (Restsch, Germany). The 
milling intensity was the maximum with a frequency of 30 Hz and was carried 
out for 2 hours on 500 mg of the each of the samples. 
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3 Chapter 3  Physico-chemical characterization of 
a model propellant clathrate formed in a 
pressurized metered dose inhaler 
 
 
3.1 General Introduction 
 
The replacement of chlorofluorocarbon (CFC) with hydrofluoroalkane (HFA) 
propellants has challenged formulators of pressurized metered dose inhalers 
(pMDIs) in several major aspects. Due to the increased polarity of HFA, the use 
of alternative (soluble) surfactants or co-solvents along with traditional 
surfactants is required in order to stabilize pressurized suspension products. The 
surfactant type and composition, as well as drug concentration and particle size 
may have an effect on the solubility of an active pharmaceutical ingredient (API) 
and, also on any related crystal growth and consequently the efficacy of the 
formulation. 
 
Drug particles used in the presence of CFC or HFA can have the tendency to 
IRUP³FODWKUDWHV´RUPROHFXODUDVVRFLDWLRQRIYDULDEOHstoichiometry (Phillips and 
Byron, 1994). Clathrates are solid solutions consisting of polyhedral cavities 
(Koh, 2002) that arise from the API molecules being linked through hydrogen 
(Englezos, 1993).  Host molecules are linked through hydrogen bonding to form 
a regular 3D structure in a connected network (Plumridge and Waigh, 2002) and 
create cavities (host lattice) that can enclose a large variety of other molecules 
(guests) (Englezos, 1993). Guest molecules occupy fully (hydrogen bonded to
 the host network) or partially (occupying void spaces) the cages in the host 
framework (Patchkovskii and Tse, 2003). Thermodynamic stability of clathrate 
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depends strongly on the size and shape of the guest molecules (Buffett, 2000) 
which must be small enough to fit into the cavities of the lattice but large enough 
to lend stability to the structure (Buffett, 2000). The area of crystal engineering 
provides insight into the physical and chemical properties of the new solid states 
formed by understanding the intermolecular interactions in the context of crystal 
packing (Desiraju, 2007). Different areas can be followed to determine the 
physicochemical characteristics of the clathrates that include: 1) the study of 
intermolecular interaction, 2) the study of packing modes and 3) the study of 
crystal properties (Englezos, 1993). 
 
Beclomethasone dipropionate (BDP) is a widely used corticosteroid for the 
treatment of asthma. BDP is formulated in pMDIs in the presence of a propellant 
and other formulation ingredients (Millard and Myrdal, 2002). Since the solid 
state chemistry can significantly alter the therapeutic effect of the formulation, it 
is crucial to determine the most stable crystal form in the presence of the 
propellant. BDP crystallizes with a channel structure forming a clathrate with the 
propellant that allows the insertion of CFC-11/HFA-134a molecules. The 
structure is held together through hydrogen bonding (Harris et al., 2003). When 
BDP is suspended in a pMDI formulation containing CFC-11, rapid crystal 
growth occurs. This has been attributed to the association of BDP and CFC-11 to 
the formation of a clathrate. The formation of these crystals in the pMDI can be 
problematic especially if they are large, as upon inhalation, the particles will 
impact on the orapharynx rather than the bronchioles or pulmonary regions of 
the lung where they are required to exert their therapeutic effects. Furthermore, 
large particles may also disrupt the operation of the valve. 
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While the crystal structure of the BDP CFC-11 clathrate has been investigated 
with respect to resolving the structure (Vervaet and Byron, 1999a), to the author 
knowledge, there is little information on the physico-chemical characteristics of 
the BDP CFC-11 clathrate and its stability.  
 
3.1.1 Chapter Aims and Objectives 
 
This chapter will investigate and characterise the physico-chemical properties of 
beclomethasone dipropionate (BDP) crystallized from 
trichloromonofluoromethane (CFC-11).  X-ray photoelectron spectroscopy 
(XPS) and X-ray powder diffraction (X-RPD) will be used to determine the 
surface chemistry and the purity of the samples. Additionally, thermal analysis 
will be used to determine the phase behaviour of the clathrate upon heating. 
Following the surface characterisation of the BDP CFC-11 clathrate, the effect of 
different BDP, CFC-11 concentration will be used in order to determine its 
influence on clathrate formation. Finally, Raman spectroscopy was used to 
determine the chemistry changes of the clathrate upon heating the clathrate to its 
melting point. From these results it may be possible to characterise the BDP 
CFC-11 clathrate and determine the effect of any changes on the chemistry of the 
latter on the potential interactions within a pMDI. 
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3.2 Materials and Methods 
 
3.2.1 Materials 
 
Anhydrous BDP (micronized) was purchased from Sicor (Italy) and CFC-11 was 
supplied by Arkerma (UK). All other chemicals were purchased from Sigma-
Aldrich Company Ltd (UK), unless otherwise indicated. 3M Drug Delivery 
Systems (UK) supplied a micronized isopropyl alcohol (IPA) clathrate of BDP 
for investigation (EP 205530).  
 
3.2.2 Methods 
 
3.2.2.1 Isolation of BDP CFC-11 clathrate 
 
Anhydrous BDP was suspended in CFC-11 in a pressure resistant vial. The 
concentrations of the API were, 0.1, 0.5, 1.67, 2, 2.5 and 3% w/w BDP in CFC-
11. All formulations were shaken using a Stuart SF1 flask shaker (Barloworld 
Scientific Ltd, UK) for 2 hours at 800 oscillations per minute DQGVWRUHGDWÛ&
for 24 hours. The material was isolated by vacuum filtration, using a glass filter, 
washed three times using the filtrate suspension, in order to filter as much as 
possible of the suspension. Excess propellant was then removed by evaporation 
for 24 hours under room temperature and pressure (Phillips and Byron, 1994). 
The extracted crystals were stored in glass vial under nitrogen after being sealed 
with a vial screw and Parafilm (Alcan, Neenah, WI, US), and stored in a fridge at 
5°C prior to use. 
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3.2.2.2 Scanning Electron Microscopy (SEM) 
 
The particle size and morphology of the synthesized clathrates were analysed by 
SEM using a JEOL JSM-6060LV (JEOL (UK) Ltd, Welwyn Garden City, UK) 
at various magnifications. The samples prepared, were mounted onto carbon 
stubs and then sputter coated with a thin layer of gold (20 nm thickness) in an 
argon atmosphere (50Pa) at 30 mA for 4 minutes for SEM analysis. SEM 
analysis was carried out at an appropriate accelerating voltage (between 1 keV 
and 10 keV) and a spot size between 48nm and 62 nm. These parameters were 
varied for each sample in order to optimise each particular image. For BDP 
CFC-11 clathrates, SEM images were taken before and after clathrate formation 
to determine whether any morphological changes occurring during the process.  
 
3.2.2.3 X-ray Photoelectron Spectroscopy (XPS) 
 
BDP and BDP CFC-11 clathrate samples were analysed using XPS in order to 
determine surface elemental composition using a Kratos AXIS ULTRA 
spectrometer (Kratos Analytical, Manchester, UK) with a mono-chromDWLF$O.Į
X-ray source (1486.6eV) operated at 15mA emission current and 10kV anode 
potential. The ULTRA was used in fixed analysed transmission (FAT) mode, 
with pass energy of energy 20eV for high resolution scans. A wide survey scan 
and high resolution scans were performed on each sample. Wide scans were run 
for 5-10 minutes and high resolution scans for 10-30 minutes. Data analysis was 
carried out using CASAXPS software with Kratos sensitivity factors to 
determine the atomic percentage (atomic %) values from the peak areas. The 
irradiating X-rays were emitted at a take-off angle of 90 degrees. 
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3.2.2.4 X-ray Powder Diffraction (X-RPD) 
 
X-RPD patterns were collected on a Bruker D8 diffractometer system (Bruker 
AXS, Madison, WI, USA), operating in a Debye-Scherrer geometry. A ceramic 
X-UD\WXEHZLWKDFRSSHUWDUJHWZDYHOHQJWKȜ ǖRSHUDWHGDWN9
mA. A scintillation counter was employed. The scan rate was 2° / min and the 
chart speed was 1cm / min. The X-ray patterns were analysed using the Le Bail 
method (Le-Bail et al., 1988) to model the patterns obtained, based on the 
reported unit cell for the clathrate. All the patterns were collected straight after 
the formation of the crystals to determine the purity of the samples and its 
crystalline structure. Theoretical diffraction patterns were calculated using 
Mercury 1.4.2 software (The Cambridge Crystallographic Data Centre, 
Cambridge, UK) 
 
3.2.2.5 Thermogravimetric analysis (TGA) 
 
A SDT Q600 TGA/DSC was used to record the weight loss of the samples 
between 25Û& DQG Û& 'U\ QLWURJHQ JDV ZDV XVHG DV D SXUJH DQG WKH VFDQ
VSHHGZDVÛ&PLQ$QLVRWKHUPDOSHULRGDWÛ&ZDVUXQIRUPLQXWHVSULRU
to the measurements and any changes in weight during that period were 
monitored. In all measurements 6 to 7mg of sample was used in an open 
aluminium pan. The thermograms obtained from the TGA results were analysed 
using TA universal analysis -NT software. 
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3.2.2.6 Differential Scanning Calorimetry (DSC) 
 
DSC experiments were carried out using a DSC 2920 Differential Scanning 
Calorimeter (TA InstrumeQWV86$ZLWKDFRQVWDQWÛ&PLQKHDWLQJUDWHIURP
Û& WR Û& LQ D GU\ QLWURJHQ DWPRVSKHUH 1RQ-sealed aluminium pans were 
used in order to allow propellant to escape during the desolvation phase. In all 
measurements 6 to 7mg of sample were used. When it was required, 
simultaneous TGA/DSC measurements were performed under identical 
conditions using a SDT Q600 TGA/DSC (TA instruments, USA). The 
thermograms obtained for the DSC results were analysed using TA universal 
analysis -NT software. 
 
3.2.2.7 Variable Temperature X-Ray Powder Diffraction (VT-XRPD) 
 
VT-XRPD patterns were collected on a Bruker D8 diffractometer system 
(Bruker AXS LTD., Coventry, UK) operating in a Debye-Scherrer geometry. X-
ray radiation was generated inside a ceramic X-ray tube from an anode made of 
FRSSHU&XLQ.ĮVSHFWUDOOLQHDWZDYHOHQJWKȜ c7KHGLIIUDFWRPHWHULV
equipped with a scintillation detector and Bruker Kristalloflex generator set on 
voltage 40kV and current 40mA. Samples were loaded in borosilicate glass 
capillary tubes BGCT with 0.7mm bore diameters (CTS Capillary Tube Supplies 
Ltd UK) and mounted on the goniometer in a preferable orientation. Samples 
ZHUHVFDQQHGIURPș ÛXQWLOÛDWDVHFVWHSVSHHGLQLQFUHPHQWVRIÛ
stepwise. DIFFRACplus software package version 2.3 was used for data 
acquisition. Cryostream Plus controller (Oxford Cryosystems Ltd., Long 
Hanborough, Oxford, UK), a heating-cooling system was provided for VT-
Chapter 3 ± Physico-chemical Characterization of a Model Propellant 
Clathrate Formed in a Pressurized Metered Dose Inhaler 
 
 103 
XRPD which was controlled by a Cryopad PC programme for VT-XRPD scans. 
VT-XRPD scanV ZHUH VHW IURP ș  Û XQWLO Û DW D VHFVWHS VSHHG LQ
LQFUHPHQWVRIÛDFTXLUHGHDFKÛ&IURPKHDWHGVDPSOHDWDUDWHRIÛ&PLQ
starting from 20-221Û & at a rate of a 3Û &/min. All patterns were collected 
straight after the formation of the crystals to determine the purity of the samples 
and its crystalline structure and prevent any decomposition and/or 
contamination. 
 
3.2.2.8 Modulated Temperature DSC (MDSC) 
 
MDSC experiments were carried out using a DSC 2000 Differential Scanning 
Calorimeter (TA Instruments, USA). MDSC measurements were conducted 
using sine wave temperature programmes defined by underlying heating rate, 
amplitude and period. Samples of anhydrous BDP and BDP CFC-11 clathrates 
were equilibrated at anGWKHQNHSWDWÛ&IRUPLQXWH WKH samples were then 
heated at a rate of 1°C/min until melted. The  temperature  was  oscillated  at  an  
amplitude  of  0.5°C  each 30 seconds.  Non-sealed aluminium pans were used in 
order to allow the propellant to escape during the desolvation phase. In all 
measurements, accurately weighed 7±0.2mg of the samples were used. The 
temperature and the enthalpy were calibrated against an indium standard. The 
thermograms obtained for the DSC results were analysed using TA universal 
analysis -NT software. 
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3.2.2.9 Raman Spectroscopy 
 
A small amount of anhydrous BDP and BDP CFC-11 crystals were spread on a 
microscope slide. Raman spectra were recorded with a Raman microscope 
(LabRam, Horiba Jobin Yvon, UK). Data processing was performed using 
LabSpec 5 (Horiba Jobin Yvon). The instrument conditions were: 200 µm wide 
confocal hole, 150 µm wide entrance slit, 600 gr/mm grating, and 100X LWD 
objective lens. Various exposure times (100, 300 and 900 ms) were used to a 
range of signal-to-noise ratios (S/N). An XYZ motorized stage (Marzhauzer) and 
a HeNe laser (783 nm) were used. Spectra were obtained using a near infrared 
diode laser operating at 783 nm working with a power source typically below 
300 mW. The spectral range measured was 0 ± 2000 cm-1. Raman calibration 
was performed before acquiring Raman measurements. This was achieved on a 
standard silicon (Si) sample. 
 
3.2.2.10 Variable temperature Raman spectroscopy 
 
Small amounts of BDP CFC-11 crystals were spread on microscope slides. 
Samples were then heated at 1Û&PLQ using a XY manual cooling/heating stage 
(Linkam LTS350) with TMS94 temperature controlling programme and LNP94 
cooling system with a 2 litres dewar for liquid nitrogen. Spectra were collected 
HYHU\ Û& IURP Û& WR Û& The instrument parameters concerning the 
Raman microscope used were the same as above. The spectral range measured 
was 0 ± 4000 cm-1. 
 
Chapter 3 ± Physico-chemical Characterization of a Model Propellant 
Clathrate Formed in a Pressurized Metered Dose Inhaler 
 
 105 
3.3 Results and Discussion 
 
3.3.1 SEM Analysis 
 
Anhydrous BDP suspended in CFC-11 showed a rapid growth of the crystals. 
SEM images of both anhydrous BDP and the crystals extracted from BDP CFC-
11 suspension are shown in Figure 3-1. There are considerable differences in the 
morphology of the two different forms of BDP. Anhydrous BDP appear more 
spherical in comparison with the crystals from BDP CFC-11 suspension 
exhibiting a well-defined crystals with hexagonal morphology. The crystals are 
polydispersed, with a size range of 30 to 70 µm. The particles of anhydrous BDP 
observed using SEM (Fig. 3-1) showed round quasi-spherical particles of less 
than 5 µm in size. 
 
 
 
Figure 3-1: SEM images of anhydrous BDP (left) and Crystals from BDP CFC-11 suspension 
(right). 
 
3.3.2 X-RPD results 
 
Diffraction techniques are definitive tools for detecting and quantifying 
molecular order in a system  (Shah et al., 2006). Four crystal structures have 
been reported and filed with the Cambridge Structural Database (CSD) for BDP 
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and its compounds: one for anhydrous BDP (Millard and Myrdal, 2002); one for 
BDP monohydrate (Duax et al., 1981); one for the HFA-134a clathrate (Harris et 
al., 2003); and one for the BDP ethanol clathrate (Kuehl et al., 2003). For the 
clathrates, only partial crystal structures are available: the guest molecules are 
disordered and only the atomic co-ordinates of the framework BDP molecules 
have been reported. The two reported clathrate structures are identical for all 
intents and purposes. The single-crystal derived structural data reported in the 
literature for these compounds were determined at 100 K, 271 K, 170 K and 170 
K respectively. 
 
For the sample of as-received anhydrous BDP, when the effects of thermal 
expansion were accounted for, we achieved an excellent match when comparing 
our room temperature data with a pattern calculated from the reported 100 K 
structure of BDP (ca. 4.5 % increase in volume at room temperature compared to 
100 K). The Rietveld method was used to model the entire powder pattern 
profile and to calculate lattice parameters. The as-received material can therefore 
be unambiguously identified as identical with the previously reported anhydrous 
BDP (Millard and Myrdal, 2002), and our bulk sample is predominantly 
crystalline, and pure, within the limits of our data collection, analysis, etc.  
 
A fair match was obtained for anhydrous BDP suspended in CFC-11 when 
comparing our data with patterns calculated based on the partial structures 
reported for the BDP HFA-134a and BDP ethanol clathrates (Fig. 3-2). The lack 
of an excellent match is expected given that the reported structures do not 
include the guest molecules. 
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Figure 3-2: Superimposition of experimental BDP CFC-11 clathrate X-RPD pattern with that of 
the calculated BDP EtOH HFA-134a clathrate X-RPD pattern without the solvent. 
 
A more rigorous comparison, using the Le Bail method (Le-Bail et al., 1988) to 
fit the observed pattern using the unit cell reported for the clathrate (and allowing 
for thermal expansion, ca. 1.5 % increase in volume at room temperature 
compared to 170 K) produces an excellent fit of the data, with no extra peaks 
present in the pattern. Particular care was taken to examine the regions of the 
pattern where peaks from anhydrous BDP might be observed. In addition to 
providing confidence that the bulk sample of anhydrous BDP suspended in CFC-
11 is pure BDP CFC-11 clathrate (referred to it hereafter as BDP CFC-11 
clathrate) (and has the clathrate unit cell), the Le Bail method allows us to 
estimate the ³LGHDOLVHG´FRPSRVLWLRQRIWKHFODWKUDWHLIVSDFHILOOLQJLVDVVXPHG
Using the tabulated atomic volumes of Hofmann and Mighell (Hofmann, 2002, 
Himes and Mighell, 1987), a single BDP molecule is expected to occupy ca. 685 
Å3. Given that at room temperature the unit cell volume is 4959 Å3 from our Le 
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Bail analysis, and that the unit cell of the clathrate contains six BDP molecules 
(Harris et al., 2003, Kuehl et al., 2003), there is 850 Å3 of void space. If this void 
space is completely occupied by CFC-11 of approximate volume 100 Å3 per 
molecule, the overall stoichiometry for the CFC-11 clathrate is expected to be 
approximately BDP CFC-11 1:1.4. Likewise, for an EtOH molecule of 
approximate volume 70 Å3, a stoichiometry of BDP EtOH of 1:2 is expected1. 
 
3.3.3 XPS results 
 
Both anhydrous BDP and BDP CFC-11 clathrate were analysed using XPS and 
ATR-IR spectroscopy in order to determine the elemental composition of each of 
the compounds in particular CFC-11 inclusion. ATR-IR spectroscopy was 
performed on a small amount of the different concentrations of BDP CFC-11 
clathrates (Fig. 3-3) in order to show the presence of fluorine on the clathrate 
crystal obtained. The spectra obtained showed very noticeable peak at a 
wavenumber of around 1000 cm-1. This peak was ascribed to CFC-11 peak 
[Integrated Spectral Database System of Organic Compounds (SBDS)]. 
 
Wide scan XPS results obtained for the anhydrous BDP, BDP CFC-11 clathrate 
0.5% w/w and BDP IPA clathrate are represented in Figure 3-4. The main peaks 
shown on the different scans are at 282, 530 and 197 eV which correspond to 
oxygen, carbon, and chlorine respectively. These elements constitute the 
backbone structure of BDP.  A very small peak at 685 eV position can be seen in 
                                                 
1
 These stoichiometries are necessarily estimates. For comparison, the unit cell volume of 
anhydrous BDP is 2655.9 Å3 from X-RPD, and 2680 Å3 from the simple atomic volume 
calculation, which corresponds to a volume per BDP molecule of 664 Å3 from X-RPD vs 670 Å3 
from the simple calculation. 
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the scan obtained for the BDP CFC-11 clathrate (Fig. 3-4B) which is ascribed to 
fluorine and hence is consistent with the formation of the clathrate.  
 
 
 
 
 
A 
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Figure 3-3: ATR-IR spectrum of A- CFC-11 as taken from the Integrated Spectral Database 
System of Organic Compounds (Data were obtained from the National Institute of Advanced 
Industrial Science and Technology (Japan)), B- Anhydrous BDP and C- BDP CFC-11 Clathrates. 
C 
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The surface composition of both BDP CFC-11 clathrate at a concentration of 
0.1% and 0.5% w/w BDP in CFC-11 did not show any significant changes in the 
atomic percentage of all the atoms present in the structure between the two 
different concentrations (Table 3-1). A very small change in the atomic 
percentage can be noticed for both anhydrous BDP and BDP IPA clathrate. The 
results obtained for both anhydrous BDP and BDP IPA clathrate (ratio of 1:1.5 
BDP to IPA as IPA has a volume of approximately 94 Å3) are quite consistent 
and comparable to the theoretical atomic percentage calculated (Table 3-1). 
However, for BDP CFC-11 clathrate, the results obtained seem quite different 
from the theoretical atomic percentage calculated for the 1:1.4 molar ratio of 
BDP to CFC-11. The results obtained showed a 1:0.4 molar ratio of BDP to 
CFC-11 for the two concentrations stated above. In order to confirm the molar 
ratio observed by XPS, a quantitative elemental analysis on the BDP CFC-11 
clathrate of 0.1 and 0.5% w/w BDP in CFC-11 was performed. The analysis was 
accomplished via the combustion of the crystal and the collection of combustion 
product which is weighed and used in order to calculate the composition of the 
unknown samples. The results showed an average of 58.90% carbon and 6.48% 
hydrogen.   
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Table 3-1: Theoretical and measured atomic percentage of the surface analysis of anhydrous BDP, BDP CFC-11 (0.5 % w/w) and BDP IPA clathrate (n=3). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Atomic % Anhydrous BDP BDP CFC-11 clathrate BDP IPA clathrate 
Theoretical Measured Theoretical Measured Theoretical  Measured 
C 1s 77.77 81.07 ± 1.21 68.37 75.1 ± 0.98 77.5 81.34 ± 0.72 
O 1s 19.44 17.01 ± 0.75 16.28 18.54 ± 0.27 20 16.54 ± 0.2 
Cl 2p 2.78 1.914 ± 0.54 12.09 5.43 ± 0.42 2.5 2.23 ± 0.35 
F 1s 0 0 3.25 0.92 ± 0.12 0 0 
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Figure 3-4: Wide survey scans of A- anhydrous BDP, B- BDP CFC-11 clathrate and C- BDP 
IPA clathrate using XPS. 
 
To summarize, X-RPD, XPS and ATR-IR results show the successful formation 
of BDP CFC-11 clathrates. 
 
3.3.4 Thermal Analysis 
 
Analytical techniques based on the thermal energy principle have been widely 
used to characterise different amorphous and crystalline pharmaceutical systems 
(Shah et al., 2006, Hancock and Zografi, 1997). Crystallization and/or any solid 
state rearrangement can be induced by the thermo-analytical techniques to 
produce an exothermic or an endothermic change which then reveals the position 
of the transition (Shah et al., 2006). The two thermal techniques used to 
characterise the different compounds here were DSC and TGA.  
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3.3.4.1 TGA results 
 
TGA relies on a high degree of precision in three measurements: weight, 
temperature, and temperature change (Shah et al., 2006). No weight loss was 
REVHUYHGIRUDQK\GURXV%'3EHWZHHQDQGÛ&Fig. 3-5A). The weight loss 
observed after 212ºC (i.e. the melting point) is due to combustion of the sample 
(Fig. 3-5A). The loss of CFC-11 from the clathrate structure, observed at around 
Û&LVFRQILUPHGE\WKH7*$UHVXOWVDQGZDVREVHUYHGZLWKWKHGLIIHUHQW%'3
CFC-11 clathrates over the range of concentrations used for the study. The 
results shown in Figure 3-5B are those observed for the highest weight loss of 
CFC-11 from the BDP CFC-11 clathrate. The loss of CFC-11 is expressed as 
14.5% weight loss which corresponds to a 0.6:1 molar ratio of CFC-11 to BDP 
for a 1.67% w/w BDP in CFC-11 clathrate. Different samples of clathrates 
formed by using different concentrations of BDP in CFC-11 showed a different 
weight loss (Table 3-2). The percentage weight loss for this latter material also 
differs from the theoretical weight loss calculated for a molar ratio of 1.4:1 CFC-
11 to BDP. All the measured weight losses of CFC-11 from the clathrates were 
lower than expected (Table 3-2). It was found from these results that CFC-11 
was successfully included in the crystal structure for the different concentrations 
to form a clathrate. The TGA data for the BDP: EtOH solvate showed weight 
loss as soon as the samples were placed in the instrument, before and as soon as 
heating was applied (Fig. 3-5C). This loss of EtOH from the structure as soon as 
the heating was initiated is consistent with the results observed using DSC.  
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Table 3-2: Percentage weight loss of BDP CFC-11 Clathrate at different concentrations (n=3). 
 
 
 
 
BDP CFC-11 clathrate concentration (% w/w) 0.1 0.5 1.67 2 2.5 3 
Percentage weight loss (%) 3.79 ± 0.92 6.14 ± 1.98 13.8 ± 1.5 4.52 ± 0.12 8.39 ± 0.86  4.00 ± 1.77 
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Figure 3-5: TGA curves of A- anhydrous BDP, B- BDP CFC-11 clathrate (1.67% w/w BDP in 
CFC-11) and C- BDP EtOH sROYDWH$OOVDPSOHVZHUHKHDWHGIURPÛ&WRÛ& at a heating rate 
of 10ÛC/min. 
 
Furthermore, the measured weight loss was similar to the theoretical weight of 
BDP: EtOH solvate at a 2:1 molar of EtOH in BDP confirming the formation of 
a solvate (Table 3-3).  BDP: IPA clathrate TGA results show similar results to 
BDP EtOH solvate without the initial weight loss observed at the beginning of 
heating (Table 3-3). 
 
Table 3-3: The different crystal samples encountered together with experimental (TGA) and 
theoretical weight loss in weight % (n=3). 
 
Samples % TGA Weight loss Theoretical % weight loss 
BDP CFC-11 clathrate 
(1.67% w/w) 
13.8 ± 1.5 19.72 (1:1.4 BDP to CFC-11) 
BDP EtOH solvate 9.7 ± 0.78 8.19 (1:1 BDP to EtOH) 
BDP monohydrate ------------ 3.39 (1:1 BDP to H2O) 
BDP IPA clathrate 10.5 ± 1.04 18.7 (1:2 BDP to IPA) 
C 
Chapter 3 ± Physico-chemical Characterization of a Model Propellant 
Clathrate Formed in a Pressurized Metered Dose Inhaler 
 
 120 
Clathrates are described as crystalline solids in which guest molecules occupy 
cavities or channels in the host lattice that are formed upon crystallization 
(Vaidya, 2004). However, in non-clathrate crystal formation i.e. solvates, the 
individual molecules are tightly packed together, with intermolecular spaces 
between neighbouring entities (Vaidya, 2004). The intermolecular voids of the 
crystal are filled by a second, solvent-type molecule or used to complete a 
coordination sphere around a functional moiety. The solvent entities are rather 
loosely held in the lattice. The stoichiometric relationship between host and 
solvent are quite difficult to predict as it depends on the size of the voids and the 
actual size of the solvent and how these interact (Goldberg, 1988). Many of the 
solvates can therefore be considered as a special type of clathrate structure. 
 
Stoichiometric analysis of the clathrates studied in this work showed a ratio of 
host to guest molecules slightly lower than would be expected. This indicates 
that all of the available cavities are not always filled. This can be explained by 
considering the process of clathrate formation where it is thought that clusters of 
host molecules begin to form in solution surrounding the guest molecules, when 
the agglomeration of host molecules reaches a critical size crystal growth begins. 
If the guest molecule is not correctly positioned or oriented at this point it will 
not be enclosed and thus some empty cavities are to be expected (Kuhs et al., 
1997, Vaidya, 2004). In addition the level of cage occupation is thought to be 
influenced by the pressure and temperature at formation. It is also possible for 
each channel to contain multiple small guest molecules (Kuhs et al., 1997). 
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Table 3-4: Stoichiometric relationship of BDP CFC-11 clathrate using calculation of molar ratio of CFC-11 to BDP using results obtained from TGA (n=3). 
 
 
 
 
 
 
Anhydrous BDP suspended in CFC-11 (% w/w) 0.1 0.5 1.67 2 2.5 3 
Number of CFC-11 molecules in the channels 0.1 ± 0.02 0.4 ± 0.04 0.6 ± 0.037 0.35 ± 0.05 0.4 ± 0.02 0.15 ± 0.03  
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The TGA results were used to determine the number of CFC-11 molecules 
present in the channels of the clathrate structure and the EtOH molecules in the 
solvate structure. The results for the BDP: EtOH solvate showed a 1:1 molar 
ratio of BDP to EtOH. In contrast, the TGA data collected for the different 
concentration of BDP CFC-11 clathrates showed a different molecular ratio of 
CFC-11 to BDP with different concentrations of BDP CFC-11 clathrate (Table 
3-4). The increasing then decreasing pattern of the number of molecules in the 
host crystal can be explained by the incorrect positioning or orientation of the 
guest molecules which will lead to molecules being not included and hence the 
formation of empty cavities (Kuhs et al., 1997, Vaidya, 2004). This process is 
influenced by the pressure and temperature at formation. The stoichiometric 
relationship is hence not clear but appears to show an increased molar ratio of 
CFC-11 to BDP with increasing concentration of BDP to CFC-11 during the 
conversion. At 1.67% w/w of BDP to CFC-11, it reaches its maximum with a 
0.6:1 molar ratio of CFC-11 to BDP and then decreases as the concentration 
increases (Table 3-4). 
 
3.3.4.2 DSC Results 
 
DSC is widely used for investigating the phase behaviour of pharmaceutical 
solids and different methodologies based on instrument type can be utilized 
(Shah et al., 2006). Conventional DSC, as used here, is based on a linear heating 
rate of the sample through to its melting point (Shah et al., 2006). DSC data 
obtained for the different samples are shown in Figure 3-6.  
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$QK\GURXV %'3 PHOWV DW DERXW Û& Fig. 3-6A) within limitations of data 
which corresponds to the literature value (Vervaet and Byron, 1999a). The 
thermogram for the BDP CFC-11 clathrate is illustrated in Figure 3-6B. A small 
H[RWKHUPLFRQVHW LVREVHUYHGDWDERXWÛ&ZKLFKPD\EHGXH WRDVROLGVWDWH
rearrangement of the BDP CFC-11 clathrate structure. In addition, an 
HQGRWKHUPLF WUDQVLWLRQ LV VHHQDW DERXWÛC. This is thought to be due to the 
release of CFC-11 from the tunnels of the clathrate structure. The melting point 
of BDP e after CFC- ORVV LVVHHQDWDSSUR[LPDWHO\Û&7KH WZRGLIIHUHQW
transitions for the release of the propellant from the structure are concomitant. 
The complex thermal events around the melting point observed in the different 
DSC curves of the different samples indicate that the BDP undergoes significant 
degradation during melting (Shah et al., 2006). Interestingly, the clathrate retains 
the solvent (CFC-11) until quite high temperatures are reached (100-Û& 
 
 
 
A 
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Figure 3-6: DSC curves of A- anhydrous BDP, B- BDP CFC-11 clathrate, C- BDP EtOH 
solvate, D- BDP IPA clathrate. $OOVDPSOHVZHUHKHDWHGIURPÛ&WRÛ& at a heating rate of 
10Û& /min. 
 
The release of the CFC-11 propellant from the channels of the crystallized BDP 
can be thermodynamically described using the following GiEE¶V IUHH energy 
equation 3-1: 
 
ǻ* ǻ+± 7ǻ6       Equation 3-1 
 
ZKHUH ǻ* LV *LEE¶V IUHH HQHUJ\ N- PRO-1 ǻ+ LV WKH HQWKDOS\ - 7 LV WKH
WHPSHUDWXUH7DQGǻ6LVWKHHQWURS\-.-1).  
 
The process by which the guest molecule is released from the clathrate crystal is 
believed to consist of two stages represented by concomitant exothermic and 
endothermic events. The first step is indicated by a small exothermic event. As 
the temperature increases, ǻ6 PXVt decrease.. This has been attributed to the 
D 
Exo up 
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clathrate crystal undergoing solid state rearrangement/recrystallization. The 
second stage of clathrate decomposition or the desolvation of the clathrate is 
shown by a large endothermic event. A large decrease in heat flow indicates a 
large increase in entropy. This can be explained by the release of the guest 
molecules into the surrounding atmosphere (Vervaet and Byron, 1999). These 
two stages occur simultaneously and cannot be observed as distinct events. This 
is further addressed and investigated in the following modulated DSC section. 
 
 Thermograms were run in a cycle in order to check if the transitions were still 
preVHQW DIWHU KHDWLQJ 7KH F\FOH FRQVLVWHG RI KHDWLQJ WKH VDPSOHV IURP Û& WR
Û& DQG WKHQ UHFRROLQJ WR Û& DQG UHKHDWLQJ DJDLQ WR Û& )RU DOO WKH
samples studied here, the thermograms showed no presence of the transitions 
DIWHU LQLWLDO KHDWLQJ WR Û& Therefore, the solid state rearrangement of the 
clathrate is irreversible and leads to a total loss of the solvent encaged in the 
channels.  
 
The thermograms for both the BDP: EtOH solvate and BDP: IPA clathrate, 
showed an exothermic onset at about 110-13Û& DQG -Û& UHVSHFWLYHO\
(Fig. 3-6C and D).  The magnitude of the exothermic transition was slightly 
variable, due to the non-stoichiometric association of the drug with the solvent 
(Vervaet and Byron, 1999b, Kuehl, 2003) and represents the solid phase which is 
recrystallization followed by desolvation (Vervaet and Byron, 1999). This can be 
explained by a solid state rearrangement of the structure of the solvate/clathrate. 
$ YHU\ EURDG HQGRWKHUPLF SHDN LV REVHUYHG DW DERXW Û& ZKLFK LV YDULDEOH
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between the different batches synthesized and could be attributable to the excess 
EtOH on the samples or on the surface of BDP EtOH solvate. 
 
3.3.5 MDSC Results 
 
On standard DSC, heating anhydrous BDP to the melting point does not show 
any transition as shown previously. MDSC raw data is a complex heat flow 
signal which contains the reversing, non-reversing and phase information. Figure 
3-7 shows a reversing, non-reversing and total heat flow signals of both 
anhydrous BDP and BDP CFC-11 clathrates. When heated, anhydrous BDP 
showed an endotherm in the total heat flow corresponding to the melting 207Û& 
(Fig. 3-7A).  The melting point between standard DSC and MDSC are different 
in temperature due to the exposure of the BDP samples to higher temperature for 
longer time at lower heating rate leading to an earlier degradation. This also 
applies to the different transitions observed. The reversing and non-reversing 
components also follow this endotherm. It can be seen that the reversing signal 
shows a change in the heat capacity in the region of 56-Û&. This transition is 
thought to be due to a solid state rearrangement on the crystal structure of BDP, 
which might confirm the rearrangement observed when CFC-11 was released 
from the clathrate structure upon heating. When looking at Figure 3-7B 
corresponding to the MDSC curve of BDP  
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Figure 3-7: MDSC curves of A- Anhydrous BDP and B- BDP CFC-11 clathrate. All samples 
were heated to 250 °C. 
A 
B 
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CFC-11 clathrate, it can be seen that the heat flow curve shows the same 
transition as seen in standard mode DSC (Chapter 3, Section 3.3.4.2) with an 
exothermic peak at approximately 90 °C followed by an endothermic peak that 
confirms the release of CFC-11 from the crystal structure of the clathrate and 
then the last endothermic peak at 208 °C representing the melting of BDP. The 
non-reversing heat flow shows an endothermic onset followed by an exothermic 
onset at 80 °C. This shows a structural rearrangement/ recrystallization of the 
sample which is identical with the results obtained by conventional DSC 
(Chapter 3, Section 3.3.4.2).  
 
In order to confirm that the release of the propellant from the clathrate structure 
is due to a structural rearrangement of the clathrate structure to the anhydrous 
from of BDP, an X-RPD pattern was taken after heating both anhydrous BDP 
and BDP CFC-11 clathrates to 150 °C as after this temperature both compound 
exhibit the same and only transition of melting. The X-RPD patterns obtained are 
shown in Figure 3-8 and compared to the calculated anhydrous BDP pattern.  
The crystal structural change was confirmed by X-RDP pattern obtained after 
heating BDP CFC-11 clathrate to 150 °C where the propellant was released from 
the crystal structure of the clathrate and these results showed that the compound 
present was pure anhydrous BDP due to the excellent match of both the obtained 
pattern of heated anhydrous BDP and BDP CFC-11 clathrate with the calculated 
pattern of anhydrous BDP. In conclusion from the results obtained in the sections 
above, the release of CFC-11 from the clathrate structure is undoubtly due to a 
structural rearrangement of clathrate structure to the anhydrous from of BDP that 
lead to the release of CFC-11. 
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Figure 3-8: X-RPD patterns of heated anhydrous BDP and BDP CFC-11 clathrate. 
 
3.3.6 VT-XRPD Results 
 
Variable temperature XRPD analysis showed that the BDP CFC-11 clathrate 
entity was stable between room temperature and approximately 71 ºC (Fig. 3-9). 
No crystal transformation was observed between these temperatures. Further 
increases in temperature lead to transformation of BDP CFC-11 Clathrate to a 
different crystal form (Fig. 3-9A and 3-9B). The XRPD of this crystal form by 
heating BDP CFC-11 clathrate to >150ºC was comparable to the crystal structure 
of anhydrous BDP (Millard and Myrdal, 2002). Therefore, this confirmed the 
transformation of the clathrate to anhydrous BDP. The data in Figure 3-9 
furthermore showed that melting and degradation process of BDP CFC-11 
clathrate started at temperature approximately 210 °C. This degradation process 
was clearly illustrated by changes in the crystal structure observed at these  
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Figure 3-9: VT-XRPD patterns of BDP CFC-11 clathrates.. A and B are the magnified areas 
from lef to right respectively. 
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temperatures and by the formation of an amorphous form at higher temperatures 
(Fig. 3-9). 
 
The pre-heated BDP CFC-11 clathrate heated to 150 ºC was analyzed upon a 
heating cycle consisting of cooling the entity to room temperature and then 
acquiring VT-XRPD patterns as described above. The results obtained are shown 
in Figure 3-10. The pattern confirmed the transformation of the clathrate to the 
anhydrous form of BDP upon heating to 150 ºC when comparing the XRPD 
pattern to the calculated pattern (Millard and Myrdal, 2002).  Variable±
temperature XRPD patterns obtained for the pre-heated clathrate indicated that 
the entity was stable through-out the heating cycle and that no crystal 
transformation was observed (Fig. 3-10). This confirms that the release of CFC-
11 from the crystal structure of BDP CFC-11 clathrate and its subsequent 
transformation to the anhydrous BDP is an irreversible transformation and that 
no further transformation occurs with increasing temperatures. However, a slight 
shift of all the different peak of the patterns was observed to the left, an artefact 
due to thermal expansion. Figure 3-10 furthermore showed that melting and 
degradation process of BDP started at temperature above 226 ºC and illustrated 
the formation of an amorphous like crystal form at higher temperatures (Fig. 3-
10). 
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Figure 3-10: VT-XRPD patterns of BDP CFC-11 clathrate being heated to 150 ºC, cooled to room temperature and reheated to 250 ºC.
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3.3.7 Raman Spectroscopy 
 
Raman spectra of both anhydrous BDP and BDP CFC-11 clathrates were 
recorded in order to explore the potential of this technique in identifying 
clathrate formation and any structural changes accompanying the release of the 
propellant from the structure of the clathrate. Raman has recently intensively 
used as an analytical tool technology in identifying different analytical processes 
as well as different compounds (Jorgensen et al., 2002, Rantanen, 2007). Raman 
spectra for anhydrous BDP and BDP CFC-11 clathrate show a very different 
pattern (Fig. 3-11). The C-F peak for the BDP CFC-11 clathrate is shown at a 
Raman shift of 1005 cm-1, which is not present in the anhydrous BDP spectra. 
Spectral differences between anhydrous BDP and BDP CFC-11 clathrates were 
also detected for the bands between 1600 and 1750 cm-1. These can be assigned 
to the changes in the bonding structure of the carbonyl group in both anhydrous 
BDP and BDP CFC-11 clathrate as these are related to the interaction between 
the BDP molecules and the CFC-11 molecules within the clathrate structure 
proving that the carbonyl group is affected by the changes in the crystal packing. 
The intensity of peaks from 0-200 cm-1 (lattice vibration in crystals) show two 
different BDP entities with a high intensity for the BDP CFC-11 clathrate 
showing high crystallinity of the compound compared to the anhydrous BDP. 
These results confirm the formation of the clathrate and strengthen the results 
obtained using X-RDP due to the presence of the C-F peak confirming the 
enclathration and entrapment of the propellant molecules within the crystallized 
BDP molecules. 
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Figure 3-11: Raman spectrum of both anhydrous BDP and BDP CFC-11 clathrate A- Lattice 
vibration (0-200 cm-1) and B- Fluorine Raman shift (980-1010 cm-1). 
 
3.3.8 Variable temperature Raman spectroscopy 
 
From Figure 3-12 it can be observed that there are two different forms of the 
BDP before and after the temperature 90-Û& The initial material observed 
A 
B 
 
A B 
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corresponds to the BDP CFC-11 clathrate. Upon heating the Raman spectra 
obtained remained the same until reaching the region of 90-100ºC where a shift 
is observed as well as the removal of some peaks that were presents before 
reaching that temperature in the Raman spectrum.  
 
Areas from the spectra (phonon, hydroxyl and carbonyl regions) were chosen 
separately in order to emphasis the different shifts observed when heating BDP 
CFC-11 clathrate (Fig. 3-12). The phonon region from 0-200 cm-1 showed a 
clear shift is observed at 90Û& showing a change in the nature of the crystal form 
of the BDP CFC-11 clathrate. An increase in intensity of the peaks in this region 
is also observed as well as peak splitting at 250 cm-1 and 350 cm-1 showing 
changes occurring to the vibrational stretching, hence, a change in the molecular 
bonding of the BDP CFC-11 clathrate molecules. The shifts are more 
pronounced at the carbonyl Raman shift at 1650 cm-1 and the hydroxyl Raman 
shift of 3000 cm-1 as these are involved in holding the clathrate structure via 
hydrogen bonding between the BDP molecules and the CFC-11. A peak that was 
present at 3500 cm-1 in the BDP CFC-11 clathrate spectra (hydroxyl region) 
disappeared after reaching 90Û& emphasising the structural changes in terms of 
molecular bonding occurring to the BDP CFC-11 clathrate upon heating and the 
subsequent removal  of the CFC-11 propellant from within the crystal structure 
of the clathrate. These changes are also observed at the carbonyl region where a 
peak at 1600 cm-1 showed an increase in intensity after reaching 90Û& and the 
splitting of a peak that was observed at 1750 cm-1 Raman shift. The different 
changes in the Raman shifts can be attributed to structural rearrangement of the 
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crystal structures that result from the release of the CFC-11 molecules from the 
crystal structure of the crystallized BDP. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-12: 3D plot of BDP CFC-11 clathrate spectra using hot stage VT-Raman spectroscopy 
 
 
The carbonyl peak was chosen for further data interpretation showing change in 
Raman shift position as well as the width of peak as it is used as a H-bonding in 
the reported crystal structure (Harris et al., 2003). A shift is observed in the 
position of the carbonyl group between 90-Û& DV ZHOO DV D FKDQJH LQ WKH
width of the peak (Fig. 3-13). The change in the carbonyl peak position is due a 
carbonyl region (1550-1780 cm-1) phonon region (0-500 cm-1) 
whole wavenumber region (0-4000 cm-
1) 
hydroxyl region (2800-3600 cm-1) 
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solid state rearrangement of the structure which is in agreement with the results 
obtained with the thermal analysis techniques due to the removal of the CFC-11 
propellant from within the crystal structure of the clathrate resulting in 
anhydrous BDP as an end product. The continuous change of peak width with 
temperature is due to dynamic disorder (vibrations of the molecules) which 
increases as the sample is heated.  
 
 
 
Figure 3-13: Changes in Raman shift and width of the carbonyl group peak of BDP CFC-11 
clathrate with increased temperature using hot stage Raman Spectroscopy. 
 
3.4 Conclusions 
 
BDP CFC-11 clathrate has been synthesized and characterised in order to 
investigate the potential benefits of clathrate formation in metered dose inhaler 
formulations. The BDP CFC-11 clathrate was produced by suspending BDP in 
CFC-11 which led to a rapid formation of the clathrate. The results obtained 
using different techniques shows an efficient growth of the clathrate with the 
different concentrations used for the study. The highest molar ratio of CFC-11 to 
BDP was obtained with a 1.67% w/w BDP in CFC-11 and of 0.6:1 molar ratio. It 
is shown that the presence of a stoichiometric relationship can be observed. The 
release of the propellant from the structure was induced by heating which is 
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proposed to be due to a structural rearrangement of the clathrate. It is understood 
that this structural rearrangement induces changes in the hydrogen bonding 
holding the clathrate from collapsing or decomposing that leads to the release of 
the propellant from the tunnels constituting the structure of the clathrate. 
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4 Chapter 4  Physico-chemical characterization of 
hydrofluoroalkane propellant clathrate formed in 
a pressurised metered dose inhaler 
 
 
4.1 General Introduction 
 
The physicochemical properties of steroids are widely studied in pharmaceutical 
contexts. Steroids tend to crystallise fairly easily and often exhibit inclination to 
polymorphism as well as solvation and hydration depending on the media they 
are formed in. Such phenomena can have a drastic effect on product performance 
and on the nature of the formulation employed (Othman et al., 2008). 
 
Metered dose inhalers can be formulated as either a suspension or a solution of 
drug in propellant, depending on the solubility of the active substance in the 
propellant-excipient mixture. Suspensions have the advantage of chemical 
stability and delivery of greater mass per unit volume compared to solutions. 
However, they have to be carefully formulated so that the physical stability is 
controlled throughout their lifetime. The potential for crystal growth, solvate 
formation or polymorph interconversion must be fully addressed early in the 
formulation development (Byron, 1992, McDonald and Martin, 2000). 
 
Ethanol is a commonly used co-solvent in pMDI systems. It is employed to 
increase the solubility of several APIs otherwise insoluble in HFA propellants, 
hence, stabilizing the pMDI performance. Also, it used to help in the normal 
functioning of the valve. Ethanol has a number of advantages as a co-solvent 
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because it is cheap, slightly dipolar and fully miscible in HFA liquids (Smyth, 
2003). The use of ethanol is most likely incompatible with HFA propellant 
suspension formulations as drug solubility will also be promoted (Smyth, 2003). 
The resulting increase in drug solubility can promote partial drug dissolution and 
crystal growth. Moreover, the raised API solubility may lead to an increase in the 
chemical instability of the API. Such induced  crystal instability problems are 
often encountered during storage of suspension formulations and are to be 
controlled to ensure the performance and the quality of the pharmaceutical 
preparations (Vervaet and Byron, 1999a).  
 
During a crystallisation process, solvent molecules may become incorporated 
into the crystal structure of APIs (Zimmermann et al., 2008). Changing the 
arrangement of the molecules in the crystal lattice generally alters solid state 
properties of APIs such as solubility and stability. The solubility of the different 
API will affect the bioavailability of the formulation as well as its stability and 
shelf life during storage. 
 
As described in the literature and in Chapter 3, BDP crystallizes with a channel 
structure allowing the formation of clathrate with propellant molecules as well as 
co-solvent molecules if present within its crystal structure (Harris et al., 2003). 
The structure is held together through hydrogen bonding (Harris et al., 2003). It 
has been reported that a BDP clathrate from HFA-134a and ethanol was formed, 
when BDP was suspended in a pMDI formulation containing HFA-134a and 
ethanol as a co-solvent (Harris et al., 2003). Jones et al have reported that the 
solubility of the BDP to be 29.85 µg/g in HFA 134a (Jones et al, 2006). Thus, 
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the formation of such crystals can be problematic especially if the particle size 
changes in the pMDI canister, as well as in terms of their solubility and stability 
in the formulation and their long term stability. Thereby, previous knowledge of 
the possible solid forms of a drug is of vital importance in the development of 
pharmaceutical drug products and drug substances (Zimmermann et al., 2008). 
 
4.1.1 Chapter Aims and Objectives 
 
This chapter will investigate and characterise the physico-chemical properties of  
the resulting beclomethasone dipropionate crystals formed upon exposure of the 
latter to both 1,1,2,-tetrafluoroethane (HFA-134a) and 1,1,2,3,3,3-
heptafluoropropane (HFA-227ae) propellants alone and in the presence of a co-
solvent (ethanol).  X-ray photoelectron spectroscopy (XPS) and X-ray powder 
diffraction (X-RPD) will be used to determine the surface chemistry and the 
purity of the samples. Additionally, thermal analysis will be used to determine 
the phase behaviour of the extracted crystals upon heating and any subsequent 
polymorphism. Finally variable temperature X-ray diffraction will be used to 
determine the chemistry changes on the clathrate resulting from heating the 
clathrate to its melting point. From these results, it will be possible to 
characterise the BDP clathrate and determine the effect of any changes on the 
chemistry and on the potential interactions within a pMDI. 
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4.2 Materials and Methods: 
 
4.2.1 Materials 
 
Anhydrous BDP (micronized) was purchased from Sicor (UK). 1,1,1,2-
Tetrafluoroethane (HFA-134a) and 1,1,2,3,3,3-heptafluoropropane (HFA-227ae) 
were supplied by Dupont (UK). All other chemicals were purchased from 
Sigma-Aldrich Company Ltd (UK), unless otherwise indicated. 
 
4.2.2 Methods 
 
4.2.2.1 Isolation of Beclomethasone HFA Propellants Clathrate 
 
4.2.2.1.1 BDP in HFA-134a 
 
Beclomethasone dipropionate was suspended in HFA-134a (1.67 % w/w BDP in 
HFA-143a) in six clear PET vials (Precise Plastic Ltd, UK). BDP was weighed 
in each of the clear PET vials and a non-metering valve (3M Health Care Ltd, 
UK) was crimped in place in each of the vials. HFA-134a was then pressure 
transferred via a transfer button into each vial from a Trimline can (Crown 
Holdings Inc, UK) fitted with a 1-inch non-metering valve (Precision Valve 
Corporation, UK). The concentration of the API was 2% w/w BDP in HFA-
134a. The six filled clear PET vials were stored in a desicator under no humidity 
for a period of six months. The crystals were then extracted by evaporating the 
propellant in a humidity controlled environment (RH = < 10%) at ambient 
pressure and room temperature. The extracted crystals were stored in glass vial 
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under nitrogen after being sealed with a vial screw and Parafilm (Alcan, Neenah, 
WI, US), and stored in a fridge at 5°C prior to use. 
 
4.2.2.1.2 BDP in 20 % w/w EtOH and HFA-134a  
 
BDP was suspended in HFA-134a (1.67 % w/w BDP in HFA-143a) with the 
addition of 20% w/w absolute anhydrous ethanol following the procedure 
described above. 
 
4.2.2.1.3 BDP in HFA-227ae 
 
BDP was suspended in HFA-227ae (1.67 % w/w BDP in HFA-227ae) as 
described in section 4.2.2.1.1. 
 
4.2.2.1.4 BDP in 20% EtOH and HFA-227ae 
 
BDP was suspended in HFA-227ae (1.67 % w/w BDP in HFA-227ae) with the 
addition of 20% w/w absolute anhydrous ethanol following the procedure 
described above in section 4.2.2.1.1. 
 
4.2.2.2 Scanning Electron Microscopy (SEM) 
 
The particle size and morphology of the synthesized BDP entities from the 
different HFA and HFA EtOH blends were analysed by SEM using a JEOL 
JSM-6060LV (JEOL (UK) Ltd, Welwyn Garden City, UK) at various 
magnifications. The BDP particles isolated as previously described were 
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mounted onto carbon stubs then sputter coated with a thin layer of gold (20 nm 
thickness) in an argon atmosphere (50Pa) at 30 mA for 4 minutes prior to SEM 
screening. SEM analysis was carried out at an appropriate accelerating voltage 
(between 1 keV and 10 keV) and a spot size between 48 nm and 62 nm. These 
parameters were varied for each sample in order to optimise each particular 
image.  
 
4.2.2.3 X-ray Photoelectron Spectroscopy (XPS) 
 
BDP HFA-134a, BDP HFA-227ae, BDP EtOH HFA-134a and BDP EtOH HFA-
227ae samples were analysed using XPS in order to determine surface elemental 
composition using a Kratos AXIS ULTRA spectrometer (Kratos Analytical, 
Manchester, UK). The spectrometer is supplied with a mono-FKURPDWLF$O.Į X-
ray source (1486.6eV) operating at 15mA emission current and 10kV anode 
potential. The ULTRA was used in fixed analysed transmission (FAT) mode, 
with a pass energy of 20eV for high resolution scans. A wide survey scan and 
high resolution scans were performed on each sample. Wide scans were run for 
5-10 minutes and high resolution scans for 10-30 minutes. Data analysis was 
carried out using CASAXPS software with Kratos sensitivity factors to 
determine the atomic percentage (atomic %) values from the peak areas. The 
irradiating X-rays were emitted at a take-off angle of 90 degrees. 
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4.2.2.4 Thermogravimetric analysis (TGA) 
 
A TGA Q500 (TA Instruments, USA) was used to record the weight loss of the 
VDPSOHVEHWZHHQÛ&DQGÛ&DWDVFDQVSHHGRIÛ&PLQXQGHUDFRQVWDQW
SXUJHRIGU\QLWURJHQ$QLVRWKHUPDOSHULRGDWÛ&ZDVUXQIRUPLQXWHVSULRU
to the measurements, during which any changes in weight were monitored. In all 
measurements, 6 to 7mg of sample was used. The thermograms obtained from 
the TGA results were analysed using TA universal analysis -NT software. 
 
4.2.2.5 Differential Scanning Calorimetry (DSC) 
 
DSC experiments were carried out using a DSC Q2000 Differential Scanning 
Calorimeter 7$,QVWUXPHQWV86$ZLWKDFRQVWDQWÛ&PLQKHDWLQJUDWHIURP
Û& WR Û& LQ D GU\ QLWURJHQ DWPRVSKHUH ,Q DOO PHDVXUHPHQWV -7mg of 
sample were used in pin-holed sealed non-hermetic aluminium pans to allow the 
escape of the propellant during the desolvation phase. The thermograms obtained 
for the DSC results were analysed using TA universal analysis -NT software. 
 
4.2.2.6 X-ray Powder Diffraction (X-RPD) 
 
X-RPD patterns were collected on a Bruker D8 diffractometer system (Bruker 
AXS, Madison, WI, USA), operating in a Debye-Scherrer geometry. A ceramic 
X-ray tube with a copper target, was used to generate x-ray radiation at 
ZDYHOHQJWKȜ ǖ7KH generator was set to operate at a voltage of 40 kV 
and current of 40 mA. A scintillation counter was employed. Samples were 
VFDQQHG IURP ș  Û XQWLO Û DW D VHFVWHS VSHHG LQ LQFUHPHQWV RI Û
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stepwise. The X-ray patterns were analysed using the Le Bail method to model 
the patterns obtained, based on the reported unit cell for the clathrate. All the 
patterns were collected straight after the formation of the crystals to determine 
the purity of the samples and its crystalline structure. 
 
4.2.2.7 Variable Temperature X-Ray Powder Diffraction (VT-XRPD) 
 
VT-XRPD patterns were collected on a Bruker D8 diffractometer system 
(Bruker AXS LTD., Coventry, UK) operating in a Debye-Scherrer geometry. X-
ray radiation was generated inside a ceramic X-ray tube from an anode made of 
FRSSHU&XLQ.ĮVSHFWUDOOLQHDWZDYHOHQJWKȜ c7KHGLIIUDFWRPHWHULV
equipped with a scintillation detector and Bruker Kristalloflex generator set on 
voltage 40kV and current 40mA. Samples were loaded in borosilicate glass 
capillary tubes BGCT with 0.7mm bore diameters (CTS Capillary Tube Supplies 
Ltd UK) and mounted on the goniometer in a preferable orientation. Cryostream 
Plus controller (Oxford Cryosystems Ltd., Long Hanborough, Oxford, UK) a 
heating-cooling system was provided for VT-XRPD, was controlled by a 
Cryopad PC programme for VT-XRPD scans. VT-XRPD scans were set from 
ș ÛXQWLOÛDWDVHFVWHSVSHHGLQLQFUHPHQWVRIÛDFTXLUHGHDFKÛ&
IURPKHDWHGVDPSOHDWDUDWHRIÛ&PLQVWDUWLQJIURP20-221Û& at a rate of a 1Û
C/min. All the patterns were collected straight after the formation of the crystals 
to prevent any decomposition and/or contamination and to determine the purity 
of the samples and its crystalline structure. 
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4.3 Results and Discussion 
 
4.3.1 SEM Analysis 
 
Concerning the morphology of BDP HFA-134a crystals, the SEM images in 
Figure 4-1 show the formation of crystalline particles. The particles are mostly 
aggregated into small clusters and do not show significant poly-dispersity. The 
crystals particle size could not be really identified due to aggregation. However, 
the crystals seem to have a particle size of approximately 10µm. On the other 
hand, the particles obtained for BDP HFA-227ae suspension, had a size of less 
than 5 µm (Fig. 4-1).  
 
 
 
 
 
 
 
 
Figure 4-1: SEM images of BDP HFA-134a crystals, BDP EtOH HFA-134a crystals and BDP 
HFA-227ae crystals and BDP EtOH HFA-227ae crystals. 
 
BDP HFA-134a 
BDP HFA-227ae 
BDP EtOH HFA-134a 
BDP EtOH HFA-227ae 
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The crystals obtained from both suspensions of BDP EtOH HFA-134a and BDP 
EtOH HFA-227ae had an elongated hexagonal structure as seen in Figure 4-1. 
The particle size obtained for the crystals ranged between 50-100 µm. A feature 
that is only observed in these crystals is the crystal defects on the surface of the 
crystals as well as small cracks on the majority of the crystals. Such observations 
might be either due to decomposition of the crystals due to the exposure to the 
high vacuum medium during the gold coating and imaging with SEM or due to 
the collapse of the clathrate structure and the release of the propellant from the 
channels of BDP clathrates after the release from the pMDI canister. 
 
4.3.2 XPS Results 
 
The four different crystals extracted from the different BDP HFA and EtOH 
suspensions were analysed using XPS in order to determine the elemental 
surface composition of each of the compounds and in particular HFA/Ethanol 
inclusion. Wide scan XPS results obtained for the BDP HFA-134 in Figure 4-2, 
BDP HFA-227ae, BDP EtOH HFA-134a and BDP EtOH HFA-227ae crystals 
are shown in Appendix 1. The main peaks shown on the different scans at 282, 
530 and 197 eV correspond to oxygen, carbon, and chlorine respectively. These 
elements constitute the backbone structure of BDP. 
 
No fluorine peaks were observed in any of the different BDP HFA entities. This 
can be explained by either no formation of clathrate or instant decomposition of 
these after being at ambient pressure and room temperature. Another possible  
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Figure 4-2: Wide survey scans of BDP HFA-134a crystals. (Similar patterns were obtained for 
the different BDP HFA/Ethanol propellants (Appendix 1)). 
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Table 4-1: Theoretical and measured atomic percentage of the surface analysis of BDP HFA-134a, BDP HFA-227ae, BDP EtOH HFA-134a and BDP EtOH HFA-227ae 
(n= 6). 
 
 
 
Atomic % BDP HFA-134a BDP HFA-227ae BDP EtOH HFA-134a BDP EtOH HFA-227ae 
Theoretical Measured Theoretical Measured Theoretical Measured Theoretical Measured 
C 1s 71.42   81.33 ± 0.7 67.38   81.08 ± 1 71.1  80.79 ± 0.75 67.34  81.42 ± 037 
O 1s 16.16 16.52 ± 0.64 15.21  16.79 ± 0.21 17.77   16.94 ± 0.57 16.32  16.54 ±0.33 
Cl 2p 2.38   2.15 ± 0.13 2.17  2.13 ± 0.21 2.22  2.28 ± 0.21 2.04  2.04 ± 0.1 
F 1s 9.52  0 15.21  0 8.88  0 14.28  0 
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explanation might be that the HFA molecules are within different particles of the 
powder mixture and these could not have been detected by the instrument as it 
just detects up to 10 nm in depth of the structure. The surface composition of the 
different BDP HFA entities did not show any significant changes in the atomic 
percentage of all the atoms present in the structure between the different crystals 
(Table 4-1). Therefore, the two different HFA propellants may have not been 
included within the channels of the crystallized BDP. However, as observed with 
the different SEM images above, a possible structural change could have 
occurred due to the changes in the pressure. Also, the different atomic 
percentages observed for the different BDP HFA entities showed very close 
similarities to the percentage atomic composition of anhydrous BDP (Chapter 3). 
Therefore, these might suggest unsatisfactory results concerning the formation of 
possible clathrates from HFA propellants and ethanol HFA propellants. 
 
4.3.3 Thermal Analysis 
 
4.3.3.1 TGA Results 
 
1RZHLJKWORVVZDVREVHUYHGIRUDQK\GURXV%'3EHWZHHQDQGÛ&Fig. 4-
3A). The weight loss observed after 212ºC (i.e. the melting point) is due to 
combustion of the sample in all the TGA curves. The total weight loss of the 
crystals extracted from the suspension of BDP in HFA-134a showed a total 
weight loss of approximately 13.25% as shown in Figure 4-3B. The weight loss 
is seen as three different phases that were observed using DSC and are going to 
be discussed further on the next section. The initial weight loss of approximately 
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6% was observed between 25 and 30 ºC which is believed to be an initial release 
of HFA-134a from the crystal structure of the BDP due to the high volatility of 
the propellant (-26.3 ºC boiling point) (Vervaet and Byron, 1999a, Millard and 
Myrdal, 2002, Harris et al., 2003). A second phase of weight loss of 5.5% was 
observed between 30 and 60 ºC which followed by the final phase of weight loss 
which ended at 125 ºC corresponding to a 2% weight loss. The two last phases of 
weight loss are thought to be due to the final release of HFA-134a from the 
crystal lattice of BDP leaving the entity as anhydrous BDP.  The results observed 
using TGA suggest the formation of a crystalline clathrate from suspending BDP 
in HFA-134a.  The TGA results were also used in order to determine the number 
of HFA-134a molecules in the crystal structure For BDP suspended in HFA-
134a, it was calculated that the molecular ratio was of 0.75:1 HFA-134a to BDP. 
The molecular ratio of the calculated BDP HFA-134a clathrate is lower that the 
theoretical one. However, the percentage weight loss confirms the inclusion of 
the HFA-134a inside the crystal lattice of BDP. 
 
When analysing the results from BDP suspended in HFA-227ae, Figure 4-3B 
shows no weight loss when heating the sample to 250 ºC apart from the weight 
loss seen after the melting point of BDP and at the point of combustion of the 
sample. Therefore, this shows that there is no transformation occurring within 
the structure of BDP when suspended in HFA-227ae and hence no clathrate or 
solvate formation as been achieved and the structure of BDP remains as 
anhydrous BDP. 
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Figure 4-3: TGA curves of A- anhydrous BDP , B- BDP HFA-134a, B- BDP HFA-227ae, C- 
BDP EtOH HFA-134a and D- BDP EtOH HFA-DH$OOVDPSOHVZHUHKHDWHGIURPÛ&WR
Û& at a heating rate of 10Û&/min. 
 
C 
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The TGA results obtained for both BDP suspended in EtOH and HFA-
134a/HFA-227ae show a similar pattern (Fig. 4-3C and 4-3D respectively). A 
total weight loss of approximately 4% was observed at an onset of 50 ºC and an 
ending of around 110 ºC. The total weight loss observed is extremely low and is 
16.66% of the theoretical total weight loss (Table 4-1). The total weight losses 
observed corresponds to the calculated theoretical weight loss of water from the 
monohydrate (3.39% weight loss). Therefore, these results suggest the formation 
of a BDP monohydrate over the formation of a BDP EtOH propellant clathrate or 
a BDP EtOH solvate. The formation of the monohydrate is believed to be due to 
the residual water present in the anhydrous EtOH when used during the 
preparation that favours the formation of a monohydrate over the other solvate 
forms. Moreover, the high volatility of the HFA propellants may be the reason 
for the high instability of the crystal structure of the BDP clathrate which 
collapses when removed from the high pressure medium in the canister to the 
ambient pressure and temperature. These lead to rapid changes in the crystal 
structure after the evaporation of the excess propellant and the solvent and leads 
to the formation of a monohydrate. 
 
Table 4-2: The different BDP entities encountered together with experimental (TGA) and 
theoretical weight loss in weight %. 
 
Samples % TGA Weight loss  Theoretical % weight loss  
BDP HFA-134a 12.14 ± 1.58 16.37 (1:1 ratio) 
BDP HFA-227ae No weight loss 24 (1:1 ratio) 
BDP EtOH HFA-134a 3.58 ± 0.57 22.42 (1:1:1 ratio) 
BDP EtOH HFA-227ae 4.25 ± 1.23 29.24 (1:1:1 ratio) 
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4.3.3.2 DSC Results 
 
Conventional DSC data obtained for the different samples are shown in Fig. 4-4 
$QK\GURXV %'3 PHOWV DW DERXW Û& DV VKRZQ SUHYLRXVO\ DQG ZKLFK
corresponds to literature (Nachiengtung, 1997, Vervaet and Byron, 1999a). The 
thermogram for BDP suspended in HFA-134a is shown in Figure 4-4A. An 
exothermic onset was observed after heating the sample to approximately 83 Û&, 
which is believed to be due to a structural rearrangement of the clathrate 
structure. This exothermic peak is in agreement with the data obtained from the 
TGA analysis that showed an initial weight loss at this temperature. Therefore, 
this structural rearrangement leads to a very small loss of HFA-134a molecules 
from the crystal lattice of the  
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Figure 4-4: DSC curves of A- BDP HFA-134a, B- BDP HFA-227ae, C- BDP EtOH HFA-134a, 
D- BDP HFA-227ae. All samples were heated from 20Û&WR250Û& at a heating rate of 10Û&/min. 
 
BDP HFA-134a clathrate. The total release of HFA-134a is thought to happen at 
an onset of 115 °C as shown by the second exothermic peak which is in 
agreement with TGA outcomes. The melting point of BDP HFA-134a clathrate 
after HFA-134a ORVV LV VHHQ DW DSSUR[LPDWHO\ Û& 7KH FRPSOH[ WKHUPDO
events after the melting point observed in the different DSC scans of the 
different samples indicate that the BDP undergoes significant degradation during 
melting (Shah et al., 2006). Interestingly, the clathrate retains the propellant 
(HFA-134a) until quite high temperatures are reached (115 Û& The release of 
HFA-134a propellant molecules from the clathrate structure of the crystallized 
%'3 FDQ EH H[SODLQHG WKHUPRG\QDPLFDOO\ E\ WKH *LEE¶V IUHH HQHUJ\ HTXDWLRQ
D 
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and follows the same principle as the release of CFC-11 from the clathrate 
structure of BDP CFC-11 clathrate as explained in Chapter 3, Section 3.3.4.2. 
 
By looking at the thermogram obtained for the crystals extracted from the 
suspension of BDP in HFA-227ae, it can be observed that there is no transition 
when heating the crystals apart from the endothermic onset at 212 Û& which 
represents the melting point of BDP (Fig. 4-4B). This result is in agreement with 
TGA where no weight loss was observed when heating the BDP HFA-227ae 
crystals to its melting point. Therefore, it can be concluded that suspending BDP 
in HFA-227ae does not result in crystallizing BDP to its clathrate form and 
hence it is not able to include the HFA-227ae into its crystal lattice to form the 
clathrate. 
 
DSC scans for both BDP EtOH HFA-134a and BDP EtOH HFA-227ae 
suspensions (Fig. 4-4C and D respectively), showed an endothermic onset at 213 
Û& FRUUHVSRQGLQJ WR WKH PHOWLQJ SRLQW RI %'3 (as reported previously by 
Saunders et al (Saunders, 2009). A broad endothermic peak was observed for 
both BDP entities starting at around 80 Û& and ending at around 100 Û& which is 
might be due to the release of water molecules as deducted from TGA results. 
These transitions are in total agreement with the results presented in literature by 
Saunders et al (Saunders, 2009). The magnitude of the endothermic transition 
was slightly variable, due to the non-stoichiometric association of the drug with 
the water molecules (Vervaet and Byron, 1999b, Kuehl, 2003). Therefore, 
combining both results obtained from DSC and TGA, suspending BDP in 
mixture of EtOH solvent and HFA propellant showed the formation of very 
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unstable crystals. These convert quite rapidly to the BDP monohydrate once 
removed from the pressurized mother liquor in the canister. The conversion 
might be due to the presence of water molecules in EtOH when preparing the 
suspensions. EtOH has a much higher boiling point (78.5 Û&) (Wikipedia, 2010) 
than both HFA propellants, therefore, when extracting the crystals from the 
suspension, the high volatility of both HFA propellant leads to very rapid 
evaporation of the propellants when exposed to ambient conditions leaving the 
BDP crystals suspended in only EtOH. The crystals then might either transform 
to an EtOH solvate (not observed from TGA results) or a conversion to a 
monohydrate due to water molecules present in EtOH.  
 
4.3.4 XRPD Results 
 
4.3.4.1 BDP HFA-134a Suspension 
 
The X-RPD pattern obtained from BDP HFA-134a samples was compared to the 
different patterns of BDP solid-state forms reported previously in the Cambridge 
Structural Database (CSD) as shown in Figure 4-5. The BDP HFA-134a pattern 
had peaks with an excellent match to the BDP CFC-11 clathrate and anhydrous 
BDP. Therefore, the sample is concluded to be a mixture of both anhydrous BDP 
and BDP HFA-134a clathrate.  From Figure 4-5, it can be observed that the two 
initial peaks at a 7.5º and 8.3º from the BDP HFA-134a pattern are present in the 
experimental BDP CFC-11 clathrate pattern and these represent the two 
characteristic peaks in identifying BDP clathrate crystal structure. Hence, the 
partial formation of BDP HFA-134a clathrate can be confirmed from these 
results. 
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Figure 4-5: X-RPD patterns of BDP HFA-134a crystals compared to experimental BDP CFC-11 
clathrate and anhydrous BDP. 
 
On the other hand, the X-RPD pattern from 9.6º to 30º shows a very good match 
with the pattern obtained from anhydrous BDP with some small peaks matching 
those of the clathrate structure. The results observed in Figure 4-5 are in 
agreement with DSC and TGA results suggesting the formation of a clathrate. 
This is consistent with the slightly lower weight loss observed with the TGA 
results compared to the calculated theoretical weight loss, which is attributed to 
the non-stoichiometric nature of the clathrate. 
 
4.3.4.2 BDP HFA-227ae Suspension 
 
An excellent match was obtained for the X-RPD pattern of BDP HFA-227ae 
crystals when comparing the data with patterns from the experimental X-RPD 
pattern of the as received anhydrous BDP (Fig. 4-6). For the as-received 
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anhydrous BDP, when the effects of thermal expansion are accounted for, we 
achieve an excellent match when comparing the room temperature data with the 
calculated pattern from the reported 100 K structure of BDP (ca. 4.5 % increase 
in volume at room temperature compared to 100 K). The Rietveld method was 
used to model the entire powder pattern profile and to calculate lattice 
parameters. Therefore, these results complement the outcomes of thermal 
investigation as shown earlier using DSC and TGA. Hence, it was proven that 
the crystals extracted from suspending anhydrous BDP in HFA-227ae results in a 
crystalline anhydrous BDP with no subsequent formation of any BDP clathrate, 
BDP solvate or its monohydrate was observed. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4-6: X-RPD patterns of BDP HFA-227ae crystals compared to experimental anhydrous 
BDP. 
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4.3.4.3  BDP EtOH HFA-134a Suspension 
 
X-RPD data of the BDP EtOH HFA-134a crystals is shown in Figure 4-7. The 
experimentally obtained pattern when compared with the calculated pattern from 
single crystal diffraction of different BDP entities showed a good match with 
BDP monohydrates pattern in most of the peaks. However, small peaks can be 
observed indicating the presence of a small amount of anhydrous BDP crystals. 
As BDP EtOH HFA-134a clathrate is quite unstable when removed from its 
mother suspension at -Û& DQG WHQGV WR FRQYHUW PRUH UHDGLO\ LQWR WKH
PRQRK\GUDWHIRUPRI%'3LWFDQEHK\SRWKHVL]HGWKDW³%'3(W2++)$-134a  
 
 
 
 
 
 
 
 
 
 
 
Figure 4-7: X-RPD patterns of BDP EtOH HFA-134a crystals compared to experimental 
anhydrous BDP and calculated BDP monohydrate. 
 
FODWKUDWH´KDYHEHHQV\QWKHVL]HG+RZHYHUGXHWRWKHUHPRYDOIURPWKHPRWKHU
suspension to room temperature, the structure has decomposed quickly (cracks 
observed in the SEM images Figure 4-1) and converted rapidly to the 
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monohydrate form, which has been observed using both TGA results and DSC. 
7KHFRQYHUVLRQRI³%'3(W2++)$-D´WRWKH%'3PRQRK\GUDWHLVWKRXJKW
to be due to the presence of some water molecules in the anhydrous EtOH used 
during the preparation phase of the suspension or some humidity that is still 
present in the environment. 
 
4.3.4.4 BDP EtOH HFA-227ae Suspension 
 
Concerning the results obtained for the X-RPD pattern of BDP EtOH HFA-
227ae crystals, similar results to BDP EtOH HFA-134a were obtained (Fig. 4-8). 
The X-RPD pattern showed an excellent match with the calculated pattern of 
BDP monohydrate with some peaks in common with anhydrous BDP at 19º and 
20º. These results show that there is a mixture of two different forms of BDP. 
The presence of the monohydrate confirms and completes the results obtained by 
DSC and TGA that show a transition at around 93º C when being heated, which 
corresponds to the release of water molecules from the crystal structure. There 
were no apparent peaks that corresponded to any clathrate formation. There is a 
very small peak on the BDP EtOH HFA-227ae pattern at 7.5 º which can be 
attributed to the remaining parts of a potential formation of some BDP EtOH 
HFA-227ae.  
 
As discussed in the previous section, the BDP EtOH HFA clathrate are very 
unstable when removed from the high pressure medium in the canister due to the 
very low boiling point of HFA propellants which leads to rapid decomposition 
and collapse of the clathrate structure when exposed to ambient pressure and 
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room temperature. This will lead to a rapid release of the propellant from the 
crystal structure and the conversion of the clathrate to the monohydrate due to  
 
 
 
 
 
 
 
 
 
 
 
Figure 4-8: X-RPD patterns of BDP EtOH HFA-227ae crystals compared to experimental 
anhydrous BDP and calculated BDP monohydrate. 
 
the presence of some water molecules in EtOH. Therefore, this increases the 
chances of conversion of the clathrate compound to either a BDP EtOH solvate 
or a monohydrate. BDP monohydrate is more easily obtainable due to the 
presence of some water molecules in the anhydrous EtOH (<0.005%) and also 
from the environment even at very low humidity levels. Hence, this leads to the 
formation of BDP monohydrate. 
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4.3.5 VT-XRPD Results 
 
4.3.5.1 Anhydrous BDP 
 
Figure 4-9 presents the measured VT-XRPD diffraction patterns for anhydrous 
BDP sample. The diffraction patterns of the anhydrous BDP sample did not 
change much during the heating from room temperature to 218 ºC indicating its 
stable crystal structure. The main changes in the VT-XRPD patterns were only 
observed in the intensities of the reflections due to the preferred orientation of 
the crystals. The reflections of the diffraction pattern showed a decrease in 
intensity and broadening of the peaks indicating the effects of melting on the 
crystal lattice at the temperature 217 °C and after which the melting of BDP was 
observed.  Some peaks showed splitting starting from 86 ºC and being more 
defined with LQFUHDVLQJWHPSHUDWXUH7KHVHWZRSHDNVDUHSUHVHQWHGDWșRI
and 22.5º. The appearance of these peaks is due to the thermal expansion of the 
molecules due to heating and the change in the vibrational state of different parts 
of the BDP molecule due to heating. Thermal expansion is a fundamental 
physical property that reflects changes in the dimensions of the solid as a result 
of temperature variations which is a consequence of atomic vibrations within the 
molecules (Taylor and He, 1998, Abdullaev et al., 2001). 
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Figure 4-9: VT-XRPD patterns of anhydrous BDP. 
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4.3.5.2 BDP HFA-134a and 227ae Clathrates 
 
Variable temperature X-RPD patterns obtained for BDP HFA-134a are presented 
in Figure 4-10. The pattern obtained at room temperature showed similar results 
to those discussed in the previous section where the compound showed a mixture 
of both anhydrous BDP and BDP HFA-134a clathrate. The clathrate peaks are 
TXLWHGLVWLQFWLYHDQGFDQEHREVHUYHGDWDșSRVLWLRQRIDQGwhile the 
other peaks are distinctive of anhydrous BDP (Fig. 4-10). VT-XRPD analysis 
showed that the mixture was stable from room temperature to approximately 95 
ºC (Fig. 4-10). A further increase in temperature led to the transformation of the 
clathrate part of the mixture to anhydrous BDP resulting in pure crystalline 
DQK\GURXV%'37KLVLVVKRZQE\WKHGLVDSSHDUDQFHRIWKHUHIOHFWLRQDWDșRI
6º and 12.5º as well as two peaks from WKH WULSOHW DW  ș OHDYLQJ MXVW D
singlet (Fig. 4-10). This transformation of the crystal structure leading to the 
release of HFA-134a from within the channels formed from the clathrate is in 
consistent with the DSC and TGA data. A further increase in temperature 
showed no major changes in the different patterns and hence no crystal 
transformation was observed. However, as seen previously with the VT-XRPD 
of anhydrous BDP, some peaks splitting were observed starting at 122 ºC. The 
peak splitting is mRVWO\REVHUYHGDWDșRIDQG7KLVLVH[SODLQHGE\
the increased vibration with temperature of the side chain of the BDP molecules 
leading to these splitting due to an increased temperature. The intensities of the 
different patterns started to reduce in intensity from a temperature 215 ºC and 
finally melting at 224 ºC. 
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Figure 4-10: VT-XRPD patterns of BDP HFA-134.  
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Figure 4-11: VT-XRPD patterns of BDP HFA-227ae.
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The VT-XRPD patterns obtained for BDP HFA-227ae particles (Fig. 4-11), 
show no formation of clathrates as observed earlier as the pattern obtained at 
room temperature displays a perfect match with the reference pattern of 
anhydrous BDP (Millard and Myrdal, 2002). Furthermore, the different patterns 
obtained with increased temperature showed no crystal transformation and had a 
similar behaviour to the as received anhydrous BDP. The slight lower angle and 
the peak split DWDșposition of 14.3º and 22.5º at a temperature above 104 ºC 
observed in the reflections were due to the thermal expansion of the molecule 
(Fig. 4-11). This split is due to the increased vibration of the side chains of the 
BDP molecules while increasing the temperature. The melting of the BDP HFA-
227ae was detected at 227 ºC where the intensity of the different patterns 
decreased due to the melting of BDP 
 
4.3.5.3 BDP EtOH HFA 134a and 227ae Clathrates 
 
VT-XRPD was run on both BDP EtOH HFA-134a and BDP EtOH HFA-227ae 
crystals extracted from both BDP EtOH HFA-134a and 227ae suspensions. The 
results of these are presented in Figures 4-12 and 4-13 for BDP EtOH HFA-134a 
and BDP EtOH HFA-227ae respectively. The patterns observed for BDP EtOH 
HFA-134a show similar results to the ones observed earlier at room temperature 
(25 ºC) where it shows a mixture of both anhydrous BDP (mostly) and some 
SHDNV DW DșHTXDO WR indicating the presence of BDP monohydrate when 
compared to the reference patterns (Duax et al., 1981, Millard and Myrdal, 2002) 
(Fig. 4-12). Furthermore, the results show that after heating the sample of BDP 
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Figure 4-12: VT-XRPD patterns of BDP EtOH HFA 134a. 
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Figure 4-13: VT-XRPD patterns of BDP EtOH HFA-227ae. 
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EtOH HFA-134a particles to 35 ºC the first sign of a small transformation to 
anhydrous BDP aSSHDUHGZLWK WKHGLVWLQFW IDGLQJRI WKHUHIOHFWLRQVDW ș
DQGWKHDSSHDUDQFHRIDVPDOOUHIOHFWLRQDWș7KHSURFHVVRIGHK\GUDWLRQ
continues up to 53 ºC. This is in accordance with the findings observed using 
DSC and TGA experiments in the section 4.3.3.1 and 4.3.3.2. Since then, the 
diffraction patterns obtained did not change much during heating to about 194 ºC 
where the intensity of the different peaks diminished until disappearing 
completely as the samples melt at 216 ºC. A split in the SHDNDWSRVLWLRQș 
was also observed starting at 59 ºC as observed for anhydrous BDP VT-XRPD 
patterns, which is due to the vibrations happening within the molecules of BDP. 
A shift to the left of the different reflections can also be noticed which is due to 
thermal expansion. Figure 4-13 presents the measured VT-XRPD diffraction 
patterns for BDP EtOH HFA-227ae from room temperature to 230 ºC. The 
pattern obtained at room temperature showed no clathrate formation and the 
pattern corresponded to the BDP monohydrate and anhydrous BDP when 
compared with the reference anhydrous BDP pattern and the monohydrate 
(Millard and Myrdal, 2002) as shown previously. As the temperature increased 
to 230 ºC, the different patterns exhibited similar results to those obtained earlier 
for anhydrous BDP, where no crystal transformation was observed with heating. 
A shift to the left was observed which is again attributed to thermal expansion of 
the molecules. Melting and degradation process of BDP started at temperature 
above 226. 
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4.4 Conclusions 
 
Beclomethasone dipropionate is of a particular interest in pMDI formulation 
stability studies because of the existence of a range of solvates, clathrates with 
the solvent molecules incorporated into the channels. This situation has been 
reported in different papers (Duax et al., 1981, Kuehl et al., 2003, Harris et al., 
2003, Othman et al., 2008) and in the work presented here.  
 
The results showed the formation of a mixture of both crystalline anhydrous 
BDP and BDP HFA-134a clathrate when BDP was suspended in HFA-134a. The 
experimental approach based on DSC/TGA, XRPD showed evidence of the 
clathrate formation with HFA-134a. The crystals exhibited a transition when 
being heated to their melting point, which is considered to be due to the release 
of the HFA-134a from the channels constituting the crystal structure of the 
clathrate. This release is due to a structural rearrangement of the crystal structure 
leading to the formation of anhydrous BDP. The release of the propellant occurs 
at a temperature of 95 ºC as observed earlier for the BDP CFC-11 clathrates 
(Chapter 3). Furthermore, a rapid conversion of BDP EtOH HFA-134a clathrate 
to the monohydrate was observed when co-solvent was used which shows the 
instability of BDP EtOH HFA-134a clathrate when removed from the high 
pressure media of the pMDI system. This is due to the very low boiling point of 
HFA-134a and its high volatility at room temperature.  In contrast, no clathrate 
formation was seen for BDP HFA-227ae which is due to the increased solubility 
of BDP in this propellant. The formation of monohydrate was observed when 
BDP was suspended in HFA-13a/ethanol and HFA-227ae/ethanol mixture 
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confirming the disability of forming a clathrate from these latter and a 
preferential monohydrate formation. 
 
The polymorphic changes of beclomethasone HFA clathrates can be determined 
using VT-XRPD diffraction. VT-XRPD gives information about proportions of 
crystal structure of the polymorphic forms as well as crystallinity. It can be used 
effectively to characterize polymorphic changes during heating. The analysis of 
different BDP HFAs suspensions showed no formation of clathrates when 
anhydrous BDP was suspended in HFA-227ae and in HFA-227ae/ethanol 
mixture. The analysis showed that the crystals of pure anhydrous BDP which are 
due to the increased solubility of BDP in HFA-227ae do not allow further 
crystallisation at high pressure. The analysis showed that anhydrous BDP as 
received as well as the crystals obtained from suspending it in HFA-227a and 
HFA-227ae/ethanol mixture were stable and that its structure did not change as a 
function of temperature and hence no polymorphic transformations occurred. 
However, an increased vibration of different parts of the anhydrous BDP 
molecules especially the side chain showed some peak splitting from 84 ºC.  
 
VT-XRPD showed that the mixture of anhydrous BDP and BDP HFA-134a 
clathrate was stable between room temperature and approximately 71 ºC. A 
further increase in temperature (to between 73 ºC and 90 ºC) leads to a 
transformation of BDP clathrate to the anhydrous form. This means that the 
formation of BDP HFA-134a is quite stable at room temperatures and that some 
clathrate channels retain the propellant to quite high temperatures. The same 
changes were observed using thermal analysis techniques. After 90 ºC, similar 
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behaviour to that observed in anhydrous BDP followed due to the increased 
vibration of the side chain of the BDP molecules. 
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5 Chapter 5  Effect of Size Reduction on API-
Clathrate Surface Interactions 
 
 
5.1 General Introduction 
 
Micronisation is commonly used to reduce the particle size and size average of 
an active ingredient before it is dispersed in the propellant system for a 
suspension-based pressurized metered-dose inhaler (pMDI) formulation. 
Because the respirable fraction of the emitted aerosol of a pMDI formulation is 
largely dependent on the aerodynamic size of the bulk drug particles, the API 
usually requires significant size reduction to the range of 2 ±5 µm by 
micronisation. The principal requirement for an effective delivery to the lung is 
that the mass median aerodynamic diameter of the particles generated from the 
device is in the range of 2 ± 5 µm. A smaller particle size of 1.0 ± 2.0 µm is 
required when the pulmonary route is being considered for a systemic drug 
administration and targeting the deep lung regions is required (Lucas et al., 
1999). While the production of smaller particle size would enhance the 
respirability of drugs, the magnitude of their inherent surface electrostatic forces 
would produce more cohesive powder system or more adhesive to the different 
parts of the device (Lucas et al., 1999). 
 
Size reduction techniques are used in order to produce smaller particles. Ball-
milling, the technique used for size reduction during this project operates by 
retaining a bed of powder in a chamber in which the powder is comminuted by 
tumbling balls for an extended period of time. The residence time in the ball-mill 
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chamber depends on the degree of size reduction desired. The technique can 
produce final particles of less than 5 µm in diameter, primarily through 
impaction. As a result of the milling, the properties of the powder will change. 
The process of milling has been reported to result in particles becoming rounder 
and more spherical in shape due to the boundaries of the particles becoming 
smoother after micronisation (Akbarieh and Tawashi, 1987). The cohesiveness 
of the particles has been shown to increase with milling when compared to the 
non-milled form (Omelczuk et al., 1997). Furthermore, the surface energy of the 
powder has been shown to be affected by the process (Buckton et al., 1988) due 
to the potential changes in the orientation of the molecules on the surface of the 
powder particles or changes in form and hence orientation of the molecules at the 
surface of the powder (Briggner et al., 1994, Ahmed et al., 1996). For example, 
amorphous regions can form on a surface of the particles due to localized 
disorder introduced due to size reduction and hence becoming more prevalent 
than the occasional molecular dislocation (Ward and Schultz, 1995, Gerhardt et 
al., 1994). Amorphous regions are thermodynamically unstable and maintain a 
higher energy state compared to crystalline regions within a powder. Therefore, 
amorphous regions can significantly modify the behaviour of powders in 
pharmaceutical formulations, for example, by enhancing the dissolution rate 
(Burt and Mitchell, 1981), decreasing the chemical stability (Otsuka and 
Kaneniwa, 1990), and increasing the potential of polymorphic transition to a new 
crystalline state during storage (Kontny et al., 1987). Such changes in the 
physical properties of powders after the milling process can have an equally 
significant impact on aerosol formulations. The understanding of the influence of 
the milling process on the pMDI formulation would be greatly beneficial, 
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especially for the process of reformulating pMDIs with ozone-friendly 
propellants. 
 
5.1.1 Chapter Aims and Objectives 
 
This chapter will aim to study the effect of particle size reduction on API 
interactions with different pMDI components. The integrity of the structure of 
the clathrate following size reduction was determined using scanning electron 
microscopy (SEM), differential scanning calorimetry (DSC) and X-ray powder 
diffraction (X-RPD). Furthermore, the surface characterization of each of the 
BDP entities utilized during this study and different pMDI components was 
investigated. Following this, colloid probe AFM was be used to determine the 
adhesive interaction in a model propellant (mHFA). Additionally, the 
characteristics of AFM force curves was assessed and used to determine the 
surface free energy (Ȗ) and the force of adhesion (Fadh) of the different BDP 
entities used in this study with different pMDI components in a model propellant 
(mHFA) and determining the effect of size reduction on the latter. 
 
5.2 Materials and Methods 
 
5.2.1 Materials 
 
All of the chemicals used were the same as the ones stated in chapter 3, Section 
3.2.1.  Concerning the pMDI components and BDP IPA clathrates, both were all 
supplied by 3M Drug Delivery Systems (Loughborough, UK). 
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5.2.2 Methods 
 
5.2.2.1 Preparation of mHFA Based Media for AFM Adhesion Experiments 
 
To examine the effect of size reduction on different BDP entities surface 
interactions in mHFA, the following solutions were used: 
 
Anhydrous mHFA: This medium was used throughout the project for the 
evaluation API-pMDI component interactions. A 2.5 litre batch of mHFA was 
placed into a clean, dry Duran bottle (Duran, Mainz, Germany). Approximately 
100g of molecular sieves were added to the bottle, to remove any trace of water 
from the solution. The bottle was sealed with a screw-lid and Parafilm (Alcan, 
Neenah, WI, US), and stored in a fridge at 4°C prior to use. 
 
5.2.2.2 Isolation of BDP CFC-11 Clathrate and BDP EtOH solvate 
 
Anhydrous BDP was suspended in CFC-11 at a concentration of 1.67% w/w 
BDP in CFC-11. The same procedure as stated in Chapter 3, Section 3.2.2.1 was 
used to extract and store the clathrate crystals. Concerning BDP EtOH solvate 
crystals, these were extracted the ethanol solution with no propellant via rotary 
evaporation. The crystals were stored using the same conditions for the BDP 
CFC-11 clathrate as mentioned in Chapter 3, Section 3.2.2.1. 
 
 
Chapter 5 ± Effect of Size Reduction on API-Clathrate Surface Interactions 
 
188 
 
5.2.2.3 Size Reduction Using Ball-Milling 
 
Size reduction on the BDP CFC-11 clathrate, BDP IPA clathrate and BDP EtOH 
solvate were carried out by ball milling using a Restsch® MM 400 ball-miller 
(Restsch, Germany). The milling intensity was the maximum with a frequency of 
30 Hz and was carried out for 2 hours on 500 mg of the BDP CFC-11. The size 
and morphology of the ball-milled particles was studied by SEM. The samples 
were used for surface energy determination and force of adhesion with different 
pMDI components. The samples were stored in glass vial under nitrogen using 
after being sealed with a vial screw and Parafilm (Alcan, Neenah, WI, US), and 
stored in a fridge at 4°C prior to use. 
 
5.2.2.4 Scanning Electron Microscopy (SEM) 
 
The surface morphology of each of the BDP entities before and after milling, 
along with the different pMDI was investigated using SEM (JEOL (UK) Ltd, 
Welwyn Garden City, UK). The positioning of the API particle on the AFM 
cantilever were analysed before and after force data acquisition using SEM. SEM 
was carried out at an accelerating voltage (between 1 keV and 10 keV) and a 
spot size of between 48nm and 62 nm. These parameters were varied for each 
sample in order to optimise each particular image. 
 
5.2.2.5 X-Ray Powder Diffraction (X-RPD) 
 
Both crystalline and ball-milled samples of BDP CFC-11 clathrate were analyzed 
using X-RPD. X-RPD patterns were collected on a Bruker D8 diffractometer 
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system (Bruker AXS, Madison, WI, USA), operating in a Debye-Scherrer 
geometry. A ceramic X-UD\WXEHZLWKDFRSSHUWDUJHWZDYHOHQJWKȜ c
operated at 40 kV, 40 mA. A scintillation counter was employed. The scan rate 
was 2° min-1. The X-ray patterns were analysed using the Le Bail method (Le-
Bail et al., 1988) to model the patterns obtained, based on the reported unit cell 
for the clathrate. All the patterns were collected straight after the formation of the 
crystals to determine the purity of the samples and its crystalline structure.  
 
5.2.2.6 Differential Scanning Calorimetry (DSC) 
 
Differences of phase behaviour between crystalline and ball-milled BDP CFC-11 
clathrate were determined using DSC. DSC experiments were carried out using a 
DSC 2920 Differential Scanning Calorimeter (TA Instruments, USA), with a 
FRQVWDQWÛ&PLQKHDWLQJUDWHIURPÛ&WRÛ&LQDGU\QLWURJHQDWPRVSKHUH
Non-sealed aluminium pans were used in order to allow the escape of the 
propellant during the desolvation phase. In all measurements 6-7mg of sample 
were used. The thermograms obtained for the DSC results were analysed using 
TA universal analysis -NT software. 
 
5.2.2.7 Thermogravimetric Analysis (TGA) 
 
In order to determine whether the clathrate structure retained the propellant 
within the channels of the crystallized BDP after size reduction, TGA was 
performed on the ball-milled BDP CFC-11 clathrate. TGA of ball-milled BDP 
EtOH solvate and BDP IPA clathrate were also undertaken in order to determine 
the effect of size reduction on the solvates structure. An SDT Q600 TGA/DSC 
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ZDVXVHGWRUHFRUGWKHZHLJKWORVVRIWKHVDPSOHVEHWZHHQÛ&DQGÛ&'U\
QLWURJHQ JDV ZDV XVHG DV D SXUJH DQG WKH VFDQ VSHHG ZDV Û&PLQ $Q
LVRWKHUPDOSHULRGDWÛ&ZDVUXQIRUPLQXWHVSULRUWRWKHPHDVXUHPHQWVDQG
any changes in weight during that period were monitored. In all measurements 6 
to 7mg of sample was used. The thermograms obtained from the TGA results 
were analysed using TA universal analysis -NT software. 
 
5.2.2.8 Atomic Force Microscopy (AFM) ± Topographical Imaging 
Acquisition 
 
Each material was topographically imaged in order to determine the root mean 
square (RMS) roughness of each BDP entity and pMDI component. Each sample 
was imaged using a Nanoscope IIIa MultiMode AFM (Veeco, Santa Barbara, 
CA, USA) in contact mode using NPS cantilevers (Veeco, Santa Barbara, CA, 
USA). A scan rate of 0.5 Hz was used over 5 µm x 5 µm scans. Three images 
were acquired from each pMDI component surface and the RMS roughness was 
calculated using software incorporated in the AFM system, via the following 
equation 5-1; 
 
 
         Equation 5-1 
 
 
where n is the number of points in the topography profile, i is the asperities and 
yi is the distance between the asperities. 
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5.2.2.9 AFM ± Surface Energy Determination 
 
The surface energy of each material (Table 5-4) was determined using the blank 
AFM cantilever method where three Force Modulation Etched Silicon Probes 
(FESP) cantilevers (Veeco, Santa Barbara, CA, USA) were used to determine the 
Fadh from compacts of each clathrate and anhydrous BDP (Stegemann et al., 
2007). In order to find out the flexibility (and hence exerted force) of each 
cantilever, the spring constants of these FESP cantilevers were determined using 
the Sader method  prior to force data acquisition (Sader et al., 1995). The spring 
constants for the FESP tips were between 2.8 and 3.6 Nm-1. The surface energies 
of the API materials were then determined based on the known surface energy of 
the silica probe (42.05 mJm-2) and the measured adhesion to each API. Before 
force acquisition, each cantilever probe was cleaned using a UV ozone cleaner 
(Bioforce Nanosciences, Ames, IA, USA) for 20 minutes to remove organic 
contaminants on the probe surface. The force of adhesion (Fadh) measurements 
were then determined using an EnviroScope AFM (Veeco, Santa Barbara, CA, 
USA). The tests were conducted at ambient temperature (20°C) and less than 1 
% relative humidity. A Triton Laboratory Instrument Control Application, 
version 1.0.32 (Triton Technology, Keyworth, UK) controlled and maintained 
the humidity within the chamber.  
 
One hundred force measurements were recorded using each cantilever, 
employing a distance of 100 nm between sampling points. Force curves using 
each cantilever were also immediately collected against a freshly cleaned 
borosilicate glass cover-slip, before and after the Fadh measurements. The 
borosilicate cover slip was used as a non-indenting reference to determine the 
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sample deformation. The cover slip was cleaned, rinsed and dried using Piranha 
solution [a mixture of 30% H2O2 and 70% concentrated H2SO4 in water (1:4)], 
deionised water and nitrogen gas respectively. Before and directly after all force 
measurements, the tip radius of each single probe used was characterized by tip 
self-imaging in order to check the integrity of the tip throughout the studies 
(Davies et al., 2005).  
 
5.2.2.10 AFM ± Tip Characterization 
 
AFM imaging was used in order to image the API particle on each probe, thus 
allowing the contact radius to be determined using a previously reported 
procedure (Hooton et al., 2004). Each colloid probe was imaged using an 
EnviroScope AFM (Veeco, Santa Barbara, CA, USA). A scan rate of 1.0 Hz was 
XVHGRYHUDȝP[ȝPVFDQVL]H 
 
5.2.2.11 AFM - Force of Adhesion Determination 
 
AFM was used in order to measure the interactive forces between the anhydrous 
BDP, BDP CFC-11 clathrate, BDP IPA clathrate, ball milled BDP CFC-11 
clathrate and chosen pMDI components. This was performed using the colloid 
probe technique, where particles of each API material were attached to AFM 
cantilevers (Davies et al., 2005). To summarise, single particles of each API 
were attached to individual cantilevers using epoxy resin. The spring constants 
for each cantilever (determined using the thermal method (Gibson et al., 2003)) 
ranged between 0.3 Nm-1 and 0.5 Nm-1. Correct positioning of the particle on the 
cantilever was verified using SEM before and after AFM analysis (note: the 
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samples were not gold coated, as this would clearly render the tips unsuitable for 
use). Three probes were prepared for each API. Prior to force measurement 
analysis, each probe was imaged using a tip-characterisation method described 
elsewhere (Hooton et al., 2002). Imaging and force determination were 
performed using the EnviroScope AFM. One hundred force measurements were 
taken using each probe against the surfaces of anhydrous BDP, BDP CFC-11 
clathrate, and BDP IPA clathrate in the presence of 20 ml of a model propellant 
2H, 3H decafluoropentane (mHFA) (Sigma-Aldrich, UK). The measurements 
were conducted at 10°C and 25% relative humidity. The force data were 
integrated and calculated using custom software. The separation energy between 
each API and each pMDI surface was determined by integrating the area under 
each force curve, using in-house software. 
 
Calculation of Results 
 
Fadh between each probe and the substrate was determined using AFM. From 
these results, the Work of Adhesion (WA) was calculated using the equation. 
 
WA = R
Fadh
S3
2
 
Equation 5-2 
 
 
Where, R is equal to the radius of the hemispherical point of contact (assumed in 
accordance with the Johnson-Kendall-Roberts theory) determined by tip 
characterisation. Subsequently, the surface free energy of material was calculated 
using the formula: 
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1J =
2
2
Ȗ4
AW
 
Equation 5-3 
 
 
In the case where blank cantilevers were XVHG Ȗ2 relates to the surface free 
energy of the silicon tip, which has a nominal value of 42 mJm-2. Different 
publications have shown that the dispersive surface energy of silica determined 
using the contact angle technique, ranges from approximately 41 to 43 mJm-2  
(Davies et al., 2005). The sample surface deformation (d) due to indentation was 
calculated from the difference in the gradient of the force - distance approach 
curve, subsequent to contact between the reference and sample surfaces. 
Following AFM measurements, the functionalised V-shaped cantilevers were 
analysed using SEM again to ensure that the imaging and force measurements 
had not changed the particle morphology or removed the particles completely 
from the apex of the AFM cantilever. 
 
5.3 Results and Discussion 
 
5.3.1 SEM Results 
 
SEM images of the different BDP entities used in this chapter before and after 
ball-milling are shown in Figure 5-1. There are considerable changes that have 
occurred in the morphology of the BDP CFC-11 clathrate, changing from a well- 
defined hexagonal crystal structure to a more spherical structure of an average 
particle size of less than 10 µm in size. SEM images of the each pMDI 
component surfaces are shown in Figure 5-2. From these images, it can be seen 
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that the surface topographies can vary considerably between the different 
materials. For example, asperities can be seen on the surfaces of the valve seals, 
whilst striations are visible on the metering chambers. These features could be a 
result of manufacturing processes such as drawing for the springs and disk-
pressing for the seals. Also, the surface of both EPDM valve seal and the Nitrile 
valve seal show a considerably higher surface roughness compared to the other 
pMDI components. 
 
Both the SEM imaging and tip characterisation imaging of the cantilevers 
functionalised with drug particles, confirmed the integrity of the particles (Fig. 5-
3). The drug particles were clearly proud of the cantilever surface and the 
morphologies of the particles were unchanged throughout the study. 
 
 
 
 
Figure 5-1: SEM photographs of crystalline BDP CFC-11 (left) and ball-milled BDP CFC-11 
clathrate. 
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Figure 5-2: SEM images of selected pMDI components used in this study. 
 
 
Figure 5-3: SEM Image of colloid probe (Left) and an AFM Image of API particle on probe 
(Right). 
FEP coated 
canister 
Uncoated 
canister 
Metering 
Chamber 
Nitrile valve 
seal 
EPDM valve 
seal 
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5.3.2 X-RPD Results 
 
A reasonable match was obtained for ball-milled BDP CFC-11 clathrates when 
compared with patterns calculated based on the partial structures reported for the 
BDP EtOH HFA-134a clathrate (Fig. 5-4). The peak positions for the ball-milled 
BDP CFC-11 clathrate show a very good match with the characteristic peaks 
observed for the calculated clathrate pattern. These results confirm that the 
clathrate structure is retained and that there is no structural rearrangement or po- 
 
 
 
 
 
 
 
 
 
 
Figure 5-4: Superimposition of both ball-milled BDP CFC-11 clathrate and calculated BDP 
EtOH HFA-134a clathrate X-RPD patterns. 
 
lymorphic changes in the crystal structure following size reduction. However, 
the characteristic peaks for the ball-milled BDP CFC-11 clathrate are broader 
and have less intensity compared to the crystalline structure. The decrease in the 
intensity of the peaks is due to the introduction of some amorphous regions upon 
milling. The amorphous regions are less ordered than the crystalline compound 
and therefore result in a broader, less sharp peaks with a lower intensity (Baites 
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et al., 2006). The same effect is observed for both ball-milled BDP EtOH solvate 
and ball-milled BDP IPA clathrate (Fig. 5-4) 
 
5.3.3 TGA Results 
 
The different BDP clathrates and solvates were heated to 300°C in order to 
investigate the total weight loss observed and determine if any structural changes 
in terms of the solvate/clathrate structure occurred after size reduction. The loss 
of CFC-11 molecules from the clathrate structure was observed between 85°C 
and 100° (Fig. 5-5) as was observed and reported in Chapter 3, Section 3.3.4.2. 
The weight loss is expressed by 11.61 ± 1.6 % which is 2% less than the non-
milled BDP CFC-11 clathrate weight loss after heating. This is interpreted as the 
weight loss corresponding to the loss of CFC-11 from the crystal structure of the 
clathrates. The total weight loss for both the BDP EtOH solvate and the BDP 
IPA clathrate was expressed by 7.3 ± 0.65 % and 9.6 ± 1.36 % respectively as 
shown in Table 5-1. The weight loss of these two BDP entities also shows an 
approximate 2% decrease in weight loss when compared to the results obtained 
for the non-milled BDP EtOH solvate and the BDP IPA clathrate. From these 
results, it is demonstrated that the structure of both the solvate and the clathrate 
retains the propellant/solvent even after undertaking size reduction and that no 
significant loss of solvent/propellant is seen. 
 
However, both TGA traces observed for ball-milled BDP EtOH solvate and ball-
milled BDP IPA clathrate show a continuous and gradual weight loss that started 
as soon as the heating of the samples was initiated and continued until complete 
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Table 5-1: The different ball-milled crystal samples encountered together with experimental 
(TGA) calculated weight loss in weight %. 
 
Samples (ball-milled) % TGA weight loss (n=3) 
BDP CFC-11 clathrate (1.67% w/w BDP 
in CFC-11) 
11.61 ± 1.6 
BDP EtOH solvate 7.3 ± 0.65 
BDP IPA clathrate 9.6 ± 1.36 
 
release of both solvents at approximately 120°C for the BDP EtOH solvate and 
125°C for the BDP IPA clathrate as shown in Figure 5-5. The initial release of 
solvents is thought to be due to the evaporation of the excess solvent present on 
the surface of the ball-milled BDP EtOH solvate and the ball-milled BDP IPA 
clathrate. The presence of the solvent at the surface of the crystal samples is a 
result of the release of the solvent from the crystal structure of the crystallized 
BDP upon milling. The process of size reduction, will lead to some 
morphological changes as observed for the BDP CFC-11 clathrate on Figure 5-1 
where the structure of the crystals becomes more rounded and spherical. Similar 
structures were observed for both ball-milled BDP EtOH solvate and BDP IPA 
clathrates (results not shown). These changes will result in the partial or 
complete destruction of the structure of some of the crystals leading to the 
release of the propellant/solvent from the unit cells constituting the crystal and 
therefore some reduction in the weight loss. As the solvent/propellant molecules 
are no longer entrapped within the crystal structure, they easily evaporate upon 
heating as shown in the results when the heating is initiated. 
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Figure 5-5: TGA curve of ball-milled: A- BDP CFC-11 clathrate, B- BDP EtOH solvate and C- 
BDP IPA clathrate. All samples were heated from 0°C to 300°C at a heating rate of 10°C/min. 
 
5.3.4 Atomic Force Microscopy (AFM) ± Topographical Imaging 
Acquisition 
 
Two-dimensional and three-dimensional AFM images of various pMDI 
component surfaces (5 ȝP[ȝPDUHVKRZQLQ)LJXUH-6. From these images, 
it can be seen that the surface topographies can vary considerably between 
different materials. For example, the asperities seen on the non-coated pMDI 
canister are far less apparent on the FEP-coated canister. Meanwhile, striations 
are visible on the metering chamber and less-ordered surface roughness is 
observed on the valve stem and the valve seal. AFM images at this scale serve to 
further highlight that these features are more than likely attributed to 
manufacturing processes such as drawing coating and disk-pressing, as seem 
with the SEM images. 
C 
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A- FEP Polymer Coated Aluminium Canister 
 
 
 
 
 
 
 
 
B- Uncoated Aluminium Canister 
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C- Stainless Steel Metering Chamber 
 
 
 
 
 
 
 
 
 
D- Nitrile Valve Seal 
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E- Ethylene Propylene Diene Monomer (EPDM) Valve Seal 
 
 
Figure 5-6: 'DQG'$)0LPDJHVRIYDULRXVS0',FRPSRQHQWVVFDOHȝP[ȝP 
 
5.3.5 RMS Roughness Analysis 
 
Table 5-2 shows the RMS roughness determined from individual particles for 
each of the API materials. The roughness of micronized anhydrous BDP is 
significantly higher compared to BDP IPA clathrate and BDP CFC-11 clathrate 
roughness values (P < 0.05). Ball-milling of the clathrate produced a 
significantly higher roughness value compared to the crystalline materials of the 
same compound (P < 0.05). In general, their relatively low levels of surface 
roughness are consistent with their crystalline nature. The increase in the surface 
roughness of the ball-milled BDP CFC-11 clathrates compared to the crystalline 
ones is due to the introduction of some irregularities on the surface of the ball-
milled clathrate that resulted from the ball-milling process. However, the AFM 
imaJHV KLJKOLJKW LUUHJXODU DUHDV RQ VRPH RI WKH $3, FU\VWDOV 7KHVH µFUDWHUV¶
could have been created due to particle-particle agitation during the post-
manufacture storage and transit of these APIs. Therefore, for the AFM adhesion 
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experiments it was important to select visibly smooth surfaces from the more 
uniform-looking crystals. 
 
Table 5-2: RMS roughness values for each of the BDP entities used in this study. Statistical 
significance was defined as P < 0.05 between anhydrous BDP and the rest of the BDP entities. 
 
 
The SEM images highlight the difference in surface topography of each 
component. For example, asperities can be seen on the surfaces of the valve 
seals, whilst striations are visible on the metering chambers. These features could 
be a result of manufacturing processes such disk-pressing for the seals or 
polishing for the metering chamber. The RMS roughness calculations support the 
SEM data. Uncoated aluminium canisters have a significantly higher roughness 
value than the FEP coated aluminium canisters (Table 5-3) (P < 0.05). This is 
probably due to the FEP coating on the canisters. The roughness value of the 
stainless steel metering chamber is lower than both the aluminium canisters 
(Table 5-3), probably due to the polishing process of the chamber during the 
manufacturing process. Unlike the metallic component of the pMDI, both EPDM 
and nitrile seal shows a higher roughness value, which might be related to the 
nature of the material. Both the SEM images and RMS roughness data suggest 
irregular surface characteristics and prominent asperities for certain materials. 
Active Pharmaceutical Ingredients RMS Roughness (nm) (n=3) 
Anhydrous BDP 117.6 ± 5.8 
BDP IPA clathrate 29.5 ± 6.5 (**) 
Ball-milled BDP IPA clathrate 98.76 ± 12.42 
BDP CFC-11 clathrate 12.1 ± 4.4 (***) 
Ball-milled BDP CFC-11 clathrate 94.2 ± 17.6 
BDP EtOH Solvate 35.16 ± 8.9 (**) 
Ball-milled BDP EtOH Solvate 101.84 ± 4.7 
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Table 5-3: RMS roughness values for each pMDI component used in this study. Statistical 
significance was defined as P < 0.05 between uncoated and FEP coated aluminium canister.  
 
5.3.6 AFM - Surface Energy Determination 
 
The surface energy (Ȗ) and work of adhesion (Wa) values determined using the 
AFM adhesion data for each BDP formulation using blank FESP tips are 
summarised in table 5-4. The observed ranges of Wa DQG Ȗ YDOXHV IRU HDFK
material indicate that the relative surface energies of the BDP formulations rank 
as follow: micronized BDP: IPA clathrate> micronized anhydrous BDP > ball-
milled BDP EtOH solvate ball-milled BDP IPA clathrate > crystalline BDP 
EtOH solvate > crystalline BDP IPA clathrate > ball-milled BDP CFC-11 
clathrate> crystalline BDP CFC-11 clathrate. The surface energy tip images 
obtained using AFM indicate that the structural integrity of each tip was 
maintained throughout the process of imaging and the force measurements. 
 
Figure 5-7 highlights the significant reduction in surface energy on the clathrate 
and solvate forms of BDP compared to anhydrous BDP (P < 0.001). Expect for 
ball-milled BDP EtOH solvate and ball-milled BDP IPA clathrate (statistically 
similar to anhydrous BDP in terms of surface energy), ball-milling had no major 
effects on the surface energy of both clathrate forms of BDP. In addition, the 
pMDI System Component RMS Roughness (nm) (n=3) 
Uncoated Aluminium Canister 40.0 ± 9.3 
FEP Coated Aluminium Canister 24.7 ± 1.3  
Stainless Steel Metering Chamber 22.8 ± 8.4  
Ethylene Propylene Diene Monomer (EPDM) 
Valve Seal 
47.5 ± 5.85 
Nitrile Valve Seal 34.45 ± 3.5 
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changes in surface energy accompanying the ball-milling show a significant 
increase in surface energy compared to the non-milled crystalline forms of the 
same material expect for BDP CFC-11 clathrates where ball-milling resulted in 
non significant change in surface energy ( P < 0.01 ± 0.001). 
 
The higher surface energy observed for the BDP: IPA clathrate and BDP EtOH 
solvate is most likely attributable to its non-solvated nature, since the IPA and 
EtOH associated with the BDP could possibly promote hydrogen bonding (Fig. 
5-77KXVWKHVXUIDFHRIWKH%'3PD\EHPRUHµDFWLYH¶FRPSDUHGWRDQK\GURXV 
 
Table 5-4: The mean force of adhesion, work of adhesion and surface free energy of the different 
BDP clathrates, determined using blank FESP cantilevers (n=100). 
 
 Mean force of 
adhesion (Fadh) 
(nN) 
Mean work of 
adhesion (Wa) 
(mJm-2) 
Mean surface energy 
ȖP-P-2) 
Anhydrous BDP 242.20 ± 16.37 88.52 ± 8.69 47.5 ± 4.9 
BDP IPA clathrate 144.12 ± 22.38 52.69 ± 11.88 16.5 ± 6.7 
Ball-milled BDP 
IPA clathrate 
197.65 ± 23.06 72.06 ± 5.75 31.04 ± 4.86 
BDP EtOH solvate 145.06 ± 11.85 53.38 ± 2.97 17.68 ± 1.88 
Ball-milled BDP 
EtOH solvate 
245.05 ± 3.44 90.43 ± 2.08 48.68 ± 1.2 
BDP CFC-11 
clathrate 
120.62 ± 4.13 44.05 ± 0.77 11.3 ± 4.1 
Ball-milled BDP 
CFC-11 clathrate 
138.25 ± 22.77 50.85 ± 2.08 15.24 ± 1.26 
 
 
 
BDP. The higher surface energy of the ball-milled BDP CFC-11 clathrate 
compared to the non-milled BDP CFC-11 clathrate may be due to either the 
formation of some amorphous material or the exposure of higher energy sites on 
the surface (Fig. 5-7). This has implications when considering interparticulate 
interactions, since a higher surface energy typically results in greater cohesive 
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and adhesive properties. The reduction in the dispersive surface energy suggests 
that the formation of the CFC-11 clathrate may have a positive effect in terms of 
reduced interaction within an MDI formulation. 
 
 
 
 
 
 
 
 
 
Figure 5-7: Surface energy of micronized anhydrous BDP, both crystalline and ball-milled BDP 
CFC-11 clathrate, BDP IPA clathrate and BDP EtOH solvate determined by AFM. Statistical 
significance was defined as P < 0.05 compared to anhydrous BDP, *** = P < 0.001, ** = P < 
0.01. The significance between the crystalline and ball-milled entities was also defined as P < 
0.05, *** = P < 0.001, ** = P < 0.01. 
 
5.3.7 AFM ± Force of Adhesion Determination 
 
As stated previously, the force of adhesion between each BDP solid form and 
each pMDI component was determined using AFM. It is clear from Figure 5-8 
that there are differences in the level of API adhesion to each pMDI material. 
There appears in general to be more API adhesion to the metallic components 
such as the metering chamber and to the valve seals. From this figure, it can be 
observed that the normalized force of adhesion is significantly highest for the 
anhydrous with the different pMDI components except for EPDM seal (P < 0.05-
0.001). BDP CFC-11 clathrates showed the most significant reduction in Fadh 
compared to anhydrous BDP and BDP IPA clathrates within all the different 
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pMDI components (P < 0.001). Furthermore, ball-milling of the BDP CFC-11 
clathrate does not seem to have any major effect in terms of adhesion to the 
different pMDI components as it showed only a slightly higher Fadh than the 
crystalline BDP CFC-11 clathrate. It can be seen from Figure 5-8, that the 
normalized Fadh for the four different BDP entities with the two types of 
aluminium canister are approximately the same with a slightly lower adhesion to 
the fluorinated ethylene propylene (FEP) coated aluminium canister. This is due 
to the FEP coated aluminium canister having a lower surface energy and a 
slightly smoother surface than the uncoated aluminium canister. Concerning the 
Fadh of the different BDP entities with the two seals, the results show a very large 
difference in the adhesive force. Higher normalized Fadh values were observed 
for the different BDP entities with the nitrile ring seal compared to the ethylene 
diene M-class rubber (EPDM) seal. However, BDP CFC-11 clathrate still show 
the lowest adhesion with both seals. The significantly high Fadh seen with the 
nitrile ring seal could be attributed to the roughness of the surface of the seal and 
the irregularities of the surface observed using AFM (Fig. 5-6). The data 
obtained for the Fadh measurements with of the APIs with the different pMDI 
components supports the results obtained with the surface energy obtained in 
Chapter 5, Section 5.3.6. Higher surface energies of the particles will 
automatically result in higher force of adhesion with other particles/surface or 
increase cohesion within the particles themselves. The higher surface energies 
observed with the micronized BDP resulted in higher adhesion with the different 
pMDI components. Similarly, the force of adhesion of ball-milled BDP CFC-11 
clathrates showed higher force of adhesion to most of the pMDI component 
compared to the crystalline BDP CFC-11 clathrate which is in total agreement 
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with the results observed with the surface energy that showed a higher surface 
energy of the ball-milled clathrates compared to the crystalline ones. 
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Figure 5-8: Normalized force of adhesion of anhydrous BDP, BDP IPA clathrate and BDP CFC-
11 clathrate (crystalline and ball-milled) with different pMDI component. Statistical significance 
was defined as P < 0.05 compared to anhydrous BDP within the individual pMDI components, 
*** = P < 0.001, * = P < 0.05. 
 
An important consideration when obtaining adhesion measurements from a 
number of different surfaces is the variation in the roughness of each surface, 
since roughness directly affects the degree of contact between the probe and the 
surface. Thus, it is undesirable for the surface roughness to be a major 
contributing factor in the adhesion forces measured. Previous studies have shown 
that significant surface roughness would results in a log-normal frequency 
distribution of adhesive force measurements, (Price et al., 2002, Young et al., 
2004), whereas a smooth surface would result in a normally distributed 
frequency distribution of force measurements (Buckton et al., 1995, Price et al., 
2002). Normal frequency distributions were obtained for all adhesion 
measurements; hence it can be assumed that surface roughness was not 
significant factor of the adhesion data produced here. 
 
*** 
*** 
*** * * * 
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5.4 Conclusions 
 
Surface roughness values for each BDP solid form were determined at sample 
sizes of 5µmx5µm. The different BDP entities ranked in terms of surface 
roughness as follow: anhydrous BDP > ball-milled BDP IPA clathrate > ball-
milled BDP CFC-11 clathrate > BDP IPA clathrate > BDP CFC-11 clathrate. 
 
It was possible to calculate the surface energy of the different material using 
single particle adhesion data. The surface free energies for anhydrous BDP 
(micronized), BDP CFC-11 clathrate (ball- milled for 2.5 hours) and the BDP 
CFC-11 clathrate (crystalline) were 47.5 ± 4.9 mJm-2, 15.24 ± 1.26 mJm-2 and 
11.27 ± 4.05 mJm-2 respectively. Normalised force of adhesion results measured 
in a model propellant showed that BDP CFC-11 clathrates had a lower Fadh 
compared to anhydrous BDP with the different pMDI components studied and 
that size reduction of the BDP CFC-11 clathrate did not have any major effect in 
terms of surface energy and Fadh. The adhesive interactions between the three 
different BDP entities and pMDI components in a model propellant had been 
characterised using AFM.  
 
The results generally suggest that the in situ formation of a clathrate in a 
propellant formulation is beneficial in terms of a reduction the force of adhesion 
with different pMDI components. This could have implications for future HFA 
formulation development with APIs that are prone to the formation of propellant 
clathrates because BDP forms a clathrate with HFA 134a much more slowly 
(over a time scale of months), when the two materials are mixed in suspension 
formulations (Vervaet and Byron, 1999).  
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6 Chapter 6  Investigation of Ostwald Ripening of 
Beclomethasone Dipropionate and Budesonide in a 
Model pMDI System 
 
6.1 Introduction 
 
The general environmental issues related to the use of chlorofluorocarbons 
(CFCs) and their replacement hydrofluoroalkanes (HFAs) are well known and 
following the advent of the Montreal Protocol in 1989, this has led to the phasing 
out of CFCs and alternative MDI systems containing HFAs have needed to be 
developed. The new MDI systems are being investigated for delivery of small 
molecule drugs as well as peptides and proteins (Vervaet and Byron, 1999, 
Brindley, 1999, Smyth, 2003, Ganderton et al., 2003, Marijani et al., 2007). 
HFAs provide a greener alternative to CFCs as propellants in these devices, 
however, their physicochemical properties have required extensive 
redevelopment of the CFC based product (McDonald and Martin, 2000). While 
CFCs are completely halogenated, HFAs are asymmetrical in that they have at 
least one unbalanced hydrogen atom (Byron and Blondino, 1996). The 
electronegative influence of fluorine on these molecules results in the hydrogen 
atom(s) becoming highly electropositive and therefore, susceptible to dipole-
dipole interactions. Consequently, HFAs have considerably higher polarity than 
CFCs which is responsible for the obstacles associated with HFA formulation 
development (Clarke et al., 1993, Vervaet and Byron, 1999, Butz et al., 2002, 
Wu and da Rocha, 2007). 
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Surfactants were incorporated into CFC pMDIs for several reasons. In 
suspensions, surfactants have been used to stabilize the dispersion by reducing 
the electrostatic charges of the micronized drug (Johnson, 1996), help solubilise 
drug and prevent crystal growth during storage in solution formulations and 
valve lubrication  (Vervaet and Byron, 1999). The solubility of the different 
surfactants in HFA 134a and 227ae is considerably lower than the concentration 
required to stabilize CFC suspensions (Byron et al., 1994, Smyth, 2003). 
Surfactants traditionally used in CFC-based pMDIs are not soluble in HFAs 
without the use of co-solvents (Smyth, 2003). However, the use of co-solvents, 
such as ethanol, is most likely incompatible with suspension formulations as 
drug solubility will also be promoted (Smyth, 2003). The resulting increase in 
drug solubility can promote partial drug dissolution and crystal growth due to 
Ostwald Ripening (Vervaet and Byron, 1999). This is a process where small 
particles (less energetically favoured) thermodynamically associate with larger 
particles (more energetically favoured), due to entropy favouring the dissolution 
of small particles. Therefore changing the aerodynamic size distribution of the 
dose (Vervaet and Byron, 1999). The consequence of this phenomenon is a 
product of limited stability due to poor dosing consistency and a decrease in the 
fine particle fraction as required for penetration of the drug into the deep lung. 
Thus, there is a need for surfactants which are significantly more soluble in HFA 
propellants. The effect of surfactants on emitted droplet size has been 
investigated by several groups. In work performed by Polli et al. the surfactant 
sorbitan trioleate decreased the mass median aerodynamic distribution (MMAD) 
of the CFC dexamethasone suspension when added to the formulation (Polli et 
al., 1969). A suspension of terbutaline in a CFC system containing sorbitan 
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trioleate surfactant was also shown to have little change in emitted particle size 
(Baeckstroem and Nilsson, 1988).  
 
Reformulation of suspension aerosols in HFAs is of great current interest and 
may help the different problems encountered in suspension pMDI formulations. 
Typically, suspension aerosols will contain a mixture of micronized drug, a 
surfactant, a co-solvent, and propellant(s). A surfactant, such as oleic acid or 
lecithin helps to disperse the drug and lubricate the metering valve. A co-solvent, 
such as ethanol helps to solubilise the surfactants. A co-solvent may also help to 
disperse the drug and is required to form a drug/co-solvent concentrate in many 
manufacturing processes currently used for suspension formulations (Tzou et al., 
1997). 
 
6.1.1 Chapter Aims and Objectives 
 
Budesonide, like beclomethasone dipropionate, has a significant solubility in 
replacement HFA propellants  ȝJJ and 29.85 for budesonide and BDP 
respectively in HFA-134a) (Jones et al, 2006, Traini et al, 2006). Therefore, 
stability with respect to particle size and morphology in the different HFA 
propellants must be determined in the presence of surfactants and co-solvents. 
This chapter will discuss the effect of three different mHFA media: mHFA 
alone, mHFA containing 2% (v/v) anhydrous ethanol as a co-solvent and finally 
mHFA containing 0.05% (v/v) oleic acid as a surfactant and 2% (v/v) anhydrous 
ethanol, on the behaviour of BDP and budesonide in the propellant. The effect of 
the different mHFA media on the morphology and the particle size of the APIs 
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will be determined using scanning electron microscopy (SEM). Following this, 
atomic force microscopy (AFM) will be used to study the surface topographical 
changes and the surface roughness (RMS) of the different APIs when exposed to 
the different mHFA media. Additionally, a laser diffraction technique was 
utilised to determine the mean particle size of the different APIs at different time 
points of storage in the mHFA media. From these data, it will be possible to 
apply the LSW theory and determine the rate of Ostwald ripening (KLSW) 
(Chapter 1, Section 1.6.2.3).  
 
6.2 Materials and Methods 
 
All of the chemicals used were the same as the ones stated in Chapter 3, Section 
3.2.1.  The pMDI components were supplied by 3M drug delivery systems Ltd 
(Loughborough, UK). 
 
6.2.1 Methods 
 
6.2.1.1 Preparation of mHFA Based Media for Ripening Studies 
 
To examine the effect of ethanol and oleic acid on the API ripening in a model 
propellant mHFA, the following solutions were used: 
 
Anhydrous mHFA: This medium was used as a control environment in order to 
determine the coarsening behaviour of the API molecules in a model propellant. 
A 2.5 litre batch of mHFA was placed into a clean, dry Duran bottle (Duran, 
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Mainz, Germany). Approximately 100g of molecular sieves (5 Å pore diameter) 
were added to the bottle, to remove any trace of water from the solution. The 
bottle was sealed with a screw-lid and Parafilm (Alcan, Neenah, WI, US), and 
stored in a fridge at 4°C prior to use. 
 
Anhydrous mHFA and 2% v/v Anhydrous Ethanol (mHFA EtOH): This was 
used as the first test environment to examine the influence of ethanol on API 
coarsening behaviour. 250 ml of anhydrous mHFA was taken from the 1 litre 
batch and placed into a clean, dry Duran bottle (Duran). 5.0 ml of anhydrous 
ethanol prepared in the same way was added to the mHFA using a glass pipette 
(SLS, Nottingham). Approximately 100g of molecular sieves (5 Å pore 
diameter) were added to the bottle, to remove any trace of water from the mixed 
solution. The bottle was sealed with a screw-lid and Parafilm (Alcan), and 
shaken vigorously by hand for 5 minutes followed by sonication in a sonic bath 
for 20 minutes. The solution was then stored in a fridge at 4°C for at least 48 
hours prior to use. 
 
Anhydrous mHFA with 2% v/v Anhydrous Ethanol and 0.05% v/v Oleic Acid 
(mHFA EtOH oleic acid): 489.75 ml of anhydrous mHFA was taken from the 1 
litre batch and placed into a clean, dry Duran bottle (Duran). Exactly 10.0 ml of 
anhydrous ethanol prepared in the same way was added to the mHFA using a 
glass pipette (SLS, Nottingham). The bottle was sealed with a screw-lid and 
Parafilm (Alcan), and shaken vigorously by hand for 5 minutes followed by 
sonication in a sonic bath for 20 minutes. Following this, exactly 0.25 ml of oleic 
acid was added to the mixture. The bottle was again sealed with a screw-lid and 
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Parafilm (Alcan), and shaken vigorously by hand for 5 minutes followed by 
sonication in a sonic bath for 20 minutes. 100g of molecular sieves (5 Å pore 
diameter) were added to the bottle, to remove any trace of water from the mixed 
solution. The solution was then refrigerated at 4°C for at least 48 hours prior to 
use. 
 
6.2.1.2 Isolation of BDP CFC-11 Clathrate 
 
Anhydrous BDP was suspended in CFC-11 at a concentration of 1.67% w/w 
BDP in CFC-11. The same procedure as stated in Chapter 3, Section 3.2.2.1 was 
used to extract and store the clathrate crystals. 
 
6.2.1.3 Preparation of APIs Compressed Discs for AFM Topographical 
Imaging 
 
API compressed discs were produced using the same method utilized to produce 
KBr discs for IR-spectroscopy. The API powders (approximately 300 mg) were 
transferred into a mortar. Two stainless steel discs were removed from a 
desicator. The cutout hole was then filled with the powders and the second 
stainless steel disc was placed on top in the hydraulic press. The die assembly 
was left under vacuum for 2 minutes to remove air from the discs in a die cast IR 
press (Specadie, Specar Ltd, Kent, UK). The pressure was then increased to 15 
tons for 5 minutes and then slowly released. The discs were then obtained by 
dismantling the two dies. A pumping movement was used to move the hydraulic 
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pump handle downward. The piston moved upwards until it reached the top of 
the pump chamber.  
 
6.2.1.4 Preparation of API Propellant Suspensions for Particle Sizing 
 
50 mg of each of budesonide, anhydrous BDP and BDP CFC-11 clathrates were 
suspended in 20 ml of each of the mHFA based media described in the section 
above in a dry vial for use in particle size determination. A small amount of 
molecular sieves was added to the suspension in order to keep the levels of water 
to a minimum. The suspensions were then vigorously shaken by hand followed 
by sonication in a sonic bath for 5 minutes. The solutions were used straight after 
the sonication. 
 
6.2.1.5 Scanning Electron Microscopy (SEM) 
 
SEM was used in order to determine the surface morphology and qualitative 
particle size range for the budesonide and BDP entities at different time points 
while in suspension. 250 µl of each of the suspension was pipetted onto a carbon 
stub at 1, 10, 20, 35, 60, 120, 360 minutes and 24 hours.  The samples were then 
sputter coated with a thin layer of gold (20 nm thickness) in an argon atmosphere 
(50Pa) at 30 mA for 4 minutes for SEM analysis. SEM analysis (JEOL (UK) 
Ltd, Welwyn Garden City, UK) was carried out at an appropriate accelerating 
voltage (between 1 keV and 10 keV) and a spot size between 48nm and 62 nm. 
These parameters were varied for each sample in order to optimise each 
particular image. 
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6.2.1.6 Atomic Force Microscopy (AFM) ± Topographical Imaging 
Acquisition 
 
Each material was topographically imaged in order to determine the root mean 
square (RMS) roughness of each BDP and budesonide entity both in a dry 
environment and then when in continuous immersion in the different mHFA 
media as prepared above. Each sample was imaged using an EnviroScope (E-
Scope) AFM (Veeco, Santa Barbara, USA) in contact mode using D-NPS 
cantilevers (Veeco, Santa Barbara, USA). The tests were conducted at ambient 
temperature (20°C) and less than 1 % relative humidity. A Triton Laboratory 
Instrument Control Application (Triton Technology, Keyworth, UK) controlled 
and maintained the humidity within the chamber. The compressed API discs 
were placed in a small petri dish then introduced in the humidity chamber of the 
E-scope AFM for imaging in both air and liquid to take place. Two different 
images in air at two different areas of the sample discs were taken in order to 
determine any topographical difference in the heights of the sample surface. A 
scan rate of 1.97 Hz was used over 20 µm x 20 µm scans. Once the images in air 
were acquired, 10 ml of each of the mHFA solutions were added to the petri 
dish, allowing complete immersion of the sample discs and the AFM tip in the 
liquid. A scan rate of 1.97 Hz was again used over 20 µm x 20 µm scans. The 
images were acquired from each of the API discs in continuous mode with an 
image being taken every 4 minutes and 30 seconds. The images were then used 
in order to generate the RMS roughness as previously reported in Chapter 5 
which was calculated using software incorporated in the AFM system, via the 
following equation 6-1 
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         Equation 6-1 
          
 
where n is the number of points in the topography profile, i is the asperities and 
yi is the distance between the asperities. 
 
6.2.1.7 Particle Size Determination Using Light Diffraction Technique 
 
Particle size distribution of the different API suspensions prepared above were 
determine using a Coulter LS 230 laser light-scattering apparatus (Beckman- 
Coulter, Miami, FL) which uses the principle of laser diffraction. 500 µl of each 
API suspension was resuspended in each of the mHFA media (20 ml) prior to 
introduction into the fluid module. The amount of sample required was 
determined by the obscuration percentage of the laser beam through the sample 
cell, with the recommended range between 8 and 12%. The particle size 
distribution of the different APIs in mHFAs solution was measured in continuous 
stirring to prevent any sedimentation or agglomeration and using a Fraunhofer 
mathematical model to determine the size of the particles.  Readings were taken 
at 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 15, 20, 25, 35, 45, 60, 75, 90, 120, 150, 180, 240, 
300 and 360 minutes then at 22, 23 and 24 hours. The length of the 
measurements was of 30 seconds per run for each reading. A number of 
statistical summary parameters were generated, which mathematically describe 
the particle size distribution, including mean, median and standard deviations.  
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In order to determine the coarsening behaviour of the different pMDI 
suspensions, LSW theory was applied to the different API suspensions following 
equation 6-2  
 
R3(t) = KLSW . t + R3(0)  (Snyder, 2001)  Equation 6-2 
 
where R is the radius of the particles, t is time and KLSW is the rate of Ostwald 
ripening. 
 
6.3 Results  
 
6.3.1 SEM Results 
 
6.3.1.1 Effects of the Different mHFA Media on Anhydrous BDP 
 
Figure 6-1 shows SEM images of anhydrous BDP, suspended in mHFA, taken at 
different time points after storage. These images show changes that have taken 
place rapidly in the morphology of the micronised anhydrous BDP after being 
suspended in mHFA. The surface of the BDP crystals becoming smoother in 
appearance and having a more defined crystalline nature than those observed for 
micronized anhydrous BDP in Chapter 3, Section 3.3.1, Figure 3.1. BDP 
particles, which were extracted after one minute, have a particle size ranging 
from 2 to 4 µm (n=50) in size which corresponds to the same particle size 
observed for micronized anhydrous BDP. However, the different fractions 
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extracted at different time points from the mHFA BDP suspension showed 
certain differences related to the size and the  
 
 
 
 
 
 
 
 
 
 
1 min 60 min 
120 min 10 min 
Before immersion 
Chapter 6 ± Investigation of Ostwald¶V 5LSHQLQJ RI %HFORPHWKDVRQH
Dipropionate and Budesonide in a Model pMDI System 
 
226 
 
 
 
 
 
Figure 6-1: SEM images showing the effect of mHFA on anhydrous BDP at different time 
points. 
 
morphology of these particles. Unlike, the particles that were extracted at the 
first minute, the particles extracted at a later storage time showed a number of 
small particle aggregates and attached to a larger one as seen in Figure 6-1 at 60 
minutes of storage. The morphology of the particles also changes from a more 
rounded structure to more ordered particles with defined edges. As storage time 
increased, small particles seem to attach to the large ones and fuse to their 
surface. Furthermore, the appearance of larger particles of approximately 8 µm 
in size with smaller (2 µm) aggregated on their surface is more pronounced after 
60 minutes and is observed throughout the experiments with a slight increase in 
the average particle size at each time point. It can also be observed that the 
30 min 
240 min 20 min 
24 hr 
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volume occupied by the particles have reduced which is due to a decrease in the 
number of particles in the suspensions. 
 
The SEM images in Figure 6-2 show the effect of mHFA EtOH on anhydrous 
BDP particles. The results show a change in the morphology of the particles as 
seen in mHFA to a more regular shape which can indicate the formation of 
crystals.  An average particle size of 2-4 µm (n=3) is observed during the first 
minutes of storage. However, as storage time increases, the surface of the 
particles changes quite rapidly which resulted in a change in the morphology of 
the particles from rounded to a more defined geometrical shape. Furthermore, the 
particles increased in size to around 20 µm after 60 minutes and continued to 
grow to reach a maximum of approximately 100 µm after 360 minutes with well 
defined geometrical shape.  
 
The SEM images of anhydrous BDP suspended in mHFA EtOH oleic acid, 
which were taken at different time points after storage, are shown in Figure 6-3. 
The different crystal extracts at different time points of storage showed an 
increase in the average particle size and a change in the morphology of the 
crystals from spherical particles to well defined edges. The particles which 
exhibited a similar size range as observed with mHFA alone do not show a 
drastic change in particle size during the first two hours of storage. However, 
360 minutes of the storage time showed a pronounced increase in size where the 
particles reached an average of approximately 100 µm as shown in Figure 6-3. 
No further growth of particle was observed after 24 hours as particle were of 
similar size to those observed at the 360 minute. It can also be observed from 
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both Figures 6-2 and 6-3 that the volume occupied by the particles has reduced 
which is due to a decrease in the number of particles in the suspensions. These 
results emphasise that EtOH and oleic acid do produce major change in terms of 
the size and morphology of particles compared to mHFA alone. 
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Figure 6-2: SEM images showing the effect of mHFA EtOH on anhydrous BDP at different time 
points. 
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Figure 6-3: SEM images showing the effect of mHFA EtOH oleic acid on anhydrous BDP at 
different time points. 
 
6.3.1.2 Effects of the Different mHFA Media on BDP CFC-11 Clathrates 
 
The SEM images of BDP CFC-11 clathrates suspended in mHFA at different 
time points are shown in Figure 6-4. The overall structure of the BDP CFC-11 
clathrate particles showed well defined crystals of a hexagonal shape as seen in 
Chapter 3, Section 3.3.1 and particle size of 60-70 µm. However, the extracted 
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crystals after 10 minutes in mHFA showed a decrease in the average size of the 
particles and a moderate change in their morphology where the structure of the 
particles changed from hexagonal shaped particles to a more disordered shape 
(Fig. 6-4). The average particle size observed was of approximately 30-40 µm. 
The decrease in the particle size and the changes observed in the morphology of 
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Figure 6-4: SEM images showing the effect of mHFA on BDP CFC-11 clathrates at different 
time points. 
 
the BDP CFC-11 clathrate particles was seen at different time points until the 
particles reached the smallest size (of approximately 10-20 µm) with a 
stabilization of the particle size at around 30 minutes (Figure. 6-4). A moderate 
increase in the average particle size of the BDP CFC-11 clathrates is then 
observed after being extracted from the mHFA suspension from 20 µm to an 
average of 40 µm. This is associated with a change in the morphology of the 
particles from hexagonal to an elongated shape. As the storage time of BDP 
CFC-11 clathrate in mHFA increased to 360 minutes, the particles continued to 
increase in size until they reached an average size of around 35-40 µm associated 
with a decrease in the small particles that were described earlier. At 24 hours of 
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storage, the particles reached their maximum particle size of approximately 50 
µm as shown in Figure 6-4. 
 
In contrast, mHFA EtOH had a different effect on the BDP CFC-11 clathrate 
particles (Fig. 6-5), featured by the different morphology of BDP CFC-11 
clathrates compared to the ones observed in mHFA. The clathrate crystals were 
slightly smaller in size (~ 20 µm) with an occasional loss of their hexagonal 
shape. During the first 60 minutes of storage time in mHFA EtOH, the SEM 
images of the BDP CFC-11 clathrate (Fig. 6-5) showed a decrease in particle 
size to an average of 10 µm. As the storage time increased, the images showed 
an increase in the particle size of the BDP-CFC-11 clathrates and the formation 
of hexagonal shaped crystals of approximately 80 µm in size. 
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Figure 6-5: SEM images showing the effect of mHFA EtOH on BDP CFC-11 clathrates at 
different time points.     
 
Concerning the results obtained for BDP CFC-11 clathrates in mHFA EtOH 
oleic acid (Fig. 6-6), the SEM images are comparable to the particles obtained by 
suspending BDP CFC-11 clathrates in mHFA EtOH. From the first minutes of 
suspending the BDP CFC-11 clathrates in mHFA EtOH oleic acid, a change in 
the surface of the clathrates is observed with small cracks at different faces of the 
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crystals are noticeable (Fig. 6-6). The particle size in the initial first minute of 
storage ranged between 30 and 40 µm, as observed previously. During the 
following 35 minutes, particles of BDP CFC-11 clathrate showed a similar 
pattern of changes as previously described with both mHFA and mHFA EtOH 
media where particles seem to collapse and form smaller particles in size (< 20 
µm). However, the morphology of the particles observed in mHFA EtOH oleic 
acid after 120 minutes of storage time is different compared to the ones observed  
previously in the two other media. The particles show small cracks at their 
surface with more round than hexagonal shape as shown previously. The 
particles seem to have reached a maximum size of around 100 µm after 360 
minutes of storage time. 
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Figure 6-6: SEM images showing the effect of mHFA EtOH oleic acid on BDP CFC-11 
clathrates at different time points. 
 
6.3.1.3 Effects of the Different mHFA Media on Budesonide 
 
Figure 6-7 shows the effects of different mHFA media on budesonide. The 
particles extracted after 1 minute of suspending budesonide in mHFA had a well 
defined structure with a particle size ranging between of 5-10 µm. However, 
some small rounded particles of approximately 1 µm or less can be observed 
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attached to the surface of the larger particles. After 10 minutes of storage time, 
budesonide particles showed a minor increase in the overall particle size of the 
sample and a small change in the size of the small particles that are still present 
at different storage times (Fig. 6-7). 
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Figure 6-7: SEM images showing the effect of mHFA on budesonide at different time points. 
 
By 60 minutes, the morphology of the particles changes to a more defined quasi-
cubic shape with a particle size that ranged between 10-20 µm. The small 
particles of around 1-2 µm in size are still present at the surface of the larger 
ones and seem to be fusing to the surface of these latter (small asperities at the 
surface of the larger budesonide particles). By the end of the experimental 
storage time, the particle size of budesonide particles was around 10-25 µm with 
a well defined structure (Fig. 6-7). The presence of small budesonide particles 
was still evident. 
 
 In contrast, the effect of mHFA EtOH on the shape and morphology of 
budesonide particles showed similar results to those observed in anhydrous BDP 
mHFA EtOH suspension. The SEM images in Figure 6-8 show very little 
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variation in terms of changes in the morphology and particle size of budesonide 
particles in mHFA EtOH media. The particle size of budesonide was of 
approximately 10 µm, similar to the results obtained earlier in mHFA media. As 
the storage in the media increases, the particles show little increase in particle 
size and no major changes are observed in their morphology up to the 35 minute 
of storage. After 35 minutes, changes in the morphology of the particles to a 
more regular shape can be seen in Figure 6-5 at 60 minutes indicating the 
formation of crystals, where small budesonide particles seem to fuse together to 
form slightly larger particles, reaching a maximum size of approximately 20-25 
µm after 360 minute of storage time and remained unchanged after 24 hours. 
Therefore, the particles in mHFA EtOH media showed a better stability in terms 
of the average particle size as observed by the size of the different budesonide 
particles by the end of the experimental time. This might be due to an increased 
solubility of budesonide in mHFA EtOH that leads to more stable particles.  
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Figure 6-8: SEM images showing the effect of mHFA EtOH on budesonide at different time 
points. 
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Figure 6-9: SEM images showing the effect of mHFA EtOH oleic acid on budesonide at 
different time points. 
 
The results obtained for budesonide mHFA EtOH oleic acid suspension, shown 
in Figure 6-9, are comparable to the ones observed earlier in both mHFA and 
mHFA EtOH. Budesonide particles seem to form crystals a soon as they are 
suspended in mHFA EtOH oleic acid and have an average particle size of 
approximately 5 µm. During the first 60 minutes, a small change in the 
morphology of budesonide particles as well as their average particle size could 
be observed. The particles then approximately doubled in size. However, after 24 
hours of storage time in mHFA EtOH oleic acid, budesonide particles still seem 
to be smaller than the particles observed in both mHFA and mHFA EtOH 
suspensions, previously described. From these results, oleic acid might have 
improved the stability of the suspension, as evidenced by the lower average 
particle size of the particles obtained. 
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6.3.2 AFM ±Topographical Imaging Acquisition 
 
6.3.2.1 Effect of the Different mHFA Media on the Anhydrous BDP 
 
Anhydrous BDP discs were continuously imaged in mHFA alone for a period of 
240 minutes and the AFM images obtained are presented in Figure 6-10. The 
images show a developing surface topography and these changes are observed 
until the end of the storage time. The AFM images indicate an active surface of 
the BDP disc i.e. structural rearrangement of the surface. At 1 minute, the 
surface of anhydrous BDP discs shows a reasonably flattened surface with very 
little variations and no defined particles (Fig. 6-10). The surface shows particles 
that are fused together which might be due to the pressure applied when forming 
the anhydrous BDP discs using the IR press. After a few minutes of immersion 
in mHFA media, it can be observed that the shape of the particles becomes more 
defined as seen in 5 minutes AFM image in Figure 6-10. 
 
As time of immersion in mHFA media increased, the topography of the BDP 
disc is continuously changing where small particles are dissolving and other 
particles already present show an increase in diameter and height. At 240 
minutes, most of the small particles that were present seem to have completely 
disappeared with only few still present and the largest particles having a 
maximum height of 2.4 µm and a maximum width of 5 µm. 
 
The results obtained for anhydrous BDP disc immersed in mHFA EtOH media at 
different time points are shown in Figure 6-11. The AFM images show a large 
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surface activity where the surface topography and the height are continuously 
changing with time. As seen with mHFA alone, the AFM images in the initial 
first minute of mHFA EtOH contact with the surface of BDP, the surface show 
very little variation in terms of height with only small particles appearing that are 
closely packed together. However, after 5 minutes, the surface starts to show 
some variations as it can be observed that some small amount of material 
disappeared from the surface of the disc and other areas increased in size. This 
behaviour is noticeable and continuous until the end of storage time. The size of 
the particles increased to approximately 5.4 µm in diameter and 3.6 µm in 
height. The rate of these changes seemed to be more rapid than observed in 
mHFA as the most significant changes were observed as early as 20 minutes of 
exposure (Fig. 6-11). 
 
In contrast, the topographical images obtained for BDP immersed in mHFA 
EtOH oleic acid (Fig. 6-12) show similar features to the ones observed earlier in 
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Figure 6-10: AFM images of anhydrous BDP in mHFA at various time points  
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Figure 6-11: AFM images of anhydrous BDP in mHFA EtOH at various time points  
VFDOHȝP[ȝP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Figure 6-12: AFM images of anhydrous BDP in mHFA EtOH oleic acid at various time points 
VFDOHȝP[ȝP 
 
mHFA and mHFA EtOH. The surface of the BDP disc in mHFA EtOH oleic 
acid show some activity similar to that observed previously in the two other 
media. As immersion time in the media increases, the surface topography 
changes included the disappearance of small particles and the increase in the 
width and height of others. However, the rate of these changes seems to be 
extremely slow in mHFA EtOH oleic acid when compared to the other medium 
and seems to reach a steady state after 120 minutes of exposure  
40 min 60 min 
120 min 240 min 
Chapter 6 ± InvestigatioQ RI 2VWZDOG¶V 5LSHQLQJ RI %HFORPHWKDVRQH
Dipropionate and Budesonide in a Model pMDI System 
 
249 
 
The different streaks observed in various AFM images of anhydrous BDP in 
Figures 6-10 to 6-12 are a result of the high surface activity of the anhydrous 
BDP where the dissolution occurring on the surface of the anhydrous BDP disc 
probably led to some very fine particles sticking to the tip leading to the 
sweeping artefact observed in the images. 
 
In order to determine the effect of the media on the surface roughness, the RMS 
values obtained at each time point for each of the mHFA media were plotted 
against time allowing the effects of each media on the behaviour of anhydrous 
BDP to be studied. The results obtained are represented in Figure 6-13. RMS 
roughness values for BDP in the different mHFA media show a continuous 
increase which confirms the effects of the nature of media on the surface activity. 
 
 
 
 
 
 
 
 
 
 
 
Figure 6-13: Effect of Different mHFA media on the RMS roughness of anhydrous BDP with 
time. 
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The surface of BDP is most affected by mHFA and mHFA EtOH as observed in 
Figure 6-13. The RMS values in mHFA EtOH oleic reached a steady state value 
quite rapidly and the percentage change in RMS was lower than in the other two 
media signifying that oleic acid might have provided some stability to the 
surface and led to a smaller surface activity compared to the ones exposed to 
mHFA and mHFA EtOH.  
 
6.3.2.2 Effects of the Different mHFA Media on BDP CFC-11 Clathrates 
 
The AFM images of BDP CFC-11 clathrates in the different mHFA media were 
taken at the surface of individual BDP CFC-11 particles due to their size (Fig. 6-  
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Figure 6-14: AFM images of BDP CFC-11 clathrates in mHFA at various time points  
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14). The AFM images were taking at different crystal faces of the BDP CFC-11 
clathrates as these were large enough (40 µm) and hence the behaviour on a 
single BDP CFC-11 clathrate particle can be determined. The AFM images show 
the formation of small etch pits at the surface of the particle as soon as these are 
immersed in mHFA. As exposure time to mHFA increases, the surface of BDP 
CFC-11 clathrate particles change very gradually with more pits appearing and 
higher asperities present. These pits might be due to the gradual collapse of the 
particles in mHFA caused by the release of the CFC-11 present in the crystal 
structure or can be associated with the preferential dissolution of the clathrate at 
high energy sites that are related to the presence of defects and dislocations in the 
structure of the clathrates. 
 
The same behaviour was observed when exposing BDP CFC-11 clathrate 
particles to mHFA EtOH and mHFA EtOH oleic acid as shown in Figures 6-15 
and 6-16. The AFM images show that as soon as the particles are in contact with 
the two different media, small etch pitches appeared on the surface of the 
clathrates and their width increases gradually in relation with time of exposure to 
the media. However, the effect of both mHFA EtOH and mHFA EtOH oleic acid 
exhibited the most rapid change in the surface of the clathrates and an almost 
instant collapse in the structure. In both figures, it is noticeable that exposure 
time to the two different media is associated with an increase in the depth of the 
etch pits. Furthermore, the formation of small particles with an apparent size of 
about 1-2 µm at the surface of the BDP CFC-11 clathrates is evident, probably as 
a result of the crystal structure of the clathrate collapsing when exposed to the 
media, eventually leading to the release of the propellant from within the 
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channels inside the clathrate structure. As the collapse of the clathrate crystal 
leads to the formation of anhydrous BDP as discussed in Chapter 3, Section 
3.3.5, the formation of a potentially small anhydrous BDP particle on the surface 
BDP CFC-11 particles is consistent with the data. Further DSC analysis of BDP 
particles after being suspended in mHFA showed no transition and hence 
confirms that the particles remained as anhydrous BDP (Figure 8-2 in appendix 
2) 
 
As for the AFM images of anhydrous BDP, RMS roughness of BDP CFC-11 
clathrate surface were obtained for the different time points of exposure to the 
different mHFA media (Fig. 6-17). These results show that mHFA had a minor 
effect in terms of the changes observed in the RMS values, with a small increase 
in RMS at 50 minutes followed by a quasi-steady state level.  
 
 
 
 
10 min 1 min 
Chapter 6 ± InvestigatioQ RI 2VWZDOG¶V 5LSHQLQJ RI %HFORPHWKDVRQH
Dipropionate and Budesonide in a Model pMDI System 
 
254 
 
 
 
 
 
 
 
Figure 6-15: AFM images of BDP CFC-11 clathrates in mHFA EtOH at various time points 
VFDOHȝP [ȝP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Figure 6-16: AFM images of BDP CFC-11 clathrates in mHFA EtOH oleic acid at various time 
SRLQWVVFDOHȝP[ȝP 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6-17: Effect of Different mHFA media on the RMS roughness of BDP CFC-11 clathrates 
with time. 
 
A rapid increase in RMS values of BDP CFC-11 clathrate surface when exposed 
to mHFA EtOH and mHFA EtOH oleic acid agrees with the topographical 
images observed in Figures 6-15 and 6-16. A large increase in the roughness of 
the surface is more pronounced in the first 50 minutes of exposure, with a slower 
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but steady rate thereafter. This continuous increase in RMS when exposed to 
mHFA EtOH and mHFA EtOH oleic acid confirms the high surface activity of 
the clathrate and their potential change when exposed to different media. 
However, the addition of oleic acid does not seem to have a great influence on 
the behaviour of the clathrates due to the similarity of the results obtained from 
both mHFA EtOH and mHFA EtOH oleic acid. 
 
6.3.2.3 Effects of the Different mHFA Media on Budesonide 
 
The effects of different mHFA media on the budesonide particles at different 
time points of the immersion process was monitored over time by continuous 
AFM imaging to acquire different topographical images of the surface of 
budesonide discs. The images in Figure 6-18, show the changes associated with 
the immersion of budesonide in mHFA alone. These shows the surface of 
budesonide discs to be very flat with most of the particles aggregated and 
flattened together with various changes over the period of the study. However, at 
later stages of their exposure to mHFA, budesonide particles show an increase
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Figure 6-18: $)0LPDJHVRIEXGHVRQLGHLQP+)$DWYDULRXVWLPHSRLQWV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in surface changes where some large asperities start to appear. Some small 
particles that were present on the surface of the budesonide disc at the start of the 
experiment significantly decreased in size by 120 minute of immersion and have 
disappeared by the end of the experimental period (i.e. 320 minutes). In addition, 
an increase in the height of various areas on the AFM images is observed, which 
might suggest the attachment of small particles to different parts of budesonide. 
This process is relatively rapid as changes in the height of budesonide particles 
are seen by the minute 5 of their exposure to mHFA media and continues over 
the experimental exposure time. 
 
Following the exposure of budesonide discs to mHFA EtOH media, the 
topographical images show minimal variation in the surface over time (Fig. 6-
19). An increase in the height of the disc surface is observed after 10 minutes 
with a steady state thereafter.  
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Figure 6-19: AFM images of budesonide in mHFA EtOH at various time points  
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Changes in the surface were relatively slow as only few asperities appeared over 
the surface area of the image, which is thought to be due to dissolution of the 
small particles. Further changes included the appearance of more rounded 
particles on the surface of the budesonide discs after 40 minutes of the exposure 
that might be due to the fusion of very small budesonide particles together to 
form larger ones. From these images, mHFA EtOH media seems to have a 
modest effect on the surface of budesonide. 
 
Similarly, mHFA EtOH oleic acid caused no major changes to the surface 
topography of budesonide particles over the first 10 minutes (Fig. 6-20). 
However, some changes can be observed after 20 minute where larger asperities 
could be observed on the surface accompanied by the dissolution of certain parts 
of the particles. With longer exposure to mHFA EtOH oleic acid, the surface of 
the budesonide discs show slight variations in the associated topography as 
featured by a decrease in the height of some areas, possibly due to the dissolution  
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Figure 6-20: AFM images of budesonide in mHFA EtOH oleic acid at various time points 
VFDOHȝP[ȝP 
20 min 
60 min 
40 min 
120 min 
320 min 240 min 
Chapter 6 ± InvestigatioQ RI 2VWZDOG¶V 5LSHQLQJ RI %HFORPHWKDVRQH
Dipropionate and Budesonide in a Model pMDI System 
 
263 
 
of some very fine particles, while others parts of the particles seem to have 
increased due to the localised merging of small particles to the surface. 
 
In order to compare the surface roughness of the budesonide particles, which has 
been described previously with both anhydrous BDP and BDP CFC-11 
clathrates, the RMS values of each of the different AFM images in the different 
mHFA media were obtained and plotted against time (Figure 6-21). The surface 
roughness of budesonide particles followed a similar pattern when immersed in 
all mHFA media with the highest increase being observed in budesonide mHFA  
 
 
 
 
 
 
 
 
 
 
Figure 6-21:  Effect of Different mHFA media on the RMS roughness of budesonide with time. 
 
EtOH oleic acid. The pattern of changes included a minimal increase in the 
surface roughness of budesonide particles (in both mHFA EtOH and mHFA 
alone) reaching a steady state by 200 minutes which is maintained thereafter. 
This can be explained by the possible formation of slightly larger particles 
following the fusion of the smaller dissolved particles of budesonide to the 
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already existent particles leading to a noticeable change in the surface 
topography of the budesonide particles and an increase in surface roughness. 
 
6.3.3 Effects of Different mHFA Media on the Particle Size of the 
Different APIs 
 
The particle size of the APIs, when suspended in the different mHFA media, was 
determined using the LS Coulter to examine the effects of the propellant on the 
size of the particles and hence its effect on the overall formulation. The mean 
particle size of the different APIs used during this project was assessed at 
different time points of their storage in different mHFA. Results in Figure 6-22 
describe changes in the particle size of anhydrous BDP, BDP CFC-11 clathrate 
and budesonide. The different APIs showed a similar pattern in terms of changes 
in the mean particle size in the different mHFA media over time, except for BDP 
CFC-11 clathrates (Fig. 6-22). The patterns observed for both anhydrous BDP 
and budesonide at different storage times in the different mHFA media exhibit 
three distinct phases where the mean particle size increase over time as shown in 
Figures 6-22A and 6-22C, respectively. An initial rapid increase in the mean 
particle size for both anhydrous BDP and budesonide in the three different media 
is observed from suspending the particles in the propellant during the first 45 
minutes. A second phase is observed for both APIs with a slower rate in the 
change in the mean particle size from 45 minutes to around 400 minutes. The 
third phase is a steady state beyond 400 minutes where the mean particle size of 
both anhydrous BDP and budesonide in the different mHFA media remains 
constant.  
Chapter 6 ± InvestigatioQ RI 2VWZDOG¶V 5LSHQLQJ RI %HFORPHWKDVRQH
Dipropionate and Budesonide in a Model pMDI System 
 
265 
 
When comparing the behaviour of anhydrous BDP in the different mHFA media 
it can be observed that the initial mean particle size in the three different media is 
similar ranging around 15 µm followed by a drastic change in the mean particle 
size of BDP as featured by an increase in size over time until reaching a steady 
state by 400 minutes (Fig. 6-22A). Anhydrous BDP suspended in mHFA alone 
showed the largest increase in the mean particle size where the particles reached 
a steady state at approximately 110 µm. The standard deviations seem to be 
relatively large for the different suspensions of the APIs in mHFA alone, 
possibly due to the high instability of the particles in these suspensions and the 
rapid kinetic changes occurring at different time points. Exposure of anhydrous 
BDP to both mHFA EtOH and mHFA EtOH oleic acid resulted in similar pattern 
of changes to those observed with BDP particles suspended in mHFA alone. 
However, the rate of changes in the average particle size in the initial phase was 
slightly lower than that observed in mHFA alone or mHFA oleic acid (Table 6-
1). Moreover, exposure of BDP in mHFA EtOH medium was associated with a 
less significant change in the average particle size compared to BDP particles 
which were suspended in either mHFA alone or mHFA EtOH oleic acid. This is 
described by a slow increase in the mean particle size of BDP to approximately 
30 µm which, unlike other media, had rapidly reached a steady state by the 
minute 120 of the storage time.  
 
Suspensions of BDP CFC-11 clathrates in the different mHFA media, however, 
exhibited a different behaviour compared to the two other APIs especially during 
the first 20-45 minutes of storage time (Fig. 6-22B). Initially, changes included a 
relatively rapid reduction in the size of the particles which was more pronounced 
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for the clathrates that were suspended in mHFA alone, from 45 µm to 
approximately 2 µm-sized particles. The same behaviour was observed for BDP 
CFC-11 clathrates suspended in the other mHFA media where the particles were 
reduced in size from 45 µm to 14 µm and to 18 µm in mHFA EtOH and mHFA 
EtOH oleic acid, respectively. 
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Figure 6-22: Effect of Different mHFA media on the mean particle size of A- anhydrous BDP, 
B- BDP CFC-11 clathrate and C- budesonide with time. 
 
After the initial reduction in particle size, the particles reached a steady state and 
then followed a similar behaviour to the one observed with both anhydrous BDP 
and budesonide in the different mHFA propellant media. The steady state phase 
was longer for the BDP CFC-11 clathrates in mHFA alone lasting approximately 
100 minutes before an increase in the mean particle size was observed (Fig. 6-
22B). 
 
The increase in the mean particle size of BDP CFC-11 clathrate was significantly 
different in the three different media with the highest rate being observed in 
mHFA alone and the lowest when the clathrates were suspended mHFA EtOH 
oleic acid. Finally, a stabilisation of the different BDP CFC-11 clathrates-
suspensions was reached after approximately 400 minutes of storage allowing 
C 
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particles to reach their largest average particle size of approximately 55 µm 
when suspended in mHFA EtOH, while clathrates which were suspended in 
mHFA alone or in mHFA EtOH oleic acid have reached a size of around 50 µm 
and 41 µm, respectively.  
 
In contrast, budesonide particles when suspended in the different mHFA media 
exhibited comparable changes in the average particle size to those observed with 
anhydrous BDP as shown in Figure 6-22C. Similarities involved the three 
distinct phases occurring during the storage time. The mean particle size of 
budesonide increased from approximately 6 µm to 35 µm, 33 µm and 11 µm in 
mHFA, mHFA EtOH oleic acid and mHFA EtOH, respectively. The rate of the 
changes in the average particle size of budesonide was similar in mHFA and 
mHFA EtOH with a lower particle size being observed for budesonide 
suspended in the latter. Unlike suspensions made with mHFA and mHFA EtOH,  
mHFA EtOH oleic acid seems to have significantly reduced the average particle 
size of budesonide, allowing the particle size to rapidly reach a steady state 
around the minute 200 of the storage time.  
 
Using data from the average particle size of the different APIs in the different 
mHFA media, the LSW theory was applied using equation 6-2 and results are 
presented in Figure 6-23. Applying the LSW theory on both anhydrous BDP and 
budesonide suspended in the different mHFA media, a linear relationship over 
the four different phases was observed where R3 was linearly increased with time 
reaching a steady state during the last phase (Figs. 6-23 A and C respectively). 
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Table 6-1: Different coarsening rates (KLSW (µm3/min)) at different stages for anhydrous BDP, 
BDP CFC-11 clathrate and budesonide. 
 
BDP    
    
Time (mins)\Medium 
KLSW in 
mHFA 
KLSW in mHFA 
EtOH 
KLSW in mHFA EtOH Oleic 
Acid 
0 - 45 3410.1 8.6628 838.81 
45 - 240 235.92 3.0381 15.656 
240 - 360 48277.1 3.0381 1374.2 
360 - 1440 504.22 1.364 148.59 
 
BDP CFC-11 Clathrate    
    
Time (mins)\Medium 
KLSW in 
mHFA 
KLSW in mHFA 
EtOH 
KLSW in mHFA EtOH Oleic 
Acid 
0 - 90 -98.138 -1146.8 -792.41 
90 - 180 67.516 172.38 48.931 
180 - 360 32.001 9.8238 7.6761 
360 - 1440 2.5027 2.6134 0.8298 
 
Budesonide    
    
Time (mins)\Medium 
KLSW in 
mHFA 
KLSW in mHFA 
EtOH 
KLSW in mHFA EtOH Oleic 
Acid 
0 - 35 42.02 7.3521 0.9928 
35 - 240 5.2693 5.4622 0.352 
240 - 1320 2.1062 0.4422 0.091 
1320 - 1440 0.104 0.4422 0.091 
 
The different phases had different slopes i.e. different rates of Ostwald ripening 
(Table 6-1). These results are in agreement with the ones obtained earlier in 
Figure 6-22, in which the mean particle size of the particles reaches a steady 
state in terms of the size. The largest increase in R3 for both anhydrous BDP and 
budesonide was observed with the mHFA media alone, while both mHFA EtOH 
and mHFA EtOH oleic acid resulted in a lower R3. Exceptionally, mHFA EtOH 
showed a significant reduction in the cubic radius of the particle size of 
anhydrous BDP compared to the two other media, whereas mHFA EtOH oleic 
acid produced the highest reduction in R3 in budesonide. 
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However, applying the LSW theory on BDP CFC-11 clathrates suspended in the 
different mHFA media showed some differences compared to both anhydrous 
BDP and budesonide (Fig. 6-23B), highlighting two major phases:  
 
- An initial phase where R3 is reduced corresponding to the collapse of the 
BDP CFC-11 clathrate structure and the formation of smaller particles 
with lower R3.  
- A second phase in which a linear relationship of the increasing R3 over 
time is similar to the other APIs. Three different phases are observed for 
the coarsening of BDP CFC-11 clathrates where the rate of each phase is 
gradually decreasing until reaching a steady state (Fig. 6-23B) and the 
rate of the coarsening is shown in Table 6-1. 
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Figure 6-23: Effect of Different mHFA media on the radius cubed of the mean particle size by 
applying LSW theory of A- anhydrous BDP, B- BDP CFC-11 clathrate and C- budesonide with 
time. 
 
6.4 Discussion 
 
6.4.1 Effects of the Different mHFA Media on the Surface of the 
Different APIs 
 
The SEM results showed, qualitatively, that the primary particle size of the 
suspended drugs was of 1-5 µm, 5-10 µm and 60-70 µm for anhydrous BDP, 
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budesonide and BDP CFC-11 clathrates respectively shortly after being 
suspended in the different mHFA media. BDP CFC-11 clathrates, showed a very 
significant reduction in the average particle size after being suspended in the 
different mHFA media. This reduction can be attributed to the collapse of the 
crystal structure as soon as these are immersed in a different media from their 
mother liquor. The collapse of the structure, led to the formation of a different 
BDP entity (anhydrous BDP) as discussed in Chapter 3, Section 3.3.5. The size 
of the particles formed was slightly larger in size than anhydrous BDP (~ 20 µm) 
and indicated high crystallinity. Evidence of a corresponding increase in the 
average drug particle size was observed for anhydrous BDP in the different 
mHFA media with time after being suspended in the different mHFA media. 
After an initial reduction during the first minutes of exposure to the different 
mHFA media, BDP CFC-11 clathrates followed a similar pattern to that 
observed for the other APIs. Budesonide showed a very small increase in particle 
size in the different mHFA media. However, the SEM images of budesonide in 
the different mHFA media revealed the presence of larger size particles at the 
end of the experimental storage time. The majority of the model propellant 
evaporates very rapidly. Thereafter, micronized drug particles may adhere 
together with surfactant in the case of the APIs suspended in mHFA EtOH oleic 
acid.  
 
The continuous changes in the surface roughness of the different APIs can be 
explained by the high activity (i.e. rapid dissolution and changes on the surface 
topography as observed by AFM) of the surface due to the exposure to the 
different mHFA media. Both BDP and budesonide have increased solubility in 
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mHFA compared to the ozone depleting CFC propellants (Tzou et al., 1997). 
This will lead to some dissolution of particles at the surface of the two different 
APIs. The dissolution of the particles led to changes in surface topography and 
differences in height that will lead to an increased surface roughness. 
Furthermore, the small particles may attach to the larger more energetically 
favoured surface leading to an increase in height that is expressed by an increase 
in the RMS roughness. Furthermore, growth tends to occur at the edge of a 
particles rather than on the flat surface (Noboru et al., 1999). This was observed 
for both BDP and budesonide compared to the BDP CFC-11 clathrates. This may 
be attributed to the higher surface energy in these positions (Mullin, 2001). This 
could mean that particles with a rougher surface are likely to grow faster than 
those with a smoother surface. 
 
The addition of ethanol showed mostly a higher surface roughness compared to 
the mHFA alone. Ethanol is used in order to solubilise the different surfactants in 
the propellants and also help to disperse the drug (Tzou et al., 1997). The 
addition of ethanol also increases the solubility of both APIs (Berry et al., 2003). 
Therefore, this may lead to an increased dissolution of the surface of the different 
APIs leading to more significant changes in surface roughness. The increase 
observed in surface roughness can be explained by the dissolution of very small 
fine particles at the surface of the APIs that will lead to changes an height and 
their corresponding attachment to larger particles already present at the surface 
forming more energetically favoured particles that have a greater size, and hence 
difference in the heights and RMS roughness values. 
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The addition of oleic acid to mHFA EtOH media reduced the rate of surface 
roughness changes compared to the other mHFA media. This can be attributed to 
the effect of the surfactant, oleic acid on the surface of the different APIs. Oleic 
acid would adhere to the surface of the API leading to an increased RMS 
roughness and providing more stability to the particles (James, 2009). The 
mechanism of this surfactant adherence to the APIs surface is most likely via the 
encapsulation of API particles by surfactant molecules in the solution, i.e. the 
hydrophilic head of the surfactant associating with the particle surface, leaving 
the hydrophobic tails to protrude into the highly hydrophobic bulk surfactant 
media. Therefore, this will lead to a lower surface activity. 
 
6.4.2 Effects of the Different mHFA Media on Ostwald Ripening of 
the Different APIs 
 
Size-dependent particle growth, in which larger particles grow more readily than 
smaller particles, has been observed for a number of suspension systems of low 
viscosity (White et al., 1976, Wey and Strong, 1977, Garside and Davey, 1980, 
Yushan et al., 1984, Jones et al., 1986, Sta´vek and Ulrich, 1994). For seed 
crystals in the size range of about 0.5 µm to 100 µm, a linear increase in particle 
growth with the size of the seed crystal has been observed (Garside and Davey, 
1980, Yushan et al., 1984, Berry et al., 2003). These conditions exist in the 
present system because the particles were within the predicted size range. Based 
on the results obtained in the previous section, the increase in particle size in the 
different mHFA media can be attributed at least in part to the particle size of the 
suspended API. 
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The move to larger particle sizes is believed to occur as a result of the dissolution 
of the smaller particles (less energetically favoured) followed by the deposition 
of these on the existing particles (more energetically favoured) (Ostwald 
ripening) (Berry et al., 2004b).  Size-dependent particle growth involves 
diffusion of the molecular growth units to the solid surface of the particle, 
followed by rate-limiting integration of these growth units onto the particle 
(Garside and Davey, 1980, Berry et al., 2003). According to the Ostwald 
ripening model, the proportion of nucleation sites would be greater on large 
particles compared with small particles (Garside and Davey, 1980, Berry et al., 
2003). There was no strong evidence of new nuclei formation in this system. The 
formation of new nuclei tends to occur for relatively dilute systems in which the 
majority of particles are < 500 nm (Verdoes et al., 1992, Auer and Frenkel, 2001, 
Mullin, 2001). This process is unlikely to have occurred as most of the particles 
in the different systems studied in this chapter have particles in the micron range.   
 
It has been found in HFA-based systems that there was an increase in API 
cohesiveness due to the tendency of the fluorocarbon propellant to self associate 
(Tzou et al., 1997, James, 2009). Therefore, a greater particle contact could result 
in particle growth through fusion of particle surfaces. This phenomenon could 
contribute to the enhanced particle growth of coarse material by the fact that 
larger surfaces are generally considered to have stronger interparticle forces, and 
these materials may also have surface properties that would lead them to be more 
prone to growth (Berry et al., 2003). Also, the effects of micronization of the 
APIs cannot be neglected as these results in particles that have a slightly higher 
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surface energy as demonstrated in Chapter 5 and hence may lead to more 
interactions between particles resulting in the formation of larger particles. 
 
For suspension formulations, by altering the surface properties of a drug can 
promote drug aggregation and or particle growth and lead to an increase in the 
average particle size of the particles due to the addition of either co-solvents 
and/or surfactants (Berry et al., 2003). Ethanol is used as a co-solvent and is 
employed to dissolve the surfactant, which in this case results in an increased 
API solubility of more than 0.5% w/w as well as  helping to disperse the drug in 
many manufacturing processes currently used for suspension formulations (Tzou 
et al., 1997). This level of solubility in the present system may be sufficient to 
provide the driving force for rate-limiting step for particle growth. As particles in 
the suspension dissolve, this will lead to the formation of a very fine particle 
with a reduced thermodynamic stability that would lead to the attachment to 
larger particles to form more thermodynamically energetically favoured 
particles. 
 
The presence of surfactant (oleic acid) in the formulation, a long chain fatty acid, 
may aid in the stabilization of the drug surface. The adhesion of oleic acid to the 
drug surface could reduce the polarity of the drug, thus making it less likely to 
interact with the highly electronegative propellant medium. Factors that affect 
the surface energy of the particles (i.e., by steric or charge stabilization), 
including the addition of additives such as surfactants, have been shown to 
control their aggregation behaviour by inducing a decrease in their cohesiveness 
(Hickey et al., 1988, Eriksson et al., 1995, Blackett and Buckton, 1995, Bower et 
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al., 1996, Ranucci et al., 1990, Parsons et al., 1992, Tzou et al., 1997). Generally, 
these additives lead to reduced particle interaction and hence less particle-
particle interaction leading to a lower rate of particle growth and result in a 
smaller average particle size within the formulation (Ranucci et al., 1990, Bower 
et al., 1996, Berry et al., 2004a). 
 
6.5 Conclusions 
 
This study showed that the particle size of the APIs in the pMDI suspension 
followed size dependent particle growth via Ostwald ripening and the LSW 
theory. This process involved the association of small thermodynamically 
unstable API particles with larger more energetically favoured particles. This 
association was shown by a linear increase in particle growth with the time. The 
level of solubility in the different systems was sufficient to provide the driving 
force for rate-limiting particle growth and thus the dominant step in the particle 
growth. However, as the storage time increases the rate of the coarsening 
decreases to reach an equilibrium and stability due to a decrease in the 
dissolution as small API particles disappear through their attachment to larger 
particles. 
 
The use of APIs in mHFA propellant alone showed particle growth following 
LSW theory. This behaviour was due to an increased cohesiveness of the API 
particles when in contact with the propellant leading to instability of the 
formulation. However, the use of ethanol as a co-solvent and oleic acid as a 
surfactant within the pMDI formulation created more stable formulations. Even 
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though, ethanol showed an increase in the solubility of the different APIs in the 
pMDI formulation. However, the effect on the particle size showed a reduction 
in the mean particle size of the APIs when compared to the use of the APIs with 
propellant on its own. The use of a combination of both ethanol and oleic acid in 
the pMDI formulation produced an increase in the stability of the colloidal 
suspension and a decrease in the average particle growth as well as the rate of 
Ostwald ripening.  
 
Since it is critical that the drug particle size of MDIs be tightly controlled, it is 
important that all factors that affect it be well understood and carefully evaluated 
as this can have an impact on aerodynamic particle size of the emitted aerosol is 
presented and hence on final product quality and effectiveness.  
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7 Chapter 7  Final Conclusions
 
 
7.1 General Introduction 
 
At the start of this PhD project, a large number of studies had been undertaken in 
order to study the performance of different inhaled therapy systems. Most of 
these studies investigated the stability and particle interaction relevant to DPI 
formulation, while fewer studies were used to determine stability in pMDI 
formulations. With the release of the new HFA propellants as a replacement of 
the non-environmentally friendly CFCs, different HFA formulations have faced 
problems with the stability of different APIs and their interactions within a 
pMDI system. HFA and CFC propellants possess different physical and chemical 
properties and are generally poor solvents for many anti-asthma drugs and 
excipients currently used in pMDIs (McDonald and Martin, 2000).  Thus the 
substitution to HFAs propellant changed the properties of some of the drugs 
delivered by CFC propellant systems and required reformulation of the drugs 
(Terzano, 2001). Furthermore, the APIs used in previous studies have been 
limited; typically salbutamol sulphate, formoterol fumarate. Few studies have 
considered the stability of corticosteroids (such as beclomethasone dipropionate 
and budesonide) that have potential use in pMDI systems. +HQFHWRWKHDXWKRU¶V
knowledge, while the crystal structure of the BDP co-solvent/propellant clathrate 
has been investigated, there is little information on the physico-chemical 
characteristics of the BDP co-solvent/propellant clathrates, their stability and 
their potential interactions within a pMDI system. Subsequently, the work in this 
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thesis sought to gain a better understanding of the effects of various formulation 
constituents on the solid-state of different APIs and their potential interactions 
within a pMDI system. 
 
Different analytical techniques have been used on several studies to determine 
the solid state behaviour of APIs in pMDIs (Phillips and Byron, 1994). Thermal 
analysis techniques (including DSC and TGA) and X-ray diffractions have been 
used in order to determine any changes on the nature of the drugs in terms of 
polymorphism and/or introduction of amorphous material following 
manufacturing processes. AFM was also used in investigating the interaction 
between individual particles from inhaled therapy systems in order to determine 
the effect on the product performance (Ashayer et al., 2004, Traini et al., 2006, 
James et al., 2008). Furthermore, AFM was used as a tool to determine the effect 
of different media on the crystal behaviour of the drugs. Other techniques, such 
as light scattering techniques have been utilised for investigating particle growth 
and have been demonstrated on several relevant systems. However, most of these 
studies were determined in model propellants without the use of any additives 
such as co-solvents and/or surfactants. The effects of these different formulation 
excipients are crucial to the formulation stability and therefore the end 
performance of a pMDI system. The different techniques described allow for an 
early-stage detection of the suitability of use of different materials in 
combination with co-solvents and surfactants to obtain an optimal stability and 
performance. 
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Moreover, this study has purposely undertaken a single particle approach via 
AFM to understand the API interactions within a pMDI system. AFM provided 
single-particle force measurements which generated information that was then 
used to determine the corresponding surface energy of the different APIs. These 
results allowed the determination of the force of adhesion in situ following size 
reduction, between the API and a corresponding surface in relation to the 
surrounding medium relevant to the formulation of an API for inhalation 
therapy.  
 
Generally speaking, most of the analytical techniques used in the different 
studies within this thesis require micrograms of material for analysis to 
characterise the different API and their combined use provide useful information 
about the solid-state of the API as well as the interactive nature of each material 
in a pMDI system.  Therefore these approaches could allow for early-phase 
development of pMDI systems with new chemical entities since any API of 
interest in research and development would warrant the use of only small 
amounts of material. These techniques would also provide information about the 
nature of the new chemical entities and their potential interactions within a 
device. 
 
Here, the relevant conclusions concerning the project will be outlined as well as 
overall comments based on the conclusions in relation to formulating an 
effective pMDI system with the environmentally friendly HFA propellants. 
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7.2 Physico-chemical Characteristics of Beclomethasone HFA 
Propellant Clathrates 
 
In Chapter 3, BDP CFC-11 clathrate was produced as a model clathrate due to its 
stability by suspending BDP in CFC-11. This formation is due to BDP 
crystallizing with a channel structure forming a clathrate that allows the insertion 
of CFC-11 within its structure (Harris et al., 2003). The results obtained using 
different techniques showed an efficient growth of the clathrate with the different 
concentrations used for the study as well as successful inclusion of CFC-11 
molecules into the BDP channels. The highest molar ratio of CFC-11 to BDP 
obtained with a 1.67% w/w BDP in CFC-11 was a 0.6:1 molar ratio. It has been 
shown that the presence of a stoichiometric relationship can be observed with 
increasing ratios of CFC-11 to BDP. The release of the propellant from the 
structure was induced by heating. This was proposed to be due to a structural 
rearrangement of the clathrate. It is understood that this structural rearrangement 
induces changes in the hydrogen bonding holding the clathrate from collapsing 
or decomposing that leads to the release of the propellant from the tunnels 
constituting the structure of the clathrate. 
 
Chapter 4, an experimental approach based on DSC/TGA and XRPD showed 
evidence of the clathrate formation with HFA-134a and HFA-134/ethanol 
mixture. The crystals exhibited a transition when being heated to their melting 
point, which is considered to be due to the release of the HFA-134a and HFA-
134a/ethanol from the channels constituting the crystal structure of the clathrate. 
The release of HFA-134 and ethanol is due to a structural rearrangement of the 
crystal structure releasing the propellant and the propellant/co-solvent leading to 
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the formation of anhydrous BDP. The use of ethanol/HFA-134a provides a more 
rigid structure of the channels and prevents the collapse and the release of both 
ethanol and the propellants from some channels at room temperature.  
 
Anhydrous BDP and BDP HFA-134a/ethanol clathrate mixture showed a high 
stability from room temperature to approximately 71 ºC. A further increase in 
temperature leads to a transformation of BDP clathrate to the anhydrous form of 
BDP which was more stable at higher temperatures. This means that the 
formation of BDP HFA-134a/ethanol is quite stable at room temperature and that 
some clathrate channels retain both the solvent and the propellant to quite high 
temperatures. After 90 ºC, a similar behaviour to the one observed in anhydrous 
BDP followed, due to the increased vibration of the side chain of BDP 
molecules. 
 
In contrast, no clathrate formation was seen for BDP HFA-227ae which is due to 
the increased solubility of BDP in this propellant and the formation of a solution 
formulation rather than a suspension. The formation of the monohydrate was 
observed when BDP was suspended in HFA-227ae/ethanol mixture confirming 
the disability of forming a clathrate from these latter. 
 
The analysis of the different BDP HFA-227ae suspensions showed no formation 
of clathrates when anhydrous BDP was suspended in HFA-227ae and in HFA-
227ae/ethanol mixture. The analysis showed the crystals of pure anhydrous BDP 
which is due to the increased solubility of BDP in HFA-227ae which does not 
allow further crystallisation at high pressure. The analysis showed that 
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anhydrous BDP was stable and its structure did not change as a function of 
temperature and hence no polymorphic transformation occurred. However, an 
increased vibration of different parts of the anhydrous BDP molecules especially 
the side chain showed some peak splitting starting at 84 ºC.  These vibrations are 
due to very small effect induced by thermal expansion of the BDP molecule. 
 
7.3 Effect of Size Reduction on API Surface Energy and 
Interactions in pMDI Systems 
 
In chapter 5, the effect of formulation processing (particle size reduction) on 
surface energy and its subsequent effect on the adhesion of the particles on the 
different parts of a pMDI system was determined. It was possible to calculate the 
surface energy of the different material using single particle adhesion data 
determined using AFM. The surface free energies for anhydrous BDP 
(micronized), BDP CFC-11 clathrate (ball-milled for 2.5 hours) and the BDP 
CFC-11 clathrate (crystalline) were 47.5 ± 4.9 mJm-2, 15.24 ± 1.26 mJm-2 and 
11.27 ± 4.05 mJm-2 respectively. Force of adhesion results measured in a model 
propellant showed that BDP CFC-11 clathrates had a lower Fadh compared to 
anhydrous BDP with the different pMDI components studied and that size 
reduction of the BDP CFC-11 clathrate did not have any significant effect in 
terms of surface energy and Fadh.  
 
The results generally suggest that the in situ formation of a clathrate in a 
propellant formulation is beneficial in terms of a reduction the force of adhesion 
with different pMDI components. This could have implications for future HFA 
formulation development with APIs that are prone to the formation of propellant 
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clathrates because BDP forms a clathrate with HFA 134a much more slowly 
(over a time scale of months) (Vervaet and Byron, 1999).  
 
7.4 Effect of Ethanol and Oleic Acid on Beclomethasone 
Dipropionate, its Clathrate and Budesonide Coarsening 
Behaviour in pMDI Systems 
 
In Chapter 6, the different studies undertaken showed that the particle size of the 
APIs in the pMDI suspension followed size dependent particle growth via 
Ostwald ripening and the LSW theory. This process involves the association of 
small thermodynamically unstable API particles with larger more energetically 
favoured particles. The level of solubility in the different systems was sufficient 
to provide the driving force for rate-limiting particle growth and thus the 
dominant step in the particle growth. However, as the storage time increased the 
rate of the coarsening decreased to reach an equilibrium and stability due to a 
decrease in the dissolution as small API particles disappear through their 
attachment to larger particles. 
 
The use of APIs in mHFA propellant alone showed particle growth following 
LSW theory. This behaviour was due to an increased cohesiveness of the API 
particles when in contact with the propellant leading to instability of the 
formulation. Even though, ethanol showed an increase in the solubility of the 
different APIs in the pMDI formulation, the effect on the particle size showed a 
reduction in the mean particle size of the APIs when compared to the use of the 
APIs with propellant on its own. The use of a combination of both ethanol and 
oleic acid in the pMDI formulation produced an increase in the stability of the 
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colloidal suspension and a decrease in the average particle growth as well as the 
rate of Ostwald ripening.  
 
Since it is critical that the drug particle size of MDIs be tightly controlled, it is 
important that all factors that affect it be well understood and carefully evaluated 
as this can have an impact on aerodynamic particle size of the emitted aerosol is 
presented and hence on final product quality and effectiveness. 
 
7.5 Final Comments and Future Work Suggestions 
 
The work undertaken in this thesis provides some insight into aspects of 
inhalation development techniques that have been utilized elsewhere. These 
approaches to obtaining an advanced understanding of the solid-state and the 
physiochemical characterization of drugs in HFA propellants as well as the 
potential interactions that may occur within a pMDI system.  
 
The different findings obtained in Chapters 3 and 4 concerning the potential 
formation of clathrate crystallized from BDP with the different HFAs propellants 
have shown that these depend on the solubility of the API in the propellants and 
hence can be the driving force in formation of the clathrate. BDP crystallizes 
with a channel structure forming a clathrate with the propellant that allows the 
insertion of CFC-11/HFA-134a molecules. The structure is stabilized through 
hydrogen bonding. When BDP is suspended in a pMDI formulation containing 
CFC-11, rapid crystal growth occurs. This has been attributed to the association 
of BDP and CFC-11 to the formation of a clathrate. However, few weeks are 
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needed to the formation of the clathrate crystals in HFA-134a and no formation 
was observed in HFA-227ae after months of storage. The use of co-solvent in 
combination with HFA-134a showed a formation of a mixture of clathrate and 
monohydrate as well as remains of anhydrous BDP.  
 
The force of adhesion and surface energy of the different API entities used in this 
thesis showed considerable changes following micronization, as seen in Chapter 
5 and depending on the form of API (i.e. either solvate or clathrate). These 
results showed an increase in the surface energy and adhesion of the APIs to the 
different pMDI components following size reduction due to the release of the co-
solvents and the propellants from within the crystals structures. Therefore it 
would be advisable to undertake a study similar to this one, with an emphasis on 
monitoring the changes in API interactions, as a function of material form and 
process-induced changes (i.e. polymorphism and amorphous material). 
Furthermore, it would be of great interest to screen for a variety of selected drugs 
that might be prone to clathrate formation in HFA-134a and 227 and if any 
mixture of solvates and clathrates can be obtained when used in pMDI 
formulations. 
 
The investigations detailed in Chapters 6 clearly demonstrate that the addition of 
surfactant led to an increased stability of the pMDI formulation by decreasing 
the Ostwald ripening rate. The use of surfactants appears to diminish the large 
levels of adhesion and cohesion in these systems. Therefore the need of HFA-
phillic surfactant should be taken into account when developing new HFA 
formulation and the effect of different surfactants with the potential use of co-
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solvent must be taken into consideration. The use of different surfactants such as 
oligolactic acid which appeared to decrease these interactions more than oleic 
acid (James, 2009) could be performed in order to determine the potential 
benefits of these latter to the formulation. The addition of ethanol led to the 
formation of smaller particles over time compared to when the propellant were 
used on its own. However, it has been shown that ethanol increases the steric 
barrier between API particles which will results in compromising the colloidal 
stability of the formulation which ultimately may result in increased Ostwald 
ripening (James, 2009). Therefore, similar studies to the ones used in Chapter 6 
could be performed using varying concentrations of ethanol. 
 
AFM was used in order to determine its applicability in studying Ostwald 
ripening and surface activity of the different APIs in different media. The results 
obtained generally displayed large complexity and unexpected results due to 
different phenomena taking place simultaneously and the high and fairly rapid 
changes occurring to the surface after exposure to the media. Other techniques 
show a potential beneficial use in order to determine the effect of different HFA 
propellant effect on pMDI formulation including the use of laser diffraction 
techniques using a high pressure cell in order to determine the in situ effect of 
HFA formulation on particle size changes and Ostwald ripening. 
 
There is little information on the quantification of surface roughness of particles 
as this is difficult to achieve especially in liquid media and when the size of the 
particles are in the micrometer dimensions (Heng et al., 2000). AFM can be used 
for evaluating the physical surface features of particles due to the direct 
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quantification of the surface textures of the particles and provides quantitative 
roughness values. However, this technique showed some limitations especially if 
the material shows considerable surface topographies and a high level of changes 
in liquid. Furthermore, some problems of this technique are due to the restricted 
movement of the cantilever on very rough sections of the samples.  Laser 
SURILORPHWU\ LV D WHFKQLTXH XVHG WR GHWHUPLQH VXUIDFH¶V SURILOH LQ RUGHU WR
quantify its roughness. This technique offers a rapid and reliable way of 
performing surface roughness measurements (Adi et al., 2008). It involves 
scanning the object through the Z axis in non contact mode, using white light and 
measuring the interference fringes (degree of coherence) at each pixel in the 
image (Kuwamura and Yamaguchi, 1997). The advantage of optical profilometry 
is rapid collection of 3D topographical data without the risk of changing the 
material. This technique has been used to assess APIs for use in dry powder 
inhalers as shown by studies by Podczek (Podczeck, 1998), Adi (Adi et al., 
2008) and (Narayan and Hancock, 2005) and shows potential in studying the 
surface roughness changes following the suspension of APIs in HFA propellants 
and the effect of different HFA media on the APIs surface characteristics. 
 
To conclude, the work in this thesis has detailed the use of surface analytical 
techniques to better understand the interactive properties of API and any 
transformation (i.e. polymorphism or process induced transformation) following 
their subsequent formulation in a pMDI system. These different studies provide 
different parameters that might influence the performance of a pMDI system and 
provide different information to the formulator to use for each API in order to 
develop an optimised pMDI system. 
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Figure 8-1: Wide survey scans of A- BDP HFA-227ae, B- BDP EtOH HFA-134a and C- BDP 
EtOH HFA-227ae crystals as obtained by XPS. 
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Appendix 2 
 
DSC Results 
 
 
 
Figure 8-2: DSC curve of anhydrous BDP particles after being suspended in mHFA. All samples 
were heated from 20Û&WR250Û& at 10Û&/min. 
